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ABSTRACT (Italian version) 
 
Il presente lavoro di tesi si propone di offrire nuove prospettive metodologiche 
nell’assessment dei disturbi dell’umore, con l’obiettivo principale di suggerire 
alternative efficaci alla valutazione dell’episodio depressivo maggiore, nell’ottica di 
sostenere la diagnosi differenziale di diverse forme di depressione. 
I disturbi dell'umore sono il più frequente disturbo mentale e la loro incidenza è 
aumentata negli ultimi decenni, diventando uno dei più significativi problemi socio-
sanitari. Perdita del lavoro, divorzio, difficoltà nel crescere i figli e abuso di sostanze 
sono solo alcuni dei gravi rischi associati ai disturbi dell’umore. Il suicidio è la più 
tragica delle conseguenze. Il decorso di questi disturbi così come la loro prognosi sono 
strettamente legati alla corretta diagnosi e al tempestivo trattamento. Purtroppo, 
attualmente è molto alto il rischio di diagnosi non corretta, con gravi ripercussioni sul 
trattamento e quindi sul decorso della malattia. In particolare l’episodio depressivo 
maggiore viene troppo spesso classificato in un solo modo e senza specificazioni, 
nonostante le possibili diverse configurazioni di sintomi che lo caratterizzano. Come 
tale esso viene trattato con farmaci antidepressivi, che in alcuni casi (ad esempio la 
depressione agitata) possono non solo aumentare i sintomi di agitazione, ma anche 
aumentare il rischio di suicidio.  
La fase di assessment riveste un ruolo cruciale in vista di un trattamento adeguato del 
disturbo. I medici dopo aver raccolto il maggior numero possibile di informazioni sul 
paziente, devono formulare ipotesi diagnostiche in breve tempo per pianificare 
interventi clinici efficaci. La qualità della valutazione clinica è fondamentale sia per la 
diagnosi che per il trattamento.  
Il Formal Psychological Assessment (FPA; Spoto, 2011; Spoto, Bottesi, Sanavio & 
Vidotto, 2013) si configura come una metodologia che unisce i vantaggi delle interviste 
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semi-strutturate e dei self-report, cercando di superare i loro limiti. Infatti l’approccio 
metodologico dell’FPA permette la costruzione di strumenti: 
• In grado di restituire delle informazioni qualitative, relative ai sintomi del 
paziente, che vanno oltre lo score numerico. 
• In grado di differenziare pazienti che ottengono lo stesso punteggio al test, ma 
che hanno risposto a item diversi, e che hanno quindi configurazioni diverse di 
sintomi. 
• Adattivi (come le interviste semi-strutturate) che permettono di indagare le aree 
sintomatologiche del paziente e di approfondirle.  
• Di rapida somministrazione come i questionari self-report. 
Nel progetto svolto in questi tre anni all’Università di Padova, sono stati utilizzati i 
concetti dell’FPA in diverse fasi. In una prima fase è stata svolta un’analisi 
metodologica dei questionari self-report più utilizzati nel campo della depressione per 
esplorare la loro capacità di indagare tutti i sintomi dell’episodio depressivo maggiore. 
La ricerca si è basata sulle relazioni tra gli “item” e i “criteri diagnostici” per la 
depressione, in linea con la metodologia dell’FPA. Nella seconda fase, è stato costruito 
un nuovo questionario di 41 item sulla base di 23 criteri clinici per l’episodio depressivo 
maggiore, ricavati dal DSM-5, e dalla diffusa letteratura sulla depressione. Nella terza 
fase il questionario è stato validato su una popolazione non clinica di 265 individui e su 
una popolazione clinica di 38 pazienti con episodio depressivo maggiore diagnosticati 
con depressione maggiore o disturbo bipolare. Il questionario ha mostrato buoni risultati 
sia per i diversi criteri di validità che per l’affidabilità. Tuttavia, la peculiarità di questo 
strumento sta nella sua capacità di andare oltre lo score numerico, permettendo di 
differenziare individui con lo stesso punteggio al test ma che presentano diverse 
sintomatologie. Questa proprietà è garantita dallo stato clinico del paziente (concetto 
fondamentale dell’FPA), come principale output del test, ossia dall’insieme di item a 
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cui l’individuo ha risposto affermativamente con il sotto-insieme di sintomi indagati da 
quegli item. In questo modo la valutazione clinica non sarà solo legata al livello di 
depressione ottenuto dallo score, ma dalla configurazione specifica di sintomi 
manifestati da una precisa persona. Nella quarta fase della ricerca, è stato implementato 
l’algoritmo computerizzato per il nuovo questionario, in modo da ottenere la forma 
adattiva dello strumento. Per raggiungere quest’ultimo step, il questionario è stato 
suddiviso nelle sue tre sotto-scale (affettiva, somatica e cognitiva) corrispondenti ai tre 
sotto-fattori della struttura fattoriale. Per ogni sotto-scala, attraverso il Basic Local 
Independent Model (BLIM), modello probabilistico dell’FPA, sono stati stimati i 
parametri relativi alle probabilità di falso positivo, falso negativo per ogni item e di tutti 
gli stati clinici della struttura. É stata utilizzata una procedura interattiva per massima 
verosimiglianza, che ha fornito una stima dei parametri e degli indici di fit. Una volta 
testato sui dati reali, la forma adattiva dello strumento permette una somministrazione 
più rapida ed efficiente. Infatti, gli item a cui l’individuo dovrà rispondere dipenderanno 
dalle risposte precedentemente date, in un processo che imita l’intervista semi-
strutturata, evitando possibili inferenze logiche del clinico. Il nuovo strumento per 
l’assessment della depressione chiamato QuEDS (Quantitative and Qualitative 
Evaluation of Depressive Symptomatology) rappresenta quindi un supporto per lo 
psichiatra o lo psicoterapeuta, in quanto offre la possibilità di distinguere i sintomi 
depressivi di ogni individuo al di là dello score ottenuto al test, e permette di 
somministrare solo gli item legati alla sua sintomatologia seguendo il flusso logico di 
domanda-risposta. Dunque due pazienti che ottengono lo stesso punteggio al test, indice 
dello stesso potenziale livello di depressione, potranno essere trattati comunque in 
accordo con i loro sintomi; infatti aver risposto allo stesso numero di item non significa 
aver risposto agli stessi item. In particolare è noto che l’uso di farmaci antidepressivi 
non è sempre consigliato nella depressione. Esistono infatti le depressioni “miste”, così 
 12
definite da moltissimi autori, perché caratterizzate sia da sintomi depressivi che da 
sintomi maniacali (come agitazione, angoscia, irritabilità, insonnia, labilità emotiva). 
Due esempi di depressione mista sono la depressione agitata e la depressione con fuga 
delle idee, in cui i farmaci antidepressivi non solo aumentano la componente eccitatoria 
(quindi i sintomi maniacali) peggiorando il decorso della malattia ma, problema ancora 
più grave aumentano il rischio di suicidio. Per questo motivo capire tutta la 
sintomatologia depressiva risulta fondamentale nella pratica clinica. L’ultima parte del 
progetto di questi tre anni, è stata svolta in Inghilterra, in collaborazione con le 
Università di Cardiff e Worcester, in particolare con Il Bipolar Disorder Research 
Network (BDRN). I dati del BDRN utilizzati in questa ricerca comprendono 3750 
pazienti con disturbi dell’umore divisi nei tre sotto-gruppi: Disturbo Depressivo 
Maggiore (MDD), Disturbo Bipolare di tipo I (BD-I) e Disturbo Bipolare di tipo II (BD-
II); nel 29,3% dell’intero campione era presente un episodio di depressione agitata, in 
particolare la depressione agitata era più presente nel disturbo bipolare, soprattutto BD-
II. Inoltre i pazienti con depressione agitata avevano più comorbidità con disturbo di 
panico e con abuso di sostanze, facevano maggior uso di psicofarmaci, e soffrivano di 
maggiori episodi misti durante l’arco di vita. La depressione agitata era correlata ai 
tentati suicidi durante l’arco di vita e all’ideazione suicidaria durante l’episodio 
affettivo. Questi risultati confermano e rafforzano le indicazioni di diversi altri studi 
svolti su campioni clinici meno ampi. Il riconoscimento e la diagnosi differenziale della 
depressione mista è essenziale per evitare una diagnosi scorretta e un successivo 
trattamento pericoloso. La costruzione di strumenti di supporto al medico, che siano in 
grado di restituire la configurazione di sintomi del paziente e di garantire maggiori 
informazioni cliniche può diventare un punto di forza nella pratica clinica. Lo strumento 
presentato in questo lavoro, rappresenta un passo avanti in questa direzione; tuttavia per 
permettere una diagnosi differenziale dell’episodio depressivo questo primo step ha 
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bisogno di essere accompagnato dall’esperienza e la consapevolezza del clinico nel 
campo dei disturbi dell’umore, e soprattutto dallo sviluppo di ulteriori approfondimenti 
nel contesto metodologico. Infatti come i dati dimostrano, riuscire a catturare i sintomi 
di una depressione mista risulta un’impresa ardua sia dal punto di vista clinico che dal 
punto di vista metodologico per quanto concerne la costruzione di strumenti adatti ed 
esaustivi. La questione fondamentale che resta aperta, riguarda la capacità di riuscire ad 
indagare quei sintomi di componente maniacale che vengono sottostimati dal paziente 
stesso (come il flusso rapido dei pensieri, la labilità emotiva ecc.) in fase depressiva. 
I primi tre capitoli di questo lavoro formano la cornice teorica, e il punto di partenza per 
la ricerca. Nel primo capitolo sono infatti descritti nel dettaglio i disturbi dell’umore: la 
prevalenza, la componente genetica, la classificazione dei vari disturbi (Depressione 
Maggiore, Distimia, Disturbo Bipolare I, Disturbo Bipolare II, Disturbo Ciclotimico, e 
disturbo a cicli rapidi); inoltre viene descritta la depressione, e in seguito la depressione 
mista con particolare attenzione alla diagnosi differenziale. Infine viene brevemente 
spiegato il trattamento farmacologico e le teorie eziopatogenetiche della depressione. 
Nel secondo capitolo viene descritto l’assessment, quindi gli strumenti maggiormente 
utilizzati con i loro punti di forza e di debolezza; vengono inoltre descritti la batteria 
CBA 2.0 (Cognitive Behavioural Assessment 2.0), e l’assessment adattivo. Il terzo 
capitolo è dedicato alla spiegazione dell’FPA a partire dalle teorie matematiche sulle 
quali si fonda fino alla realizzazione del metodo nel contesto clinico. I capitoli 4, 5, 6, 7 
descrivono le quattro ricerche principali di questo progetto di dottorato. Infine nel 
capitolo 8 sarà presentata la discussione finale dell’intero percorso. 
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ABSTRACT (English version) 
 
This dissertation work aims to provide new methodological perspectives in the 
assessment of mood disorders, with the main task of suggesting effective solutions for 
the evaluation of major depressive episode (MDE), in order to support the differential 
diagnosis of different forms of depression. 
Mood disorders are the most prevalent of all mental health diagnoses and their 
incidence has increased in recent decades, becoming one of the most significant public 
health problem. Many people fail to go to school or university, lose their jobs, lose their 
partner and friends, and may commit suicide. The course of these disorders as well as 
their prognosis are closely related to proper diagnosis and well-timed treatment. Despite 
this, the risk of misdiagnosis is currently high, with serious consequences both for the 
current episode and for the course of the illness. In particular, the MDE is often 
classified without specification, also if there are different possible configurations of 
symptoms that characterize it. Thus, MDE is almost always treated with antidepressant 
drugs that in some cases (e.g., agitated depression) may increase the symptoms of 
agitation and the risk of suicide. 
The assessment phase plays a crucial role for the proper treatment of the disorder. 
Physicians after collecting patient’s information, need to formulate diagnostic 
hypotheses in a short time to plan effective clinical interventions. The quality of clinical 
evaluation is crucial for both diagnosis and treatment. 
Formal Psychological Assessment (FPA; Spoto, 2011; Spoto, Bottesi, Sanavio & 
Vidotto) is a new methodology able to maximize the benefits of both semi-structured 
interviews and self-reports, trying to overcome their limitations. Indeed, the FPA 
methodological approach allows the construction of: 
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• Tools that are able to provide qualitative information about patient symptoms that goes 
beyond the numerical score. 
• Tools that are able to differentiate patients who obtain the same score, but replied to 
different items, and therefore have different symptoms configurations. 
• Adaptive tools (as semi-structured interviews) that allow investigating and deepening 
the patient’s symptoms. 
• Rapid administration as self-report questionnaires. 
In this three-year project at the University of Padua, the FPA concepts have been 
applied to achieve different aims. In a first phase, a methodological analysis of the most 
used self-report questionnaires of depression was carried out to explore their ability to 
investigate all the symptoms of the MDE. The research is based on the relationship 
between “items” and “diagnostic criteria” for depression, in line with the FPA 
methodology. In the second phase, a new self-report questionnaire of 41 items was built 
on the basis of 23 clinical criteria for MDE from DSM-5 and literature. In the third 
phase, the same questionnaire was validated on non-clinical sample of 265 individuals 
and clinical sample of 38 patients with MDE diagnosed with major depression or 
bipolar disorder. The questionnaire provided good results both in terms of validity and 
reliability. However, the strength of this tool stands in its ability to go beyond the 
numerical score, allowing to differentiate individuals with the same score but with 
different symptoms and possibly different severity of the episode. This property is 
assured by the patient’s clinical state (the fundamental concept of FPA) as the main 
output of the test, which is the set of items the individual replied affirmatively with the 
subset of symptoms investigated by those items. In this way, clinical evaluation will not 
only be related to the level of depression obtained from the score but also to the specific 
configuration of symptoms manifested by the individual. In the fourth phase of the 
research, the computerized algorithm was implemented in the new questionnaire to 
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obtain the adaptive form of the tool. The questionnaire was subdivided into its three 
sub-scales (affective, somatic and cognitive) corresponding to the three sub factors of 
the factorial structure. For each sub-scale, through the probability model of the FPA (i.e. 
the Basic Local Independent Model; BLIM) the false negative, false positives for each 
item and all the clinical states of the structure were estimated. An interactive procedure 
was used with maximum likelihood, which provided an estimate of parameters and fit 
indexes. After being tested on real data, the adaptive form of the tool allows faster and 
more efficient administration. Indeed, the items to which the individual will respond 
will depend on previous responses, in a process that mimics the semi-structured 
interview, avoiding possible logical inferences of the clinician. The new tool called 
quantitative and qualitative evaluation of Depressive Symptomatology (QuEDS) can be 
a support for clinicians; in fact, it differentiates the individual’s depressive symptoms 
beyond the score and allows administering only the items related to its symptomatology 
following the logical flow of question-answer. Thus, two patients who obtain the same 
score on the test can be treated differently according to their symptoms, since answering 
the same number of items does not mean responding to the same items. In particular, it 
is well known that the use of antidepressant drugs is not always recommended in 
depression. There are “mixed” depressions, as defined by many authors, because they 
are characterized by both depressive symptoms and manic symptoms (such as agitation, 
anguish, irritability, insomnia, mood lability). Two examples of mixed depression are 
agitated depression and depression with flight of ideas, in which antidepressant drugs 
not only increase the excitatory component (manic symptoms) worsening the course of 
the affective episode but, more seriously, increase the risk of suicide. For this reason, 
understanding all depressive symptoms is crucial in clinical practice. The last part of 
this project was carried out in England, in collaboration with the University of Cardiff 
and Worcester, in particular with the Bipolar Disorder Research Network (BDRN). The 
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BDRN data used in this research include 3750 mood disorders’ patients divided into 
three subgroups: Major Depressive Disorder (MDD), Bipolar Disorder Type I (BD-I) 
and Bipolar Disorder Type II (BD-II). The 29.3% of the whole sample had suffered 
from an episode of agitated depression (AD), particularly AD was more related to 
bipolar disorder, especially BD-II. Moreover, patients with agitated depression had 
higher comorbidities with panic disorder and substance abuse, made greater use of 
psychiatric drugs, and suffer of more mixed states in lifetime. Agitated depression was 
related to lifetime suicide attempts and suicidal ideation during the affective episode. 
These results confirm and strengthen the indications of several other studies on smaller 
clinical samples. The recognition and differential diagnosis of mixed depression is 
essential to avoid improper treatment with dangerous consequences.  
The construction of tools to support clinicians’ task providing the patient symptom 
configuration with more clinical information can become a strength in clinical practice. 
The tool presented in this work represents a step in this direction; however, to allow 
differential diagnosis of each MDE, this step needs to be combined to the experience 
and awareness of the clinician in the field of mood disorders, and especially to the 
development of further insights in the methodological context. Indeed, as the data 
demonstrate, the recognition of mixed depression is a difficult task both from a clinical 
and from a methodological point of view in relation to the construction of suitable and 
exhaustive instruments. The fundamental issue that remains unclear concerns the ability 
to investigate the symptoms of manic component that are underestimated by the patient 
itself (such as racing crowed thought, mood lability etc.) during depression phase. 
The first three Chapters form the theoretical framework, and the starting point for the 
researches. In the first Chapter, mood disorders are described: prevalence, genetic 
component, diagnostic classification (major depression, dysthymia, bipolar disorder I, 
bipolar disorder II, cyclotymic disorder, and rapid-cycle disorder); Also depression is 
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described, followed by mixed depression and the differential diagnosis. Finally, the 
pharmacological treatment and the etiopathogenetic theories of depression are briefly 
explained. The second Chapter describes the assessment, therefore the tools most used 
by the clinician with their strengths and weaknesses; The CBA 2.0 (Cognitive 
Behavioral Assessment) and Adaptive Assessment are also described. The third Chapter 
is devoted to the explanation of FPA starting from the mathematical theories to the 
implementation of the method in the clinical context. Chapters 4, 5, 6, 7 describe the 
four main researches carried out in this PhD project. To conclude, Chapter 8 will 
present the final discussion. 
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CHAPTER 1  
Mood Disorders 
 
1. Global estimates of mood disorders prevalence  
According to World Health Organization 2017 (World Health Organization, 2017; 
WHO), the proportion of the global population with depression in 2015 is estimated to 
be 4.4%. Prevalence varies by WHO Region, from a low of 2.6% among males in the 
Western Pacific Region to 5.9% among females in the African Region. A systematic 
analysis for the Global Burden of Disease Study (Forouzanfar et al., 2015) showed that 
the total estimated number of people living with depression increased by 18.4% 
between 2005 and 2015. This phenomenon could mirror the proportionate increase of 
depression along the time. The total number of people living with depression in the 
world is 322 million (Vos et al., 2016), and prevalence rates vary by age, peaking in 
older adulthood (above 7.5% among females aged 55-74 years, and above 5.5% among 
males). Depression also occurs in children and adolescents below the age of 15 years, 
but at a lower level than older age groups. However, this may be due to the fact that 
depression in children and adolescents manifests with different symptoms (Abela, 2008; 
Connolly et al., 2017). 
More in general mood disorder is among the most prevalent of all mental health 
diagnoses (Waraich, Goldner, Somers, & Hsu, 2004). It is the most significant public 
health problem (Bland, 1997) and according to different studies, the high prevalence is 
significantly associated with its disability, the long duration of illness, high probability 
of recurrence, the difficulties in diagnosis, the delay in finding the right treatment (Bijl, 
Ravelli, Van Zessen, 1998; Murray & Lopez, 1996) and, in most cases, with the 
inefficacy of  available pharmacological treatments (see Baldessarini et al.,  2013). 
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Waraich and colleagues in a review of 2004 reported a lifetime prevalence of mood 
disorders that ranged between 5.5% in Korea and 31.5% in Montreal, while a study of 
Weissman and colleagues (1996) showed a range of prevalence of 1.5% in Taiwan to 
19% in Beirut. The lifetime prevalence was systematically higher for women than for 
men (Waraich et al., 2004). In particular, in every country rate of major depression were 
higher among women, but in Bipolar Disorder the female to male ratio was 
approximately equal at all sites (Cross-National Collaborative Group, 1992; Weissman 
et al., 1996). For Major Depressive Disorder (MDD) the best estimate rate for lifetime 
prevalence was 6.7% (Waraich et al., 2004), while the estimate rate for Bipolar Disorder 
(BD) lifetime prevalence changes depending on the study from 1% to 5% (Bauer & 
Pfennig, 2005; Judd  & Akiskal, 2003; Waraich et al., 2004; Wittchen, 2000; 
Stefansson, Lindal, Bjornsson, & Guoomundsdottir, 2011). However, it is important to 
emphasize that the concept of bipolar spectrum includes a significant percentage of sub-
threshold cases that are either not diagnosed or diagnosed as major depressive disorder 
(Bauer & Pfennig, 2005; Frank & Thase, 1999; Merikangas et al., 2011). For this 
reason, BD with a range of bipolar conditions with less-obvious manifestations is still 
under-estimated. In other words, investigations of depression and mixed symptoms 
severity associated with sub-threshold bipolar conditions suggest that this category 
encompasses clinically significant symptoms that are comparable to people needing 
treatment for bipolar in outpatient settings, but the manic phases (Especially hypomania 
of BD-II) are often harder to recognize both by the clinician and by the individual 
(Goodwin & Jamison, 2007). Furthermore, mood disorders also include the Dysthymic 
Disorder characterized by chronic low-grade depressive symptoms (McCullough & 
Clark, 2017; MacQueen et al., 2017). The best estimate rate for lifetime prevalence of 
Dysthymia was 3.6% (Waraich et al., 2004). Despite the reliability of these results, 
having a real estimate of the prevalence of mood disorders is a challenge for several 
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reasons. First because the various conditions of mood disorders can be transient, or 
recurrent, and in these phases the disorder may not be recognized (Waraich et al., 2004). 
Second, because the uncertainties of the diagnostic constructs for mood disorders (i.e. 
the sub-threshold cases of Bipolar spectrum and the Dysthymic disorder). Third, 
because many people with Major Depressive Disorder develop Bipolar Disorder with 
antidepressants drugs or, they are reclassified in bipolar spectrum (Goodwin & Jamison, 
2007; Holma, Melartin, Holma, & Isometsä, 2008). Fourth, because the differences in 
the prevalence rates in different studies may be attributed to differences in the method 
of assessment and in the descriptions used to define depression or more in general mood 
disorders (Merikangas et al., 2011). Mood disorders are constructs (that cannot be 
directly measured or observed) developed through inference, hypothesis, deduction, and 
conjecture.  
Suicide is the most tragic consequence of mood disorders (Bauer & Pfennig, 2005; 
Hasin, Goodwin, Stinson, & Grant, 2005), and up to 20% of Bipolar patients die of 
suicide (Oquendo et al., 2000).  In particular, the odds ratio for suicidal behavior was 
6.2 in the people with Bipolar disorder versus control group, while the odds ratio for 
suicide attempt in people with MDD was 3.1 versus control group (Chen & Dilsaver, 
1996) according with US National Epidemiological Catchment Area (ECA). These 
results mean that about 1 in every 4 or 5 persons with bipolar disorder had made suicide 
attempts (Batterham et al., 2015; Merikangas et al., 2011). Some data suggest that 
several factors are associated with an increased risk of suicide: genetic and 
sociodemographic variables, loss of social and medical support, comorbidity with other 
disorders or substance abuse, recent environmental adversities (Leverich et al., 2003), 
and incorrect identification of the illness (e.g. misdiagnosis; Hjorthøj, Madsen, Agerbo, 
& Nordentoft, 2014).  
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Mood disorders are associated with high disability, which often compromise critical 
period of educational, occupational, and social life (Bijl & Ravelli, 2000; Hurley, 2006; 
Phillips et al, 2009). For all these reasons, an early and adequate treatment could be 
essential for effective prevention of both suicidal behavior and other complications 
(Goodwin & Jamison, 2007).  
To conclude the incidence of mood disorders has increased in the last decades, and 
especially in this latter period after the profound socio-economic crisis that has hit the 
whole world (Editorial Lancet, 2012; Lee, Guo, Tsang, Mak, Wu, & King , 2010; 
Kupfer, Frank, & Phillips, 2012). Many authors recently reported alarming data on the 
increase in the incidence of depression and suicides in advanced and developing 
countries in the world (Pitman, Krysinska, Osborn, & King, 2012; Brent, & Mann, 
2005; Rihmer, Kapitany, Gonda, & Dome, 2013; Reeves, Stuckler, McKee, Gunnell, 
Chang, & Basu, 2012). Some authors argue that because of the severe economic crisis, 
mood disorders are the most frequent illness in the world, though often unrecognized 
and sometimes inadequately treated (Editorial Lancet, 2012; Lee et al., 2010; Kupfer et 
al., 2012; Lozano, Naghavi, & Foreman, 2012). In the last period, suicide is associated 
with a mood disorder in 90% of cases and with a standard mortality ratio compared to 
the general population of 20:1 (Baldessarini, Pompili, & Tondo, 2006). Suicide is also 
the third cause of death in the population aged 15 to 35 (Gunnell & Middleton, 2003). 
 
2. Genetic Epidemiology in mood disorders 
  
In bipolar disorder the risk of became ill for a first-degree relative is around 10 times 
compared to the risk to became ill in a random person. The risk of became ill in 
identical twins is about 63 percent (Goodwin, & Jamison, 2007). For major depressive 
disorder, the risk for first-degree relative to became ill (with major depressive disorder) 
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is about three times higher than the overall population risk (Goodwin, & Jamison, 
2007). The risk in identical twins of person with major depressive disorder is about 34 
percent, and the calculated heritability is also about 34 percent. When there are 
recurrent forms of depression the percentage is higher. Thus considering the data there 
is a strong genetic component to susceptibility to bipolar disorder and a less strong, 
though still significant, genetic component to susceptibility to major depressive 
disorder, especially in the more recurrent forms. Moreover, suicidal behavior is highly 
familial, and on the basis of twins’ studies, is genetic as well. A family history of 
suicidal behavior is associated with suicidal behavior in the patients especially with 
mood disorders (Faraone, Tsuang, & Tsuang, 1995). In particular, traits of 
impulsiveness and aggression in patients and family members are associated with 
family suicidal behavior, and may contribute to familial transmission of suicidal 
behavior (Brent, & Mann, 2005). 
 
3. Diagnostic Classification 
The classification of mood disorders in DSM-5 (2013) has changed from DSM-IV. The 
main demarcation in mood disorders is between bipolar and depressive (unipolar) 
disorders (Regier, Kuhl, & Kupfer, 2013). Several changes may significantly influence 
how the diagnosis is used in both clinical and research settings. Thus, bipolar disorders 
range from the classic manic and depressive episodes of psychotic intensity (bipolar I 
disorder) through recurrent major depressive episodes, alternating with hypomanic 
episodes (bipolar II disorder), and cyclothymic mood swings. Likewise, depressive 
disorders include those with psychotic severity, melancholia, atypical features, and 
dysthymic variants recurring. In general, all mood disorders are characterized by 
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pervasive dysregulation of mood and psychomotor activity and by related biorhythmic 
and cognitive disturbances (Akiskal, & Pinto, 1999). 
3.1. Major Depressive Disorder 
MDD is now located in the “Depressive disorders” section, among the new “disruptive 
mood dysregulation disorder”, persistent depressive disorder, and premenstrual 
dysphoric disorder. In each chapter, “other specified” and “unspecified” disorder 
categories allow for diagnosis of individuals who fall short of diagnostic criteria for the 
core specific disorders (DSM-5, 2013). Most of the criteria for MDD are identical in 
DSM-IV and DSM-5. The disorder is defined by one or more major depressive episode 
(MDE) and the lifetime absence of mania and hypomania. To meet criteria for an MDE, 
it is required that five of nine symptoms are present during the same 2-week period. 
One of these symptoms must be depressed mood or anhedonia (loss of interest or 
pleasure). MDD is only diagnosed if an MDE is not better explained by other disorders 
(schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional 
disorder, or other psychotic disorder) and if there is no history of hypomania or mania 
(DSM-5, 2013).  
In DSM-5, the MDD diagnosis can be divided into 14 subcategories using severity 
specifiers. In addition, the MDD section of DSM-5 concludes with a list of specifiers 
that can be added to diagnoses in this section, including “with anxious distress”, “with 
mixed features”, “with melancholic features”, “with atypical features”, “with mood-
congruent psychotic features”, “with mood-incongruent psychotic features”, “with 
catatonia”, with “peripartum onset”, and “with seasonal pattern” (Uher, Payne, Pavlova, 
& Perlis, 2014).  
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3.2. Dysthymic Disorder 
 
Dysthymic disorder is distinguished from Major Depressive Disorder by the fact that it 
is not a sequel to well-defined major depressive episodes, and it is defined by chronic 
symptoms that are long standing (lasting two years or longer), but do not correspond to 
all MDD criteria (DSM-5, 2013; Devanand, 2014). Patients often complain that they 
have always been depressed. People with dysthymic disorder differ from people with 
MDD because in that depressive symptoms tend to outnumber objective signs of 
depression (Pakriev, Vasar, Aluoja, Saarma, Shlik, 1998). For this reason marked 
disturbances in appetite, sleep and libido are uncharacteristic, and psychomotor 
agitation or retardation is not observed. This all translates into a depression with 
attenuated symptomatology.  Most cases of Dysthymia are of early onset, beginning in 
childhood or adolescence and certainly by the time patients reach their 20 years 
(Akiskal, & Cassano, 1998;  Pakriev, 1998; Regier et al., 2013). 
 
3.3. Bipolar Disorder  
In DSM-5, bipolar disorders are no longer included in a single category with depressive 
disorders. This new edition of the manual acknowledges for the first time that patients 
without previous history of bipolar disorder under antidepressant treatment who develop 
a manic episode of sufficient intensity and duration can be considered as patients with 
bipolar disorder (DSM-5, 2013). Bipolar Disorders are characterized by severe 
alterations in mood, emotions, and behaviors, all of which have a variable time span. 
These mood swings are characterized by the alternation of Maniac/Hypomanic Episodes 
and Depressive Episodes, for this reason the pathology is defined as Bipolar. Both 
Mania and Depression have a significant impact on the life of the individual, and are 
deeply debilitating on the working, social, affective, and family levels. In the DSM-5 
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the mixed episodes of DSM-IV (the presence of a concurrent manic and major 
depressive episode) have been removed and replaced with a “mixed features” (De Dios, 
Goikolea, Colom, Moreno, & Vieta, 2014). The mixed features refer to when depressive 
or manic/ hypomanic symptoms are present at the same time of mood episodes 
(depressive or manic/hypomanic; DSM-5, 2013). Bipolar Disorder includes the sub-
categories of Bipolar Disorder I, Bipolar Disorder II, Rapid-Cycling Bipolar Disorder, 
and Cyclothymic Disorder.  
 Bipolar Disorder I: It is characterized by one or more manic episodes, usually 
accompanied by major depressive episodes (or manic/hypomanic episodes). 
Diagnosis of Bipolar Disorder I can exist with the exclusion of schizoaffective 
disorder, Schizophrenia disorder, delusional disorder, or Disorder of 
schizophrenia spectrum and other Psychotic disorders with other specification or 
without specification (DSM-5, 2013). Bipolar I Disorder typically start in the 
teenage years, the 20s, or the 30s; the first episode could be manic, depressive, 
or mixed (Judd et al., 2002). There are different way of onset: the mild retarded 
depression for a few weeks or months, which switches into a manic episode; else 
a severely psychotic manic episode with schizophreniform features; 
alternatively, a classic manic episode occurs and it is easier to diagnose. It is 
also frequent that several depressive episodes occur before the first manic 
episode (In this case, the diagnosis may be late). Although the overall sex ratio 
is about one to one, men have on average of more manic episodes and women 
experience more mixed and depressive episodes (Goodwin & Jamison, 2007). 
Bipolar I disorder in children is not as rare as previously thought. Childhood 
affective episode onset is based on irritability features, labile moods, and 
explosive anger and resulting familial affective loading (Judd et al., 2002). 
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 Bipolar Disorder II (and the Soft Bipolar Spectrum): Different studies 
conducted showed that between the extremes of classic manic-depressive illness 
defined by at least one acute manic episode (bipolar I disorder) and strictly 
defined major depressive disorder (MDD) without any personal or family 
history of mania, exists an overlapping group of intermediary forms 
characterized by recurrent major depressive episodes and hypomania (Goodwin 
& Jamison, 2007; Benazzi, 2007). Hypomania refers to a distinct period of at 
least a few days of mild elevation of mood, positive thinking, and increased 
energy and activity levels, typically without the impairment characteristic of 
manic episodes. Bipolar disorder II is characterized by at least one hypomanic 
episode and at least one Major Depressive Episode (with Maniac Episode 
Exclusion). In order to diagnose the disorder, it is also necessary to exclude: 
schizoaffective disorder, schizophrenia disorder, delusional disorder and other 
psychotic disorders with other specification or no specification (DSM-5, 2013). 
Because hypomania is experienced as a pleasant, ego-syntonic mood state, 
persons with bipolar II disorder rarely report it spontaneously (This can be a risk 
for proper diagnosis). Current data worldwide indicate that bipolar II disorder 
(with his sub-categories) is actually more prevalent than bipolar I disorder. This 
certainly appears true in the outpatient setting, where 30% to 50% of persons 
with MDD have been reported with bipolar II form (Angst, 1998). 
 Cyclothymic Disorder: it is characterized by frequent short cycles of sub-
syndromal depression and hypomania (DSM-5, 2013). People with cyclothymia 
experience at least 2 years (1 year in children and adolescents) several periods 
with hypomanic symptoms that do not meet the criteria for a hypomanic episode 
and numerous periods with depressive symptoms who do not meet the criteria 
for a major depressive episode (MDE). During this period of 2 years (1 year in 
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children and in adolescents), hypomanic and depressive periods were present for 
at least half the time and the individual was not without symptoms for more than 
2 months (Perugi, Toni, Travierso, & Akiskal, 2003; Perugi et al., 1998). The 
course of cyclothymia is continuous or intermittent, with infrequent periods of 
euthymia. Shifts in mood often lack adequate precipitants (e.g., sudden profound 
sadness with social withdrawal for a few days switching into happy, social 
behavior). Circadian factors may account for some of the extremes of mood 
lability, such as the person goes to sleep in good mood and wakes up early with 
death thoughts (Perugi et al., 1998). 
 Rapid-Cycling Bipolar Disorder: it is defined as the occurrence of at least four 
episodes both depression and hypomania/ mania in a year (DSM-5, 2013). Many 
such patients require frequent hospitalization because they develop explosive 
excitement and precipitous descent into severe depression. The disorder is a 
roller coaster nightmare for the patient, and for family and clinician. Treating 
these patients is hard and often ineffective. Factors associated with its 
occurrence include female gender, menopause, temporal lobe dysrhythmias, 
alcohol, other tranquilizer, stimulant, or caffeine abuse; and long-term, 
aggressive use of antidepressant medications (Koukopoulus Reginaldi, Tondo, 
Visioli, & Baldessarini, 2013). Most clinically identified patients are bipolar II 
women in middle age. Rapid cycling appear less common from bipolar I patients 
(Calabrese, Rapport, Findling, Shelton, & Kimmel, 2000). 
 
4. Depression: clinical features 
 
The major depressive episode (MDE) is common to both Unipolar Disorder (MDD and 
Dysthymia) and Bipolar Disorder (in all of their sub-categories). Several features 
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differentiate different types of MDEs often depending on the type of clinical manifested 
disorder. “Depressed mood” refers to negative affective arousal, variously described as 
depressed or anguished, irritable, or anxious. Mood in all of the depressive states is 
bleak, pessimistic, and despairing (Goodwin & Jamison, 2007). The high perception of 
pain in many persons with depression is accompanied by an inability to experience 
normal emotions (Gaillard, Gourion, Llorca, 2013). Patients with MDE may lose the 
capacity to cry or otherwise have crying spells. The patient often lose the sense of 
pleasure (anhedonia) he may give up previously enjoyed pastimes. When strong, 
anhedonia evidences with decreased interest in life and the individual lose all interest in 
things. In the extreme, patients lose their feelings for their children or spouses, who 
once were a source of joy (Treadway, & Zald, 2011). Thus, the hedonic deficit in 
clinical depression might represent a more pervasive inability to experience emotions. 
The inability of the person to experience normal emotions in depressed patients differs 
from the schizophrenic patients because the loss of emotions is itself experienced as 
agonizing; that is, the patient suffers immensely from the inability to experience 
emotions (Goodwin & Jamison, 2007). Work and social relationships are often severely 
compromised, and the patient is forced to stop the work and abandon all activities, 
including leisure activities (Goodwin & Jamison, 2007; Treadway, & Zald, 2011). The 
essential characteristic of depressive thinking is that the sufferer views everything in an 
extremely negative light. A deep sense of futility is often accompanied with feeling of 
guilt. The negative triad of depression includes negative evaluations of the self, the 
world, and the future (Beck, 1991; Goodwin & Jamison, 2007). Those distorted 
thinking patterns are clinically expressed as ideas of loss; low self-esteem and self-
confidence; self-reproach and pathological guilt; helplessness, hopelessness, and 
pessimism; and recurrent thoughts of death and suicide. Death ideas are very common: 
life is not worth living, the patient hopes to die or he plans suicide, makes suicide 
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attempts, and a high percentage of individuals kill themselves (Goodwin & Jamison, 
2007). As reported by Goodwin and Jamison “The strong tendency to suicide sometimes 
it accompanies the whole course of the disease, without coming to a serious attempt 
owing to the incapacity of the patients to decide…. Sometimes the impulse to suicide 
emerges very suddenly without the patients being able to explain the motives to 
themselves. Only too often the patients know how to conceal their suicidal intentions 
behind an apparently cheerful behavior, and then carefully prepare for the execution of 
their intention at a suitable moment” (Goodwin & Jamison, 2007 pp. 167).  Depression 
often occurs with somatic symptoms: stomach cramps, vomiting, digestive problems, 
diarrhea, palpitations, hyperventilation, paresthesia, sweating, hot flashes, tremors, 
headache, increased heart rate, back pain or muscle pain, decreased energy and fatigue. 
Changes in appetite and weight are also frequent (Harris, Young, & Hughes, 1984). 
Sexual dysfunction as well as alterations in circadian rhythms, especially worsening of 
morning mood are typical features of depression (Goodwin & Jamison, 2007). 
Depressed people are typically unresponsive to sexual activity or are disinclined to 
participate in it; this situation could lead to relationship issues. Insomnia is a cardinal 
sign of depression, often it is characterized by multiple awakenings, especially in the 
early hours of the morning, rather than by difficulty falling asleep (Tsuno, Besset, & 
Ritchie, 2005). The attempt to overcome the problem by drinking alcohol or taking 
sedative-hypnotic may initially work but later aggravates the sleep patterns and 
insomnia. Although sedatives (including alcohol) effectively reduce the number of 
awakenings in the short term, they are not effective in the long term because they 
further diminish stage 3 and stage 4 sleep. They tend to prolong the depression (Benca, 
& Peterson, 2008). Sleep is perceived by the patient, however, not restorative, because 
he awakens as if he had not slept for nothing and rested at all (Goodwin & Jamison, 
2007). Some patients on the contrary exhibit hypersomnia and have difficulty waking 
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up in the morning (Billiard, Dolenc, Aldaz, Ondze, & Besset, 1994). In depression, 
psychomotor disturbances refer of changes in the expression of mental and emotional 
activity. Psychomotor retardation can be the core of pathology in mood disorders in 
which the patient experiences inertia, being unable to act physically and mentally. 
Sometimes depression what patients describe as being “down” can be understood in 
terms of moderate or extreme psychomotor slowing (Bennabi, Vandel, Papaxanthis, 
Pozzo, & Haffen, 2013). This may occur with the simple motor slowdown, but it is 
more often associated with a slowing down of the conception, the speech, and the 
difficulty of concentration. The same patients who experience psychomotor retardation 
or other depressed individuals can manifest psychomotor agitation. Agitation clinical 
picture occurs more frequently with symptoms as restlessness, irritability, crying, 
anguish, incapacity to sit still, repetitive activity such as pacing up and down, wringing 
of hands, or even biting nails and/or lips (Benazzi, 2004a, 2004b; Goodwin & Jamison, 
2007; McGuffin, Farmer, & Harvey, 1991; Sobin, & Sackeim, 1997). Agitated 
depression especially in bipolar disorder can assume the features of “mixed state” 
(Goodwin & Jamison, 2007; Swann et al., 1993). 
 
4.1. Depression with mixed features 
Mixed states are mood episodes that have typical symptoms of both depression and 
mania. It has traditionally been considered a distinct episode from both the depressive 
and the manic episode (Goodwin & Jamison, 2007; DSM-IV, 2000). According to the 
last Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5, 
2013) MDE with mixed features requires the simultaneous presence of at least three of 
manic/hypomanic symptoms and a full Major Depressive Episode. Many authors had 
proved it is a very rare feature with the lack of satisfaction of these criteria (Faedda, 
 32
Marangoni, & Reginaldi, 2015; Koukopoulos, & Sani, 2014; Maj, Pirozzi, Magliano, & 
Bartoli, 2003). On the contrary, many studies have shown the presence of episodes of 
dysphoric mania and agitated depression that do not match the description of major 
depressive episode with mixed features of the DSM-5 (Dilsaver, Chen, Swann, Shoaib, 
Tsai-Dilsaver, & Krajewski, 1997; Swann et al, 1993). Particularly according to Sani 
and colleagues (2014) this change in DSM-5 is able to describe the manic episode with 
mixed features but is not sufficiently satisfying for the definition of mixed depression 
(e.g. agitated depression). According to several studies (Benazzi, 2004a; 2004b; Sobin, 
& Sackeim, 1997; Sani et al., 2014), symptoms of mixed depression that occur most 
frequently are agitation, irritability, anguish, insomnia, racing or crowded thoughts, 
mood lability or marked reactivity, talkativeness, dramatic description of suffering or 
frequent spells of weeping (in addition there are the other common symptoms of the 
major depressive episode). Mixed features in depression can also manifest with the 
flight of ideas: thinking processes and perception are accelerated, experienced as 
unusually sharp; the patient may speak with such pressure that associations are difficult 
to follow (Goodwin & Jamison, 2007). Kraepelin (1913; 1921) described patients with 
mixed features as suffers of extreme mental anguish, including the terrifying racing 
thoughts and feelings. Kraepelin (1913; 1921) classified agitated depression as a result 
from the combination of opposite polarity of symptoms: mood and thought in 
depressive polarity and activity in manic polarity. In the same way, Kraepelin classified 
depression with flight of ideas as a result of negative polarity of mood and activity and 
positive polarity of thought. In his view, it was enough to have one of the three 
components (psychomotor activity, mood and thinking) in manic polarity to have mixed 
state (Akiskal & Benazzi, 2004). 
A critical issue exists about Mixed Depression related to its specific characteristics, its 
prevalence, and its ratio in the different disorders (major depressive disorder, bipolar 
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disorder I and II). In recent years, this form of depression has drawn the attention of a 
great number studies (Akiskal, & Benazzi, 2004; Benazzi, Koukopoulos, & Akiskal, 
2004; Koukopoulos, Sani, Koukopoulos, Manfredi, Pacchiarotti, Girardi, 2007; Swann 
et al., 1993), which suggest that it is not at all a rare observation and underscore the 
necessity of a corrected diagnosis in order to avoid erroneous treatment. Concerning the 
possible variables associated with AD, some studies correlated the AD with lower age 
at onset of the mood disorder, more Bipolar disorder, female gender, longer duration of 
illness, more MDE recurrences, more MDE symptoms (suggesting more severity), more 
patients with atypical features specifiers (i.e. mood reactivity), and more family history 
of bipolar disorders. Compared to patients with non-agitated depression, they had a 
longer time to 50% probability of recovery from the index episode, were more likely to 
receive standard antipsychotic drugs during that episode, and spent more time in an 
affective episode during the observation period. Moreover, psychomotor agitation and 
suicidal ideation were found to be correlated in many studies (Andreasen and Grove, 
1982; Kendler, Eaves, Walters, Neale, Heath, & Kessler 1996; Korszun et al., 2004; 
Maj et al., 2003; Raskin, Schulterbrandt, Reatig, & Mckeon, 1969; Sullivan, Kessler, & 
Kendler, 2002). Thoughts of death are often linked with mixed depression; the patients 
wish to die or plan, attempt and, relatively frequently, die by suicide (Goodwin & 
Jamison, 2007; Olin, Jayewardene, Bunker, & Moreno 2012; Bocquier, Pambrun, 
Dumesnil, Villani, Verdoux, & Verger, 2013). All these information could play an 
important role in the assessment and treatment of mixed depression. 
 
5. The importance of Differential Diagnosis 
 
Clinical observations and epidemiological studies prove a vast overlap between Bipolar 
and Major Depressive Disorder. These observations are in line with Kraepelin’s view of 
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mood disorders and his attempt to bring all affective diseases under one rubric 
(Goodwin & Jamison, 2007). Thus the diagnosis between the various affective subtypes 
are not fast neither easy. For instance, bipolar disorder can be overlapping on 
cyclothymic disorder that could persist after the end of manic or depressive episodes. 
Likewise, evidence indicates that dysthymic disorder may precede major depressive 
disorder in a third of cases and, crossing from dysthymic disorder to hypomanic/manic 
episodes has also been described, suggesting that some forms of dysthymia are 
precursors of bipolar disorder. Moreover, one in four persons with major depressive 
disorder subsequently develops hypomanic/manic episodes and so should be reclassified 
as having bipolar disorder. There are many causes for the misdiagnosis of bipolar 
depression as unipolar depression: for instance patients’ lack of insight with regard to 
manic (especially hypomanic) symptoms (Goodwin & Jamison, 2007); in this regard is 
well known that depression not only impairs memory but also makes it more likely that 
memories will focus on past depressions. Thus, even if patients had previously some 
insight about manic symptoms, they often have difficulty recalling those symptoms 
clearly and accurately. Furthermore, during depression, mania or hypomania may be 
remembered simply as a good period and therefore patients do not report it 
spontaneously in the interview with the clinician (Benazzi Helmi, & Bland, 2002; 
Goodwin & Jamison, 2007). Moreover clinicians often don’t investigate about patient’s 
history from family or other significant and clinicians often focus on euphoric 
symptoms to diagnose mania, and they don’t account on dysphoria or irritability which 
are also symptoms of manic episode (Benazzi, & Akiskal, 2005; Perugi, Akiskal, 
Micheli, Toni, Madaro, 2001; Sato, Bottlender, Schroter, Moller, 2003). Rihmer and 
Kiss (2002) reported that patients with bipolar-II disorder are often misdiagnosed and 
then included as unipolar patients. Thus, the tendency to misdiagnose bipolar-II disorder 
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as unipolar depression may contribute to the apparently higher suicide rates in unipolar 
illness.  
Many authors compared the symptoms of unipolar depression with those of bipolar 
depression, the result may be very helpful for psychotherapeutic and pharmacological 
treatment. The findings showed more symptoms of anxiety, somatic complaints (Beigel, 
& Murphy, 1971; Greenhouse, & Geisser, 1959) and psychomotor retardation 
(Goodwin & Jamison, 2007) in Major depressive Episode (MDE) of Unipolar Patients; 
while there are more symptoms of tension (Goodwin & Jamison, 2007; Vöhringer, & 
Perlis, 2016), mood lability (Brockington, Helzer, Hillier, & Francis, 1982; Hantouche, 
& Akiskal, 2005;), irritability (Benazzi, & Akiskal, 2005; Fava, & Rosenbaum, 1999), 
late insomnia (Goodwin & Jamison, 2007; Oral, & Vahip, 2004), psychotic features 
(Coryell, & Tsuang, 1985; Mitchell, 2001; Parker et al., 2000) and  comorbid substance 
abuse (Judd et al., 2003; Marneros, 2004) in MDE of bipolar patients. Furthermore 
many authors assessed different depressive episodes between bipolar I and bipolar II 
patients. Bipolar II patients have more number of episodes, more rapid cycling and they 
spend more time in depression (Benazzi, & Akiskal, 2005; Goodwin & Jamison, 2007; 
Vieta, Gasto, Otero, Nieto, & Vallejo, 1997); conversely Bipolar I patients have more 
hospitalizations, irritability, and psychotic features (Goodwin & Jamison, 2007; Serretti 
& Olgiati, 2005; Vieta et al., 1997). Regarding the prevalence of suicide attempts, 
different findings have been reported. Some studies show greater suicidal behavior in 
bipolar II (Goldring, & Fieve, 1984; Rihmer, & Pestality, 1999), other studies suggest 
suicide attempts are the same in the two disorders (Coryell, Keller, Endicott, Andreasen, 
Clayton, & Hirschfeld, 1989; Vieta et al., 1997). 
Considering the assessment phase, mixed depression have a significant clinical 
relevance in mood disorders and may occur in both bipolar and unipolar disorder 
(Akiskal, Benazzi, Perugi, & Rihmer, 2005; Benazzi, Helmi & Bland, 2002). 
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Nevertheless, there are limits of information of mixed depression and therefore it is 
already an underestimation of the consequences, which could result in misdiagnosis and 
inappropriate/wrong treatment, often with very dangerous outcomes both for the course 
of the illness and for the suffering of patients (Akiskal et al., 2005; Bocquier et al., 
2013). In particular, treatment with antidepressant drugs in agitated depression (AD) 
could worsen the excitatory symptoms resulting in the failure to relieve the patient’s 
pain (Akiskal et al., 2005; Koukopoulos, & Koukopoulos, 1999; Vázquez, Tondo, 
Undurraga, & Baldessarini, 2013). Indeed, it has been reported that antidepressants 
monotherapy in AD might increase psychomotor agitation. Moreover, concerns have 
been reported about the possibility that the antidepressant administration in the agitated 
depression could increase the risk of suicide (Akiskal et al., 2005; Baldessarini et al., 
2006a; Koukopoulos, & Koukopoulos, 1999; Vázquez, Tondo, Undurraga, & 
Baldessarini, 2013).  
These observations suggest that much of the unipolar spectrum might be “soft bipolar”. 
The clinical significance of these considerations are of clinical relevance especially as 
far as it is concerned the switches in polarity and the resulting clinical and 
pharmacological treatment of various types of depression (Goodwin & Jamison, 2007). 
Irritability may be a good marker of depression with mixed features, a view consistent 
with that of others who have found high rates of irritability and anger attacks associated 
with these states (Akiskal, & Benazzi, 2003; Koukopoulos et al., 2007; Sani et al., 
2014). According to several studies, there is a significant greater proportion of Agitated 
Depression in Bipolar Disorder than in MDD (Benazzi, 2004a; Benazzi et al., 2004; 
Koukopoulos et al., 2007; Takeshima, & Oka, 2013). 
This awareness can help the clinician to avoid the all-too-common misdiagnosis of 
agitated depression and other depressive/manic symptoms, a mistake that can lead to the 
almost always frustrating treatment decision and the administering an antidepressant in 
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the absence of a mood stabilizer (Baldessarini, Tondo, Davis, Pompili, Goodwin, & 
Hennen, 2006b; Baldessarini et al., 2013). 
Anyway, the data suggest greatly elevated suicide rates in both unipolar and bipolar 
disorders in comparison with other psychiatric diseases (Sharma, & Markar, 1994; 
Harris, & Barraclough, 1997).  
The most prudent approach is perhaps to give clinicians the opportunity to maximize the 
assessment phase of each case. The result of a good assessment and therefore of a 
correct diagnosis is the possibility of treating the individual in an effective way. The 
diagnosis of a type of depression cannot be accomplished by a checklist: The DSM-5 
diagnostic criteria for major depressive episode provide only a general guide. Only after 
an in depth phenomenological approach can a clinician ascertain diagnosis of a specific 
affective episode and choose the most appropriate treatment. 
6. Etiopathogenetic theories of depression 
 
Hippocrates (460-377 AC) considered depression to as the result of excessive secretion 
of “black bile” and therefore gave it the name Melancholia, a term that many scientists 
prefer to name of depression. The Hippocrates intuition could be considered the first 
biological hypothesis of depression. 
The formulation of the first neurobiological hypothesis of depression based on 
experimental evidences, was the “monoaminergic hypothesis”. It still continues to have 
its validity, although revised by new discoveries (Schildkraut, & Kety, 1967; Serra, & 
Fratta, 2007). It is based on the studies on the mechanism of the antidepressant effect of 
the serendipitous discovery of imipramine and MAO-inhibitors and the depressant 
effect of reserpine (a drug used in the treatment of hypertension, which cause severe 
depression). 
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The observation that imipramine potentiates noradrenaline and serotonin transmission 
by inhibiting the reuptake of these neurotransmitters and that MAO-inhibitors enhances 
monoamine activity by inhibiting the enzymatic degradation, led to the hypothesis that 
depression should be associated to a reduced activity of these monoamines (NA and SE) 
in the SNC. In keeping with this hypothesis, reserpine, which causes severe depression, 
depletes monoaminergic neurons from their neurotransmitters (NA, SE, DA). 
The discovery that antidepressant drugs potentiate also the dopaminergic transmission 
(See Demontis, Serra, & Serra, 2017) suggested that depression may be associate also to 
a reduced dopamine activity. 
More recently, it has been suggested that depression could be a consequence of a 
neurodegeneration phenomenon and that the antidepressant and/or the mood stabilizing 
effect of the drugs should be attribute to their ability to promote neurogenesis 
(Schloesser et al., 2015). 
A detailed description of the various neurobiological theories of depression is not part 
of this work, thus we will be focused on relevant psychological theories. 
Among the “psychological” theories proposed in the last century to explain the 
psychological mechanisms underlying depression, the most acclaimed cognitive 
behavioral matrix theories are Beck’s “hopelessness theory”, and Seligman’s “learned 
helplessness theory”. Both have led the development of today’s widely used 
psychotherapeutic techniques. 
7.1. Beck's Theory 
Beck's cognitive model has been described in numerous publications (Rush, & Beck, 
1978; Beck, 1991; Beck, 2005). At the basis of its descriptive model, there are the 
persistent structural representations of human experience, called schemes that guide the 
identification, interpretation, categorization and evaluation of experience. These 
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schemes are structurally rigid, impenetrable and absolute; their content is a distorted 
representation of the experiences. 
The schemes are quickly triggered by a whole series of stimuli and once turned on 
dominate the information evaluation system. The dominance of the negative assessment 
also interferes with the assessment of positive events. 
Another important aspect concerns childhood experiences; the creation of distorted 
conceptions of oneself is due to early childhood events, such as loss of parents or 
abandonment, which sensitize the individual to experiment more seriously future losses 
in adolescence and adulthood. 
These cognitive distortions are triggered by adverse events that, associate with these 
specific cognitive vulnerabilities, result in systematic cognitive distortions (Clark, & 
Beck, 2010). 
Because of repeated activations, the negative self-scheme, acquires a coherent and 
elaborate organization that over time turn on easily through a variety of modest, 
stressful events. Cognitive errors due to these fixed patterns in the individual mind are 
very important in the development and maintenance of depressive disorder. 
In Beck’s theory, subjects are considered more vulnerable when are guided by 
depressive schemes, in which personal value is related to perfectionist standards or with 
other’s approval. When they are faced with negative events, they experience a lack of 
control. These individuals tend to consider themselves responsible for adverse events 
and failures (e.g. social relationships, work levels, etc.) due to poor personal value and 
poor personal skills. A negative self-view is a central feature of subjects who feel 
depressed; they tend to distort the actual information about their skills in different areas. 
At the base of depression, there would be distorted beliefs and dysfunctional 
expectations that cause affective reactions and symptomatic cognitive manifestations 
 40
(Beck, 2005; Clark, & Beck, 2010). Beck has found that cognitive beliefs and errors 
affect a “cognitive triad” that includes: 
• A negative view of self: in terms of personal value (“I'm a loser”, “I'm a failure”) and 
in terms of loveliness and anyone’s guess (“no one loves me”; “I'm not a person worthy 
of love”) 
• A negative view of the world (“The world is a bad and unhappy place”; “Others take 
advantage of me”; “Life is unfair to me”). 
• Negative expectations about the future (“It will never change anything”; “I'll always 
be a failure”) 
Concerning cognitive distortions, Beck argues that all of us are continually committed 
in attributing significance to life events and that in depressed patients, the evaluation of 
such events is often distorted by different dysfunctional cognitive processes. 
7.2. Seligman’s theory  
The origin of Seligman’s theory is based on experimental evidence of animal behavior, 
and in particular by Seligman’s best - known experiment on dogs, described by him in 
1972. 
Seligman’s classic experiment for his learned helplessness theory can be summarized as 
follows: When a dog is instructed to escape from an electric discharge, which is given 
to his feet, the animal first has a set of behaviors (defecation, urination, etc.) until he 
accidentally finds way to escape. At times, the animal becomes more and more capable 
of escaping from the electric discharge as quickly as possible. 
Conversely, when a dog gets electric shock in a situation where there is no way to 
escape, it shows a behavior that is absolutely different. Indeed, this dog soon stops 
moving and stands still until the end of the shock; in other words, the dog does not 
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attempt to escape the electrical shock, but rather seems to accept it passively, even when 
it can avoid them (Seligman, 1978).  
From his experiment, Seligman hypothesized that at the base of depression in humans 
was, in analogy of the animals, a conviction that he could not do anything in the face of 
the stressful events of life. Thus, he passively accept the consequences of such events 
(Abramson, Seligman, & Teasdale, 1978; Miller, & Seligman, 1975; Rosellini, & 
Seligman, 1975; Seligman, Weiss, Weinraub, & Schulman, 1980). 
The subject exposed to stressful events, from which he can not escape, learns that his 
actions have no power to control and modify such events, developing a sensation of 
learned helplessness at a cognitive level (Abramson et al., 1978; Seligman et al., 1980). 
This would also show an attitude of passivity towards the environment, as the subject 
would learn that his behavior is independent of the result. This attitude tends to 
generalize to new situations because of the expectations of the impossibility of having 
any control over the future (Alloy, Peterson, Abramson,, & Seligman; 1984; Seligman, 
1978). 
7. Treatment of depression 
 
Depression treatment includes psychotherapy and pharmacotherapy. The present work 
focuses in particular on the relationship between depressive symptoms and the 
appropriate assessment methodology. For this reason, the treatment will only be 
mentioned but will not be deepened. 
The psychotherapist should be able to understand deeply the type of depressive episode. 
Then, clinician should have solid knowledge of mood disorders and at the same time be 
flexible to possible mood changes.  
Cognitive Behavioral Therapy has proven to be a clear efficacy and has been indicated 
(Clark, 2011; National Collaborating Centre for Mental Health. UK, 2010) as an 
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elective therapy in mild and moderate depression. It is also indicated in combination 
with medications for serious forms of depression. 
Drugs used in the treatment of mood disorders include antidepressant, anti-manic/mood 
stabilizer and antipsychotic drugs (Goodman & Gilman, 2011). 
Antidepressants are used in the treatment of depressive episodes and include tricyclic 
antidepressants (imipramine, amitriptyline, etc.), which increases monoaminergic 
transmission by inhibiting the neurotransmitter (Serotonin and Noradrenaline) reuptake 
by the synaptic cleft; monoamine-oxidase inhibitors (tranylcypromine, etc.), which 
increases monoamine transmission by blocking their enzymatic degradation. These 
antidepressants have been discovered “serendipitously” in the late 1950s, and are still 
the most efficacious treatment of depression. More recently have been introduced in the 
clinical use the selective serotonin (SSRI such as fluoxetine)-noradrenaline (SNAI such 
as reboxetine)-dopamine (SDAI such as bupropion) reuptake inhibitors that are a class 
of the more prescribed drugs today. 
However, it should be emphasized that administration of antidepressants in agitated 
depression or other mixed states worsen the symptomatology, possibly because it 
intensify the manic component of the disorder (see Serra et al, 2014). In particular, the 
use of antidepressants in patients with mixed symptoms can increase the excitatory 
symptoms (a switch from depression to mania) and it may result in a higher risk of 
suicide (Baldessarini et al., 2006a; Koukopoulos, & Koukopoulos, 1999; Vázquez et al., 
2013). Indeed, these forms of depression should be treated with anti-manic/mood-
stabilizer or antipsychotic drugs. 
The first choice of anti-manic and mood stabilizer treatment is lithium: it is used to treat 
mania and mixed features and to prevent the recurrences of depressive episodes in the 
Major Depressive Disorder; lithium is used also to prevent (hypo) manic, mixed and 
depressive episodes in Bipolar disorder. 
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Some anticonvulsants and atypical antipsychotics are used in patients who are lithium 
non-responders, but their efficacy are limited and/or questionable. 
Antipsychotics include the first generation or neuroleptics drugs, which are in clinical 
use since the late 1950s (chlorpromazine, haloperidol, etc.) and the more recent 
introduced “so called” atypical or second-generation antipsychotics (Clozapine, 
olanzapine, quetiapine, etc.). These drugs are used in the treatment of severe 
mixed/manic episodes with psychotic symptoms or high agitation (McIntyre et al., 
2014).  
The psychiatrist should carefully assess the symptoms before prescribing a drug. 
Several studies have shown that antidepressants are suitable in some types of depression 
but not in others. In particular, Goodwin and Jamison (2007) report the results of 
several studies suggesting the use of a mood stabilizer and (sometimes) an atypical 
antipsychotic in agitated depression in which antidepressant drugs may worsen the 
course of the affective episode as stated before. 
8. Conclusion 
 
Mood disorder is among the most prevalent of all mental health diagnoses. It is 
associated with high disability, the long duration of illness, high probability of 
recurrence, the difficulties in diagnosis, the delay in finding the right treatment, and, in 
most cases, with the inefficacy of available pharmacological treatments. Consequently, 
it has a high risk of suicide with a standard mortality ratio compared to the general 
population of 20:1. Some data suggest that several factors are associated with an 
increased risk of suicide over the incorrect identification of the illness: genetic and 
sociodemographic variables, loss of social and medical support, comorbidity with other 
disorders or substance abuse, recent environmental adversities.  
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Clinical observations and epidemiological studies prove a vast overlap between Bipolar 
and Unipolar disorder; in particular, patients with bipolar-II disorder are often 
misdiagnosed and included as unipolar patients. Major depressive episode (MDE) is 
common to both Unipolar Disorder and Bipolar Disorder (in all of their sub-categories). 
The proper treatment of mixed depression is essential for the subsequent proper 
treatment. Indeed, many studies have demonstrated the ineffectiveness of antidepressant 
treatments in this form of depression, which may, on the contrary, worsen the symptoms 
and increase the risk of suicide.  
In the light of these observations, the result of a good assessment is essential to treating 
the individual in an effective way. 
In the next section, we will present the assessment phase, describing in detail strengths, 
weaknesses and progress of the research in the field of psycho-diagnostic evaluation.  
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CAPTHER 2   
Assessment 
 
1. Assessment description 
The central role of clinicians conducting assessments should be to answer specific 
questions and to support the patient in making relevant decisions (Grossberg, 1964). 
The Assessment, or psycho-diagnostic examination, can be defined as a complex 
process of collecting, analyzing and processing information. The assessment phase is 
the first action that clinician has to face when he starts to help a patient and, clinicians 
must integrate a wide range of data and bring into focus different areas of knowledge.   
The assessment is based on a first broad-spectrum evaluation to establish psychiatric 
treatment and psychotherapy, or to relocate the patient to appropriate interventions to 
the specific case (Groth-Marnat, 2009).  
Clinical evaluation and treatment may have different aims; in fact, psychologists and 
psychiatrists face many forms of suffering and discomfort. The case formulation is 
obtained by collecting all necessary data, which allows clinicians to reconstruct the 
mechanisms and processes underlying the presented disorders, agree on treatment goals, 
and to identify the most appropriate therapy in an effective way (Serra, Spoto, Ghisi, & 
Vidotto, 2017). 
The assessment consists of a systematic sequence of interconnected phases. The first 
phase involves collecting data about the patient. It begins with the patient’s previous 
history and records followed by the development of tentative hypotheses and the 
investigation in more detail. At this point, the clinician conducts an interview and 
administers a variety of psychological tests. From this information, the clinician starts to 
make inferences. This step focuses on the development of a wide variety of inferences 
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about the case, which guides future investigation to obtain additional information that 
are used to confirm, modify, or negate later hypotheses. 
Often, in investigating the validity of an inference, a clinician alters either the meaning 
or the emphasis of an inference or develops entirely new ones (Groth-Marnat, 2009). 
The validity of that inference is progressively strengthened as the clinician evaluates the 
degree of consistency and the strength of data that support a particular result. The 
central aim of the following step is to develop and begin to elaborate on statements 
relating to the specific case with a further investigation of the personality traits of the 
person to better understand and integrate the patient’s background. It may include 
describing and discussing general factors, such as cognitive functioning, affect and 
mood, and interpersonal-intrapersonal level of functioning. In addition, the clinician 
analyses the social context. Finally, the crucial phase involves the decision-making and 
requires that the clinician take into account the interaction between personal and 
situational variables (Bokhari, & Hubert, 2015). Yet the goal of clinician is not merely 
to describe the person but rather to develop relevant answers to specific questions. 
DSM-5 diagnosis needs to be considered within the context of case specific 
considerations. An example is how a disorder such as depression may be manifested as 
a stressful event (i.e., bereavement) or within a bipolar disorder (i.e. as a depressive 
episode). In fact, a reactive depression should be considered in a totally different way 
from depression with a genetic basis, and differential diagnosis is also essential for 
treatment. Likewise, the way to manifest depressive symptoms is often related to 
personality or culture. In addition to noting the cultural identity of the patient, it is also 
crucial to carefully consider his personality and social context. Anyway, the individual 
history would need to be decoded in order to identify the underlying depression. 
The information obtained through the Assessment allows creating a hypothesis about 
the person’s clinical features, useful for treatment. When errors in diagnosis do occur, 
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they have the potential to result in dangerous decisions and wrong treatment (Groth-
Marnat, 2009). 
For all these reasons, it is crucial to take into account both the nomothetic approach and 
the ideographic approach. The first one focuses its attention on common aspects of 
various personalities and therefore tends to categorize individuals according to the 
psychological disorder in question; the second one analyses the single case, and 
considers each person unique and different and therefore not classifiable (Diener, & 
Fujita, 1995). These two approaches are not necessarily mutually exclusive, but can be 
integrated. In fact, in the case formulation, the evaluation uses patterns, laws and 
explanations applicable to all people to prepare a scientifically founded and nomothetic 
formulation; but this is then translated into an ideographic explanation, valid only for 
that individual, with all its specifics and peculiarities (Hayes, Nelson, & Jarrett, 1987). 
To avoid missing crucial information, clinicians should use comprehensive approaches 
by collecting data from the three main levels of information: the subjective level, the 
behavioural level, and the physiological level (Sanavio, 2007; Spoto, 2011).  
 The subjective level covers the information the patient provides during the 
clinical interview, the structured interview, the diaries, the tests, etc. These 
information are related to the context in which they are collected, to the 
truthfulness of the information given and, to the relationship with the 
psychologist and also to his possible mistakes; when the patient is hostile and 
uninclined to collaboration, is common making the analysis useless.  
 The behavioural level (i.e. non-verbal channel) is given by the information that 
comes from direct observation of the individual’s behaviour (e.g. non-verbal 
behaviour during a clinical interview: facial gestures, posture, tone of voice, 
etc.). None of this information are neutral as the same observer influences it. 
More the clinician experience will be, the greater the ability to capture this kind 
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of information will be. The non-verbal sphere is of fundamental importance in 
the diagnosis of mental disorders. Negative emotions and social behaviours are 
important indicators and predictors of the severity of mental illness (e.g. 
depression) and of its clinical remission that however escape the patient’s 
awareness (Annen, Roser, & Brune, 2012; Fiquer, Boggio, & Gorestein, 2013). 
 The third level of information is the recording of the psychophysiological 
activation of the individual (e.g. skin conductance, cardiac frequency, 
temperature etc.). Although this information is fairly reliable, it is not neutral but 
depend on the conditions in which the person is at that particular time. These 
“new” techniques are particularly used in specific disorders such as headache, 
hypertension (Nicassio, Meyerowitz, & Kerns, 2004), anxiety disorders and 
phobias (Barlow, 2002). 
Measures relative to one or the other channel are not interchangeable; they cannot be 
considered as measures of the same phenomenon, but should be considered as 
evaluation of related but independent aspects (Sanavio, & Sica, 2004). 
For instance, when clinician uses a test, he should consider it not as a real and unique 
description of a construct (e.g. depression) but as a description of only the subjective 
dimension of the construct, which is multidimensional (Sanavio, & Sica, 2004). 
These three levels, or rather analysis’ channels, form the “horizontal integration” of the 
assessment; “vertical integration”, on the other hand, is given by the subsequent levels 
of in-depth test analysis it is carried out according to the psychologist’s logical point of 
view, considering the interview, the observations, and then the more suitable measuring 
instruments (Sanavio, Bertolotti, Michielin, Vidotto, & Zotti, 2008).  
In particular, the main tools available to carry out an assessment are classifiable into 
four categories (Groth-Marnat, 2009; Serra, Spoto, Ghisi, & Vidotto, 2015a): clinical 
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interview with observation, psychophysiological measurements, structured/semi-
structured interviews, and self-report questionnaires. 
1.1. Clinical interview and Observation 
The first aim of clinical interview is the examination of the problem; it is a mainly 
hypothetical-deductive process (Sanavio, 2007). Clinical interview and observation 
provide a large amount of information, can follow adaptive logic, and allow taking 
advantage from multiple channels (verbal and non-verbal).  Nevertheless, they require a 
great amount of time to be completed. Moreover, they are not always systematic and 
some inference problems may be introduced by the clinicians’ bias, which could lead to 
wrong diagnosis and consequently ineffective treatment (Serra, Spoto, & Vidotto, 
2015b; Spoto, 2011).  The exclusive use of the clinical interview does not allow an 
exhaustive understanding of the individual’s problems. In fact, it is known that patients 
often feel less uncomfortable in reporting their symptoms in self-report questionnaires 
rather than during interview. Moreover, during the clinical interview, the trust that the 
patient has in the clinician, as well as the ability of the individual to describe his 
symptoms, play a fundamental role. With regard to the observation, the expert must be 
able to focus on the object to be observed (e.g. a specific attitude) and, at the same time, 
to consider the context. For example, when the clinician is facing a depressed patient, it 
is necessary not only to consider patient complaints but also to understand through his 
behaviour his symptoms. In fact, the patient in the first interview can describe an 
inhibited depression and an agitated depression identically, but non-verbal clinical 
manifestations can play a crucial role in the assessment. Psychomotor agitation often 
manifests with incapacity to sit still, repetitive activity, pacing up and down, such as 
wringing of hands or even biting nails and/or lips (Goodwin & Jamison, 2007; 
Koukopuloulos et al., 2007). The ability of the clinician as well as the use of 
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observation grids for non-verbal behaviour can be of great help in observing the 
behaviour (Spoto, 2011). 
1.2. Psychophysiological measurement 
Psychophysiological measurement provides objective data, and deeply assess aspects 
that cannot be evaluated in other ways. However, it is limited in the areas of application, 
sometimes it has difficult accessibility, and it can be affected by artefacts.  Moreover, 
the mood of the individual and the context in which he is can modify the results; For 
example, conditions that make the person uncomfortable may produce 
electrophysiological changes in heart rate or conductance beyond the experiment. 
1.3. Structured interviews and Semi-structured interviews 
 
Structured interviews (Van Zaane, van den Berg, Draisma, Nolen, Van den Brink, 2012) 
and Semi-structured interviews (Ferentinos, Paparrigopoulos, Rentzos, Zouvelou, 
Alexakis, Evdokimidis, 2011; Zimmerman, McGlinchey, Chelminski,  & Young, 2012) 
are two tools used by the clinician at various stages of the assessment following a 
different procedure. Structured interviews are similar to orally administered 
questionnaires and follow a predetermined order of questions; they are standardized 
and, provide a numerical score on the analysed construct. Semi-structured interviews 
are of great importance. They do not follow a predefined sequence of questions but the 
various questions are investigated by the clinician during the interview taking into 
account any previous answer; so this is a clinician-led interview to find out the problem. 
The international reference point of semi-structured interview is the Structured Clinical 
Interview for DSM-IV (SCID). There are two versions of SCID: the first one refers to 
the axis I disorders of the DSM IV (SCID-I; First, Spitzer, Gibbon, & Williams, 1996), 
while the second one evaluate the axis II disorders of the DSM IV (SCID-II; First, 
Benjamin, Gibbon, Spitzer, & Williams, 1997). Semi-structured interviews, in our 
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perspective, are really interesting since they introduce the crucial concept of adaptivity 
in a systematic form. The selection of the areas to be investigated are guided by the 
clinician depending on the individual’s responses; this means that not all questions are 
proposed to the patient, but only those in line with his symptomatology. The cons of this 
kind of interview are the great amount of time they require, and the possible inference 
errors introduced by clinicians. As in clinical interview and observation, even in semi-
structured interviews, the clinician can make wrong logical inferences and consequently 
create problems in subsequent questions asked by the patient; In addition, the patient 
may become confused when answering, as he needs to respond immediately. In such 
cases, the result of the evaluation may not be reliable (Zimmerman et al., 2012). 
1.4. Self-report questionnaires 
Self-report questionnaires are often used in a hierarchical sequence; in the initial stages 
are explored several potentially problematic areas. These tests carry out a “broad 
spectrum” analysis and can be of great help to the psychologist for a first picture of the 
problem and for the focus of his subsequent examination strategies. Subsequently, in the 
later stages, more specific tests are used depending on the clinical case and its features 
noted in the previous stage. These tests offer the analysis of more specific and targeted 
constructs (Sanavio, & Sica, 2004). Therefore, the purpose of the tests is not just to 
classify the individual in a diagnostic category, but to provide the clinician with a more 
in-depth knowledge of the patient’s problem. Tests should be considered as tools that 
make the work of the psychologist more detailed, allowing a more systematic and easy, 
clear and rapid exploration (Sanavio, & Sica, 2004). Tests allow to systematically and 
quickly collecting a lot of information; moreover, they avoid the possible 
embarrassment of patients. Nonetheless, they redundantly (non-adaptively) investigate 
constructs and they are conceived to provide a quantitative numeric score that does not 
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account for the qualitative information collectable from the single answer of the 
individual (Serra, Spoto, & Vidotto, 2015b). 
2. Cognitive Behavioural Assessment (CBA 2.0) 
According to Sanavio and Sica, “psycho-diagnostic examination is not a passive 
collection of information, but an active process, essentially similar to a process of 
problem solving and decision-making: a complex process of collection and processing 
information about the individual case” (Sanavio & Sica, 2004, p.9). A multidimensional 
Assessment integrates information and measurements from different levels. 
Clinicians should not only consider the data that supports their hypotheses using only 
one channel, but also carefully consider or even list evidence that may not support their 
hypotheses take into account all the information’s levels. This will likely reduce bias 
(Sanavio, 2007; Groth-Marnat, 2009). 
In the Italian context, the Cognitive Behavioural Assessment test battery (CBA 2.0; 
Sanavio, Bertolotti, Michielin, Vidotto, & Zotti, 1997) was one of the first attempts 
aimed to mimic the clinician’s evaluation including both horizontal and vertical 
integration.  
This tool allows: 
• To collect data; 
• To analyse clinical indexes (included also the reliability of the results) 
 
• To produce a preliminary report on the results  
• To advise on areas which should be investigated further through the score 
obtained in the various primary scales and the analysis of so-called “critical 
items” (i.e. suicidal behaviours) 
• To select new tests in order to understand specific clinical features (secondary 
scales)  
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• To indicate treatment strategies for a single case. 
The authors of this self-evaluation battery wanted to develop a broad-spectrum 
instrument for clinical and therapeutic practice. CBA 2.0 suggested an attempt for a 
comprehensive approach to the psycho-diagnosis; the underlying procedure to analyse 
the individual replies is founded on the idea of a continuous progress in the process of 
diagnosis in order to decrease the uncertainties and strengthen the assumptions on the 
variables involved in the evaluation process (Bertolotti, Zotti, Michielin, Vidotto, & 
Sanavio, 1990). Authors consider the assessment in a multidimensional perspective; the 
information collected by self-report tools are integrated with the information obtained 
from other approaches (i.e. horizontal integration). CBA 2.0 allows to achieve the 
vertical integration thought the primary and secondary scales. The primary scales have 
the role of giving a first picture of patient’s problems; they are broad-spectrum tests to 
explore several potentially symptomatic areas. The primary scales consist in ten 
sections. Sheet 1 collects personal data, while Sheet 4 evaluates personal life events (i.e. 
the educational and school situation, the affective relationships, the general state of 
health, eating and sleep habits, motivation to psychological treatment etc.). These two 
sections are useful for providing general relevant information to the clinician (such as 
interviews); they allow getting a more complete view of the individual case (horizontal 
integration). Sheet 2 is the State-Trait Anxiety Inventory X1 (STAI-X1; Lazzari & 
Pancheri, 1980; Spielberger, Gorsuch, & Lushene, 1970) and consider the state-anxiety 
of the individual when he/she starts to complete the test; it is mainly a measure of 
reliability of the test as a high level of anxiety can alter the performance of the subject. 
Sheet 3 (STAI-X2) and Sheet 10 (STAI-X3) assess the individual’s anxiety 
(respectively trait-anxiety and state-anxiety) by means of the test STAI-X (Lazzari & 
Pancheri, 1980; Spielberger, Gorsuch, & Lushene, 1970). The sheet 5 is the brief form 
of the Eysenck Personality Questionnaire (EPQ/R; Eysenck, & Eysenk, 1975) and it 
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evaluate stable dimensions of personality such as the introversion-extroversion, 
emotional stability, anti-social behavioural etc. It consist of four main scales N 
(Neuroticism), E (Extroversion), P (Psychotic) and scale L (Lie); the latter one aims to 
provide a measure of the propensity of the subject to give a falsely “positive” profile. 
The sheet 6 is Psycho-Physiological Questionnaire brief form (QPF-R; Sanavio 
Bertolotti, Michielin, Vidotto, & Zotti , 1986) and it provides an evaluation of stress and 
psychophysiological symptoms. Sheet 7 is the Fears Inventory (IP-R; Sanavio et al, 
1986; Wolpe & Lang, 1964); it evaluates individual’s fears and the relationships 
between problem situations and emotional reactions. Sheet 8 is the Depression 
Questionnaire (QD; Sanavio et al., 1986) and assesses depressive symptoms. Finally, 
the sheet 9, Maudsley Obsessional-Compulsive Questionnaire brief form (MOCQ-R; 
Hodgson & Rachman, 1977; Sanavio & Vidotto, 1985) consists of three sub-scales: 
Checking, Cleaning and Doubting-Ruminating, which investigates the three sub-
dimensions of the Obsessive Compulsive Disorder. All of these 10 scales form the first 
broad-spectrum evaluation. In line with the vertical integration of assessment, the 
secondary scales consist in much more specific tests, which should be used deepening 
on the clinical evidences obtained in the previous phase; they provide analyse of 
specific and target constructs. If a patient obtained a high score to QD, specific tools to 
relieve the severity of depression (i.e. Beck Depression Inventory) will investigate the 
depressive symptoms.  
One of the main aims of CBA 2.0 project was to create a pathway as faithful as possible 
to the logical process of human operator (i.e. in circumscribing problems to successive 
phases and proposing hypotheses concerning therapy). The CBA 2.0 provides a 
descriptive computerized report of the patient score. It includes: analysis of the 
reliability of the test, high scores obtained in potential problem areas and finally 
positive responses to critical items. Although this attempt represented a great 
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improvement when compared with other similar researches developed in that period, 
CBA 2.0 still presents many limits when compared with what clinician needs (Serra et 
al., 2015b). 
One of the most important critical things is that the question-answer progression 
followed a mechanic deterministic order. There were no ideas about how to simulate a 
well-articulated interview, which could be effective, efficient, and considering the 
natural and logical flow of question and answers contents.  
A second critical aspect was related to the unsatisfactory use of the resulting scores. 
When a test is administrated, indeed, different combinations of symptoms may produce 
the same score in a way that such information may not be quite useful in clinical 
practice (i.e. the answer to each single item is not taken into account). Individuals may 
be classified under the same diagnostic category if they meet sufficient criteria even 
when they present dissimilar clinical features and are leaded by different underlying 
psychological mechanisms (Serra et al., 2015b).  
A new formal approach, which gives a new perspective to the CBA 2.0 in terms of 
automatic-assisted procedures, is designed to cope with these problems. Formal 
Psychological Assessment (FPA; Spoto, Stefanutti, & Vidotto, 2010; Spoto, Bottesi, 
Sanavio, & Vidotto, 2013) will be discussed in the following chapter. In this work, FPA 
aims to overcome both the problem of adaptability and to be able to go beyond the 
numerical score in the assessment of mood disorders. 
 
 
3. Adaptive Assessment 
Psychological assessment has been based primarily on subjective judgment of clinician 
and classical psychometric test theory. Despite all the pros of the clinical interview, the 
problem of the subjective inferences of the clinician can cause errors in later evaluation 
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and diagnosis (Nordgaard, Sass, & Parnas, 2013). Indeed, the clinician’s evaluation 
could be affected by underestimation or overestimation of patient’s symptoms. 
Regarding the psychometric approach, typically, a total score determines the 
impairment level, which requires that all the same items are administered to all 
respondents. This last approach is primarily data oriented, and the product is often a 
series of scores. The score’s descriptions are typically unrelated to the person’s overall 
context and do not address unique problems the person may be facing (Hayes, Nelson, 
& Jarrett, 1987). In contrast, psychological assessment attempts to evaluate individual 
data in a broad perspective, with its focus being individual problem solving and 
decision-making.  
Psychological assessment should include the evaluation of individual specific features. 
The central role of the clinician performing psychological assessment is that of an 
expert in human behaviour who must deal with complex processes and understand test 
scores in the context of a person’s life (Groth-Marnat, 2009). 
Thus, rather than just knowing the labels and definitions for various types of anxiety or 
thought disorders, clinicians should also have in-depth operational criteria for them. For 
example, the construct of depression, as represented by the score, can sometimes seem 
misleadingly straightforward. Depression can manifest with a variety of different 
symptoms that may be due to a different culture or a different aetiology (as reported in 
the Chapter on mood disorders). Only through personalized assessment can be possible 
to distinguish these conditions (Groth-Marnat, 2009). Unless clinicians are familiar with 
these areas, they are not adequately prepared to understand different types of depression 
(i.e., agitated depression, depression with flight of ideas, inhibition of depression, etc.). 
An alternative to administration of a full scale achieving a personalize assessment is 
adaptive testing. It means that each individual may receive different scale items that are 
targeted to their specific impairment level (Fliege, Becker, Walter, Bjorner, Klapp, & 
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Rose, 2005). In adaptive testing, a person’s initial item responses are used to determine 
a provisional estimate of his or her standing on the measured trait (for example, 
depression or anxiety) to be used for the selection of subsequent items (Wainer, 2000). 
This form of testing has recently emerged in the field of knowledge and mental health 
research (Falmagne & Doignon, 2011; Weiss, 2004). Procedures based on item 
response theory (Embretson & Reise, 2013) can be used to obtain estimates for 
individuals (for example, severity of depression) to more efficiently identify suitable 
subsets of item for each individual (Gibbons et al., 2008). In particular in the last years 
several studies demonstrated that diagnostic instruments could benefit substantially 
from modern statistical approaches like models of item response theory (IRT), e.g., the 
Rasch model. Indeed, by using IRT-modelling it was shown that unidimensionality, an 
important aspect of test theory, cannot be taken for granted. For example, if a patient 
suffering from a severe somatic illness reported somatic symptoms in a depression 
questionnaire those symptoms may be ascribed to the somatic illness or a depressive 
episode (Forkmann et al., 2009). Moreover, it was shown that questionnaires could be 
shortened without loss of information. This testing approach is referred to as 
computerized adaptive testing (CAT) and can be applied to achieve a more effective 
assessment (Petersen, Groenvold, Aaronson, Fayers, Sprangers, & Bjorner, 2006). The 
main idea is to administer a small, optimal number of items to the individual without 
loss of measurement precision and according with his previous answer. This process 
mimics the semi-structured interview, with the difference that the inferences are made 
by an algorithm which considers all the information and step by step goes through the 
assessment following logically correct process (Spoto, 2011).  
Eggen and Straetmans (2000) combined IRT with statistical procedures, like sequential 
probability ratio test and weighted maximum likelihood, for classifying people under 
exam. Other systems use Bayesian statistical techniques instead of IRT in the evaluation 
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of students’ knowledge (e.g. EDUFORM, Nokelainen, Silander, Tirri, Nevgi, & Tirri, 
2001; and PARES, Marinagi, Kaburlasos, & Tsoukalas, 2007). 
In the field of knowledge assessment ALEKS (Assessment and LEarning in Knowledge 
Spaces) is a complex system able to adaptively assess a subject’s knowledge and 
provide a consequent learning individualized path (Grayce, 2013; Donadello, Spoto, 
Sambo, Badaloni, Granziol, & Vidotto, 2016). Starting from a set of items on a specific 
topic, the output of ALEKS system is the subset of items, which the subject is able to 
reply; this subset is called “knowledge state” and it refers to the level of knowledge of 
the individual in a particular field. 
However, the formulation of the adaptive algorithm is even more difficult in the clinical 
setting. In fact, the objectivity of the questions and therefore of the answers given by the 
subject is much more questionable, and the probabilities of making mistakes in the 
answer increase.  Despite this, research has demonstrated that both item response theory 
and CAT (Baek, 1997) can be applied to the measurement of attitudes and personality 
variables (Reise & Waller, 1990). In the clinical context, Spiegel and Nenh (2004) 
developed an expert system, which calculates possible symptom combinations and 
returns all possible risk diagnoses. Yong and colleagues (2007) developed an interactive 
self-help system for depression diagnosis that provides advice about patients’ levels of 
impairment. Simms, Goldberg, Roberts, Watson, Welte, & Rotterman (2011) developed 
the CAT for Personality Disorders (CAT-PD) aimed at realizing a computerized 
adaptive assessment system. CAT has been applied also in developing adaptive 
classification tests by means of stochastic curtailment using CES-D for depression 
(Finkelman, Smits, Kim, & Riley, 2012; Smits, Finkelman, & Kelderman, 2016). 
Gibbons and colleagues (2008) used the combination of item response theory and 
computerized adaptive testing (CAT) in mood and anxiety disorder assessment. In 
particular they applied a bifactor structure, consisting of a primary dimension and four 
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sub-factors (mood, panic-agoraphobia, obsessive-compulsive, and social phobia). 
Participants completed the Mood and Anxiety Spectrum Scales (MASS) at two times. 
The first administration was used to define an adapting testing version of the MASS, the 
second confirmed the functioning of CAT in live computerized testing. Authors created 
item banks with a large item pool, and being able to administer a small set of the items 
most relevant for a given individual with no loss of information, allowing a strong time 
reduction and consequent patient and clinician burden. A chart review was performed 
for six patients with mood disorders (three major depressive disorder and three bipolar 
disorder) who were interviewed by the psychiatrist. Most of the CAT items that were 
endorsed positive were not documented in the six patients’ psychiatric evaluation 
through SCID-I. These items included clinically important information, such as a 
history of manic symptoms, potentially risky behaviours etc. This last study is an 
important example of how adaptive testing can be effective. Despite this, it has several 
limitations: first, the proposed model is totally deterministic; it starts from a theory 
based on the factorial structure and does not take into consideration the possibility that 
the subject’s answers are not corrected. A second limitation, according to the bifactor 
model, there is only one main dimension and the sub-dimensions related; so, if this 
condition is not satisfied the model can not be used. Finally, this model works only if 
each item loads on a primary dimension and no more than one sub-dimensions. If items 
are related to multiple sub-dimensions, they will not be appropriate for the bifactor 
model and therefore CAT is not applicable. 
However, although there have been several attempts to apply adaptive clinical 
assessment, as far as we know, no system was able to combine adaptability, quantitative 
and qualitative information, and estimate error parameters through a probabilistic 
model. 
 60
The Formal Psychological Assessment, and its application to mood disorders, is the 
core of this work, and represents a further step to overcome the obstacles encountered 
up to now in adaptive testing. 
 
3. Conclusion 
 
The assessment is a crucial moment in the therapeutic process; the clinicians, after 
collecting as much information as possible on the patient, must formulate diagnostic 
hypotheses in a short period to plan clinical interventions. The quality of clinical 
evaluation is crucial for both diagnosis and treatment; In fact, a misdiagnosed psycho-
diagnostic evaluation could result in therapeutic failures, dissatisfaction and patient 
suffering.  
Keeping in mind the previous background, we can list the key features of an ideal 
assessment tool: 
1. Adaptive logic as a semi-structured interview that allows examining in depth 
only the individual’s symptomatic areas (questions are guided by the 
psychologist depending on patient answers to previous questions). 
2. Ability to perform systematically correct inferences, avoiding inference errors 
by clinicians. 
3. Exhaustivity similar to a clinical interview; to get all the information needed to 
contextualize the problem of the single case. The tool should be completed for 
the investigation of the target construct. 
4. Rapid administration (as a test), allowing to collect a lot of important 
information in a short time. 
5. Ability to provide quantitative and qualitative information. The tool should be 
able to have a numerical score that allows to classify the individual into a 
diagnostic category (nomothetic approach); on the other hand it should underline 
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the set of peculiar symptoms of the individual case in order to distinguish its 
symptomatology and to treat it properly (ideographic approach). 
6. Validity and Reliability; the instrument must be built following all the 
psychometric criteria, tested and validated before use. 
 
To achieve this result, the ideal tool should have the positive features of the interview 
and the strengths of the tests without the critical aspects of both. In the next section, the 
new methodological proposal will be presented and discussed. 
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CHAPTER 3:  
The Formal Psychological Assessment 
 
1. Introduction 
 
The FPA is a methodology potentially capable of maximizing the advantages of both 
semi-structured interviews and self-report questionnaires by overcoming the limitations 
of these tools and managing the problems of traditional assessment (Spoto, Bottesi, 
Sanavio, & Vidotto, 2013). 
The ability to analyse clinical symptoms is important when evaluating the responses to a 
questionnaire. FPA is able to go beyond the score of the patient and investigates the 
diagnostic features implicated by the responses (Serra et al., 2015a). The crucial 
underpinning that represents the starting point of FPA is consideration of all the 
information that can be collected from a patient’s numeric score on a questionnaire. For 
instance, if a nine dichotomous items scale is administered to a patient and the clinical 
cut-off score of the scale is 7, there are 46 different clinically significant response 
patterns (one pattern with score 9, nine patterns with score 8, and 36 possible patterns 
with score 7). It is clear how each of these patterns may convey clinically different 
information about the patient’ symptoms. Notice that all this information is already 
included in the questionnaire, even if the mere score somehow hides it.  
Nevertheless, at the present time, the only ways the clinician has to account for the 
specific information endorsed by the pattern are:  
A. To read all the items the patient has answered affirmatively, and from them, try 
to deduce his/her clinical situation (it is noteworthy that this solution is 
applicable only when the questionnaire counts a low number of items, and that 
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this operation cannot be carried out when tolls like the MMPI-2 are 
administered). 
B. To further, investigate this issue through psychological interview. Clinical 
interview, although essential during assessment, if used alone may not be 
reliable. As demonstrated by several studies, the clinician may overestimate 
some symptoms and underestimate others, or make logical inferences that are 
not entirely correct. 
Both of these solutions do not provide any standardized procedure comparable to the 
systematic scoring of the questionnaire. The FPA aims to provide an in depth analysis 
of the specific response pattern observed, thereby informing the clinician about the 
actual diagnostic configuration of the patient at hand (Spoto et al., 2013). This 
opportunity is assured by an a priori analysis of the clinical elements investigated by 
each of the items of the questionnaire. Such analysis is the deterministic skeleton on 
which it is possible to implement a probabilistic adaptive procedure capable of 
mimicking a semi-structured interview within the frame of a questionnaire. By 
highlighting the specific clinical elements investigated by each single item of a 
questionnaire, FPA highlights the differences among patients that would otherwise be 
hidden by the simple score. From a clinical perspective, it allows for an idiographic and 
nomothetic diagnosis (Serra et al., 2015a). Moreover, this approach, compared to both 
the IRT and the classical psychometric approach, allows: first, a higher level of 
reliability and validity of the measurement; second, an ability to process in a faster way 
a higher number of information in the vertical integration inference process through 
adaptive algorithm (Spoto, 2011). 
The FPA (Spoto et al., 2010; Spoto et al., 2013) developed from the conjunction of two 
mathematical psychology theories: Knowledge Space Theory (KST; Doignon and 
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Falmagne, 1985, 1999; Falmagne and Doignon, 2011) and Formal Concept Analysis 
(FCA; Wille, 1982; Ganter and Wille, 1999). 
 
2. Knowledge Space Theory 
Knowledge Space Theory (KST) was born from a search of an efficient and objective 
measurement of the knowledge acquired by an individual in a learning program. It is 
applied in the field of education, and it consists of a computerized procedure for 
assessing the knowledge of the individual in an adaptive way. In the KST language, the 
items proposed to the subject are sorted according to their difficulty; in this way, the 
teacher will be informed about what the student already knows and what he/she is ready 
to learn in the following steps. According to KST given a set of items on a specific 
topic, the output of the assessment (called “knowledge state”) is the subset of items that 
the individual under evaluation has showed to master. The basic concepts of this theory 
are the knowledge domain (Q), the knowledge state (K ⊆ Q), the knowledge structure 
(), the knowledge space, the skill-map (Q, S, f), and the probabilistic knowledge 
structure (P, K, π). These elements provide the basis for building the FPA model. 
 Knowledge domain (Q): is the set of questions that can be asked about a topic in 
order to investigate an individual’s knowledge. 
 Knowledge state (K): is the subset of Q containing all the questions that an 
individual is able to answer correctly. 
 Knowledge structure (): is a collection of knowledge states (subset of Q) 
which contains at least the empty set (Ø) and the total set Q. In the traditional 
formal notation a knowledge structure is denoted as (Q, ) where Q represents 
the knowledge domain and  represents the collection of subsets included in the 
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structure. The knowledge structure is a representation of the implications among 
the items belonging to Q.  
Given a knowledge domain Q = {a, b, c}, a, b, c are the questions to evaluate. A 
possible knowledge structure could be = {Ø, {a}, {c}, {a, b} {a, b, c}}, where Ø, {a}, 
{c}, {a, b}, {a, b, c} are the different states of knowledge K0, K1, K2, K3, K4. 
It is important to note that in this precise knowledge structure the mastery of the item a 
is a prerequisite for the mastery of item b; indeed, there is no knowledge state in  that 
contains b and does not contain a. If a subject does not solve the item a, he will not 
solve the question b (except in the case of lucky guess- i.e. false positive -; ). In KST 
this means that a is a prerequisite for b. 
 Knowledge space: is a particular class of knowledge structures. It is defined as a 
knowledge structure in which the union of any group of knowledge states 
generates a new subset already included in the knowledge structure (that 
property is defined as closure under union). An interesting property of a 
knowledge space is that more than a single set of prerequisites are allowed for 
an item. This means that the same item can be solved using different solution 
strategies. 
 Skill-map (Q, S, f): The skill map is defined as a triple (Q, S, f) where Q is a 
non-empty set of items, S is a non-empty set of skills, and f is a mapping from Q 
to 2s \ {Ø} (i.e. the power-set of S excluding the empty-set; Doignon & 
Falmagne, 1999). The skill map concept is important for delineating a 
knowledge structure. For this purpose, three models are used: The Disjunctive 
Model, the Conjunctive Model and the Competency Model (Doignon & 
Falmagne, 1999). In this work, only the first two will be considered, translated 
into the language of the Formal Psychological Assessment. In the disjunctive 
model, in order to master an item it is sufficient to have at least one of the 
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required skills, on the other hand, in the conjunctive model, all the skills are 
necessary in order to achieve a specific item. The knowledge structures 
corresponding to these two models are respectively closed under union 
(knowledge space) or intersection (each intersection of sets of states is included 
in the structure). The skill-map can be represented by a Boolean matrix with the 
items in the rows and the skills in the columns. 
 Probabilistic knowledge structure (P, K, π): Since the formal deterministic 
model does not fully reflect reality, it is necessary to define a probabilistic 
model. The Basic Local Independence Model (BLIM) allows to assign 
probability values to the different states of a knowledge structure; responses to 
each item are considered locally independent. This model has been applied in a 
number of different contexts (e.g. Falmagne, Koppen, Villano, Doignon, & 
Johannesen, 1990; Spoto, Stefanutti, & Vidotto, 2010). In the model, starting 
from the probabilistic structure (Q, K, π) and a response pattern R ⊆ Q, a 
probability distribution p(R, K) can be derived for each response pattern R given 
a knowledge state K, in the clinical structure. Formally: 
 =  	 
, ∈  
 
In the probability model, the response function is also determined on the basis of 
the two error parameters: the lucky guess and careless error (also called false 
positive and false negative errors). In case of a careless error (β) a subject does 
not solve an item that he is able to solve, while in case of a lucky guess () the 
subject solves an item that he is not able to solve.  
Formally:  
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All KST described concepts will be used in the application of FPA, so they will be 
translated into a clinical language suitable for psycho-diagnostic evaluation. 
3. Formal Concept Analysis 
Formal Concept Analysis (FCA) is based on a simple observation: when we think to an 
object, we identify the characteristics that define it and that allow distinguishing it from 
other objects; on the other hand, given a set of features, we are able to identify which 
object it describes. The main concepts of FCA are the formal context (G, M, I), and the 
formal concept (A, B).  
The Formal context is defined as a triple (G, M, I). G is a set of objects, M is a set of 
attributes and I is a binary relation between the set of objects and the set of attributes. 
Starting from a Boolean Matrix objects are placed in the rows, while the attributes are 
placed in the columns. In the formal context, each row represents an object and each 
column represents an attribute. Whenever in the cell is present value 1 means the 
relation gIm holds; in other words it means that the object g has the attribute m. 
Between the objects and the attributes of a formal context a Galois connection is 
defined. For all the sets A ⊆  G and B ⊆ M, the following two transformations define 
the Galois connection: 
 ≔   ∈ !|#$  ∀# ∈ & 
' ≔  # ∈ (|#$  ∀  ∈ '& 
 
It means that  is the collection of all the attributes that all the objects in A have in 
common. Dually ' is the collection of all the objects that possess all the attributes in B. 
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It is now possible to introduce a fundamental notion of FCA. The pair (A, B) is called a 
formal concept if it satisfies the following two conditions: A = ' and B = . The so 
called extent A of the formal concept contains exactly those objects of G that have all 
the attributes in B; the so called intent B of the formal concept includes exactly those 
attributes satisfied by all the objects in A. A sub-concept super-concept relation is then 
defined in the following way: 
(A1, B1) ≤ (A2, B2) ↔ A1 ⊆ A2 
or equivalently: 
(A1, B1) ≤ (A2, B2) ↔ B1 ⊇ B2 
A concept is of a lower level when it has a larger extent (or equivalently a smaller 
intent). The concepts of a context form a complete lattice (Birkhoff, 1937, 1967) that is 
called the concept lattice of (G, M, I). The intents of a concept lattice are closed under 
intersection (i.e. each intersection of sets of attributes is included in the lattice). The 
collection of the complements of the intents of a formal context is closed under set-
union and then it is a knowledge space (Rusch & Wille, 1996). 
Thus, the concept lattice can be described as a particular diagram, which describes the 
order relationships among the objects within a knowledge space. A lower order 
relationship is defined when a set of objects in a formal concept is contained in another 
formal concept. From this definition, we can deduce that larger is the set of attributes, 
the smaller is the set of objects characterized by those attributes. By increasing the 
number of attributes, the object can be specified. FCA concepts are integrated with 
those of KST in the application of the Formal Psychological Assessment. 
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4. Formal Psychological Assessment description 
FPA approach, by the conjunction of the two described theories, allows the 
development of an instrument with multiples benefits based on the formal 
representation of the relationship between the items of a questionnaire and a given set of 
clinical criteria. The Formal Psychological Assessment can be applied both for the 
construction of new evaluation tools and for the description of the self-report 
instruments used in clinical practice.  
In the first case, FPA allows the creation of an efficient tool:  
 Adaptive, where the item proposed to the patients depend on his/her previous 
answer in a process that mimics semi-structured interviews. 
 Able to provide quantitative and qualitative information. It does not only 
provide a quantitative numeric score, but it also explores the entire patient’s 
symptoms configuration.  
In the second case, FPA allows to analyse in detail the self-report questionnaires in 
order to underline both the strengths and the weakness. 
In FPA, each item included in a clinical self-report questionnaire (or interview) is 
defined as an object. Each object can be described on the basis of a set of elements 
referring to a given theoretical framework. Such elements (which can be either clinical 
symptoms or the decomposition of the diagnostic criteria used to specify one or more 
clinical disorder), are named attributes. Thus, each object can be related to the set of 
attributes it endorses. For instance, in characterizing the items (objects) of a given 
clinical self-report questionnaire, the attributes may be represented by the DSM-5’s 
diagnostic criteria of disorder the questionnaire is supposed to investigate.  
Theoretical flexibility is one of the major strengths of the FPA. In fact, the same objects 
can be described in terms of attributes by referring to different appropriate frameworks 
(Spoto et al., 2013). Each item may investigate one or more attributes and each attribute 
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can characterize one or more items. For example, the item “I am less interested in sex 
than I used to be,” related to depression, investigates the attributes “Diminished interest 
and pleasure” and “Decreased interest in sex,” which represent two diagnostic criteria 
for depression in the DSM-5. On the other hand, the attribute “Diminished interest and 
pleasure” is investigated by several items (i.e., “I have lost most of the interest in other 
people or things”, “I am less interested in sex than I used to be”, “I do not want to do 
anything” and “I seem to have lost interest in the future”). 
Starting from a set of objects (items) and a set of attributes (clinical criteria), a Boolean 
matrix can be built assigning to each object its own set of attributes. The items are 
placed in the rows of the matrix, and the attributes are placed in the columns. Every 
time an item investigates a specific attribute, the corresponding cell of the matrix will 
contain “1”, otherwise the cell will contain “0.” In FPA this matrix represents the 
clinical context. The entire set of objects is the clinical domain of the clinical context. 
The clinical state of a patient consists of the subset of items he/she answered 
affirmatively. It is noteworthy how each clinical state (depicted by the response pattern 
endorsed by a patient) correspond to a subset of attributes. Thus, even if two patients 
respond affirmatively to the same number of items (i.e., obtain the same score to the 
questionnaire), the representation of their two states in terms of attributes are 
systematically different, if the items affirmatively answered are also different. Thus, 
different states may have the same clinical score (Serra et al., 2015a), but will collect 
different attributes. This is fundamental from a clinical point of view, since it allows for 
the analysing and, therefore, the treating, of each subject individually, according to 
his/her symptoms configuration. The configuration of symptoms as an output also 
makes possible to overcome the problem of gender differences in depression assessment 
(Santor, Gregor, & Welch, 2006); indeed, the clinician will not have only the numerical 
score, but the whole symptomatology of the individual. The clinical context is the 
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Boolean representation of the clinical structure, which is the set representation of the 
implications among the items of the domain. The clinical structure contains all the 
clinical states that are formally expressed by the matrix. In fact, not all the subsets of 
items are admissible response patterns given a theoretical framework (thus, given the 
formal context). For instance, if a given item i endorses attribute a, while item j 
endorses attributes a and b, the clinical state corresponding to {i} is admissible. On the 
other hand, the state {j} is not admissible since a person who affirmatively answers item 
j is supposed to present both attributes a and b, and thus, he/she should affirmatively 
answer even item i. For this reason, the state {i,j} is admissible too. In this case, item i 
is said to be a prerequisite of item j since there is no state in the structure that includes 
the latter but not the former. The prerequisite relation among the items, obtained from 
the matrix through the formal mathematical passages, can be represented as a complete 
lattice depicting the clinical structure. Thus, the implications of the items form 
prerequisite relations can be described in the same way as KST but in a clinical context. 
In other words, the prerequisite is an item that contains the same attribute “a” of another 
item that contains the same attribute “a” and another one or more (for example “b”). 
The first item is needed to get a positive answer to the second item. The prerequisite 
relation among the items obtained from the matrix can lead to the development of 
adaptive and qualitative tools as well as quantitative tools (Donadello et al., 2016; Spoto 
et al., 2010). 
From a strictly methodological perspective, the clinical structure derived from the 
matrix can be developed in various ways using the concepts of KST and FCA. From a 
clinical perspective, we would like to explain two model derived from the clinical 
structure: The conjunctive model and the disjunctive model, which have been 
mentioned for the KST. 
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 Conjunctive model assumes that if an individual positively responds to an item, 
he/she should endorse all the attributes, in FPA clinical criteria (i.e. symptoms) 
investigated by that item. With this model, the affirmative answers are more 
informative than the negative ones; indeed each affirmative answer inform us 
that the patients has all the symptoms investigated by that item. For example, 
item j “I do not have need and energy to have sex” could include two symptoms. 
The two clinical criteria associated are “decreased interest in sex” and “fatigue 
or energy loss” for the major depressive episode of DSM-5. The conjunctive 
model assumes that if the patient answers “yes” to the item j, then he/she will 
have both symptoms (attributes) associated with that item. 
 Disjunctive model assumes that if an individual responds positively to an item, it 
means that he/she has at least one attribute investigated by that item. In this 
model, the negative answers are the more informative because they inform us 
that the patient has none of the symptoms signalled by that item. In other word, 
in the item j “I do not have need and energy to have sex”, if the patient replies 
“yes” it can mean three possible thinks: A) the patient has the diagnostic criteria 
“fatigue or energy loss” and not “decreased interest in sex”. B) The patient has 
the diagnostic criteria “decreased interest in sex” and not “fatigue or energy 
loss”. C) The patient has both the clinical criteria. Otherwise, if the patient 
replies “no” it means that he/she has not these two clinical criteria. 
From the clinical point of view, we prefer to use the conjunctive model as each 
affirmative answer inform us that the patients has all the symptoms investigated by that 
item. Then in our model, we assume that when the individual replies “yes” he has all the 
criteria endorsed by the item in question.  
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To sum up, the first step of FPA methodology is the deterministic model construction, 
which consists of the construction of the matrix assigning to each item of the scale the 
subset of attributes it investigates.  
The second step concerns the construction of the clinical structure from the attributes 
assignment. The result can be represented as a lattice where each node represents a 
clinical state and its set of attributes (Spoto et al., 2010). The lattice is a deterministic 
representation of the prerequisite relation among the items of the domain.  
It is evident how a completely deterministic approach is inadequate for assessment in 
clinical practice for three main reasons: 
 First, not all clinical states have the same probability of occurring.  
 Second, in self-report tools, problems with patient insight or with item wording 
may prevent a perfect correspondence between the observed response pattern 
and the actual clinical condition of the patient. 
 Third, the deterministic model needs to be tested on real data.  
Therefore, a probabilistic approach is needed and, it is applied in the same way of KST. 
The basic local independence model (BLIM; Doignon, & Falmagne, 1999) is a 
probabilistic model that defines a probabilistic clinical structure where a probability 
value is assigned to each clinical state. In the BLIM, the responses to each item are 
locally independent given the clinical state of a subject. Starting from the probabilistic 
structure, the probability of a response pattern depends on the conditional probability of 
that pattern given an underlying clinical state (for each state; Doignon & Falmagne, 
1985). The false negative (β) and the false positive (η) rates for each item define the 
conditional probability (Falmagne & Doignon, 2011). The clinical structure, by means 
of the probabilistic weights obtained through the application of the BLIM, could be 
used to implement an algorithm.  
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The last step in the application of FPA is the implementation of the obtained structure, 
weighted through the estimated parameters, into an adaptive algorithm for the clinical 
assessment. Such an algorithm can be roughly divided into three main parts 
corresponding to different moments of inferential process. First, the algorithm has to 
select, among all the possible items to be asked, the most informative one. To perform 
this task, one of the most reasonable solutions is to identify the item that best splits the 
probability mass. Later the system registers the reply provided by the individual and it 
automatically updates the new probability of the states. Indeed, in case of positive reply, 
the system increases the probability of the states that include the asked item, and 
decreases the probability of the other states. If the reply of the individual is “no” the 
system increases the probability of the states which do not include the asked item. In 
this way, a sequence of question is asked and at the end, one of the all clinical state of 
the structure should achieve an high probability value (with a fixed cut-off). This 
clinical state represents the most likely symptomatic representation of the patient’s 
situation regarding a specific disorder. At this point, the algorithm stops and provides 
the clinician with the score, the response pattern, and the attributes configuration (all the 
symptoms complained by patients).   
In this way, FPA allows for an adaptive, quantitative and qualitative tool: adaptive 
because, based on the structure, it selects each question to maximize the collectable 
information; quantitative because it could provide a numerical score; and qualitative 
because it provides information about all the subjects’ symptoms. 
The next three chapters of this work will be devoted to describing how we applied the 
FPA in assessing mood disorders. This dissertation work is divided into four parts: 
• The first will describe the application of the FPA method in the analysis of 
seven self-report questionnaires for the evaluation of the major depressive 
episode. 
 75
• The second will describe the construction and validation of a new self-report 
questionnaire using the FPA methodology that allows differentiating patients 
with the same score but different depressive symptoms. 
• In the third, the application of the adaptive algorithm to the new questionnaire 
via the FPA will be shown. 
• The last research deepens the topic of agitated depression, in a study of 3750 
patients with mood disorders. This study, carries out in England (data come 
from BDRN of UK) underlines the need of new effective tool for the differential 
diagnosis in Major Depressive Episode. 
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CHAPTER 4  
 
Application of FPA to analyse the relations 
between item and diagnostic criteria in Major 
Depressive Episode  
 
1. Introduction & Research aim 
The increase of depression in the last few years is a debated topic (Serra et al., 2015a). 
Some authors argue that, nowadays, depressive disorders with bipolar disorder are the 
most common type of disease in the world, though often unrecognized and inadequately 
treated (Kupfer et al., 2012; Lancet Editorial, 2012). 
The correct identification of depression during the assessment phase is a critical issue. 
Despite this, many authors report that the evaluation tools available to the clinician are 
not effective enough for a proper identification of depressive symptoms for various 
reasons (Serra et al., 2015a). 
In a critical study, Balsamo and Saggino (2007) underlined the strengths and 
weaknesses of some important self-assessment tools of depression. The purpose was to 
avoid confusion in clinical practice. Specifically, the study explored the psychometric 
properties of six self-report measures of depression. The Beck Depression Inventory-II 
(BDI-II; Beck, Steer, & Brown, 1996). The Center for Epidemiological Studies 
Depression Scale (CES-D; Radloff, 1977). The Zung Self-Rating Depression Scale 
(Sakamoto, Kijima, Tomoda, & Kambara, 1998). The Clinical Depression 
Questionnaire (CDQ; Krug and Laughlin, 1976). The Questionnaire for Depression 
(QD), included in the Cognitive Behavioral Assessment 2.0 battery (CBA 2.0; Sanavio 
et al., 1986); and the D scale of the Minnesota Multiphasic Personality Inventory 
(MMPI; Hathaway and McKinley, 1942). Balsamo and Saggino (2007) showed that 
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each scale reflects the authors’ theories, which were constructed to measure different 
aspects of the same construct. Thus, each scale emphasized the evaluation of some 
symptoms and neglected the evaluation of others, leaving incomplete overall evaluation. 
Pettersson, Boström, Gustavsson, & Ekselius  (2015) conducted a systematic review on 
evaluating depression tools, which revealed that only the Structured Clinical Interview 
for DSM-IV Axis I Disorders (SCID-I; First et al., 1996), the Mini-International 
Neuropsychiatric Interview (MINI; Sheehan et al., 1998), and the Patient Health 
Questionnaire (PHQ-9; Manea, Gilbody, & McMillan, 2012) fulfilled the minimum 
criteria for sensitivity and specificity. Out of these three tools, only the PHQ-9 is a self-
report measure that can be used for screening, diagnosis, monitoring, and measuring the 
severity of depression. 
Regarding PHQ-9, although it is composed of nine items that correspond to the 
symptoms of depression according to DSM-IV, it does not distinguish insomnia from 
hypersomnia, and does not distinguish psychomotor retardation from psychomotor 
agitation. In fact, in PHQ-9 there is only one item for insomnia-hypersomnia and one 
item for psychomotor retardation-psychomotor agitation. Therefore, it is not potentially 
able to differentiate different depressive symptoms that, as such, should be treated in 
different ways. 
The present work aims to describe a practical application of FPA to illustrate procedural 
issues, discuss the advantages of the approach, and show its potential for psychological 
assessment, relating to depression. In particular, in this work FPA is applied to analyze 
the “item content” of the most used self-report questionnaires for the depression’s 
evaluation. Indeed FPA allows creating relations between “item content” and diagnostic 
criteria to the assessment of Major Depressive Episode (MDE). In keeping with 
previous research, the main task of the first study is to underline the strengths and the 
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weaknesses of widely used depression tools, in relation of their ability to investigate all 
the symptoms of MDE. As suggested by Balsamo and Saggino (2007) it is crucial to be 
aware of what aspects may not be investigated through the specific used assessment 
tool. To achieve this aim we use the main concept of FPA described in the Chapter 
above. 
2.  Method 
2.1 Attributes’ selection 
In order to analyze the relations among a large set of items used to investigate 
depression through self-report measures and a set of symptoms of MDE, we mostly 
refer to three areas to derive the symptoms of Depression:  
1. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5; 2013). We 
have chosen to use the DSM-5 as it appears to be an exhaustive manual designed 
for both the researcher and the clinician (Reed et al., 2013)  
2. The clinical features most frequently reported in literature to describe MDE. 
3. Seligman’s and Beck’s etiopathogenetic theories. 
As described in detail in the first chapter, depression is characterized by deep sadness 
and despair, hopelessness, helplessness, and worthlessness (Goodwin & Jamison, 2007; 
Otto, Andreas, Von Klitzing, Fuchs, & Klein, 2014). Furthermore, a depressed mood is 
associated with anhedonia (Gaillard et al., 2013; Goodwin & Jamison) apathy 
(Alexopoulos et al., 2013; Mulin et al., 2011) loss of motivation (Jormann, & Quinn, 
2014) crying (Goodwin & Jamison; Koukopoulos et al., 2007), and irritability (Akiskal, 
& Benazzi, 2003; Henderson, Johnson, Vallejo, Katz, Wong, & Gabbay, 2013; Pedrelli 
et al., 2013). Feelings of guilt are frequent (Goodwin & Jamison, 2007; Singh, & 
Sharma, 2013) in more severe forms, they can result in delusion of guilt (Goodwin & 
Jamison, 2007). Sleep problems characterize depressed patients and frequently their 
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insomnia is “terminal” (waking early in the morning) or characterized by frequent 
nocturnal awakenings or by feelings of not being rested after waking up (Goodwin & 
Jamison, 2007; Hamoen, Redlich, & Weerd, 2014); conversely, some patients 
experience hypersomnia (Goodwin & Jamison, 2007). Work and social relationships are 
often severely compromised (Fried & Nesse, 2014; Goodwin & Jamison, 2007). 
Psychomotor retardation can present as simple motor slowing, but more often does so as 
ideation and speech slowing as well as concentration difficulties (Bracht et al., 2012; 
Goodwin & Jamison) which accompany fatigue and energy loss (Fava et al., 2014). 
Many patients experience agitation, which can manifest as restlessness, incapacity to sit 
still, torturing hands and/or hair or even biting nails and/or lips (Akiskal, & Benazzi, 
2004; Goodwin & Jamison, 2007; Koukopoulus et al., 2007; etc.). Sexual disorders such 
as decreased libido can be observed (Goodwin & Jamison, 2007). Lastly, ideas of death 
such are usually associated with depressed mood (Goodwin & Jamison, 2007; Olin et 
al., 2012). Suicide is the most tragic consequence of depression and the number of 
suicides has not decreased since the use of antidepressants (Baldessarini et al., 2006a).  
Beck’s and Seligman’s theories have been described at the end of the first chapter. 
Beck’s model (Beck, 1991, 2005) categorizes typical beliefs and mistakes of depression 
as a cognitive triad that includes a negative view of self, a negative view of the world, 
and a negative view of the future.  
Seligman’s theory (Seligman, 1972), based on animal experimentation, suggests that 
depression is associated with the conviction that nothing can be done to face stressful 
life events. This is learned helplessness, which tends to be generalized to new situations 
with the expectation of having no control over the future (Abramson et al., 1978). 
In the research we explored the symptoms derived from DSM-5 diagnostic criteria for 
major depressive disorder (15 attributes), Seligman’s and Beck’s theories (3 attributes) 
and, finally, attributes widely described in the literature (2 attributes):  
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 apathy (Alexopoulos et al., 2013; Mulin et al., 2011) as a state of indifference to 
the world, characterized by inability to express feelings and lack of will. 
  irritability (Akiskal, & Benazzi, 2003; Henderson et al., 2013; Pedrelli et al., 
2013) which is expressed with frequent spells of weeping, mood lability, 
nervousness, and marked reactivity. 
Subsequently, tools and clinical symptoms of depression have been selected for the 
construction of the model according to FPA procedure. In line with FPA all the 
clinical criteria in Table 4.1 were placed in the columns of the Boolean matrix.  
 
Table 4.1: the twenty attributes (clinical criteria) of the clinical context. 
Attribute Explanation 
A1 Depressed mood  
A2 Diminished interest and pleasure  
A3 Decreased interest in sex 
A4 Increase or loss of weight  
A5 Gain or loss of appetite  
A6 Insomnia or hypersomnia 
A7 Agitation 
A8 Psychomotor retardation 
A9 Fatigue or energy loss 
A10 Feelings of worthlessness (or Beck’s negative view of self)  
A11 Feelings of guilt 
A12 Diminished ability to think and concentrate  
A13 Indecision 
A14 Recurrent thoughts of death 
A15 Suicidal ideation or attempted suicide  
A16 Beck’s negative view of the world  
A17 Beck’s negative expectation of the future  
A18 Seligman’s learned helplessness 
A19 Irritability 
A20 Apathy 
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2.2. Object’s description (Self-report Questionnaires)  
Four self-evaluation questionnaires developed in English, one self-report questionnaire 
in French, and two self-report questionnaires in Italian were selected (each here 
presented in English). 
• The Beck Depression Inventory II (BDI-II; Beck, Steer, & Brown, 1996) is one 
of the world’s most widely used self-report questionnaires for the evaluation of 
depression. BDI-II contains 21 items that explore various facets of depression. 
Each item has four possible answers of increasing severity, for a total of 84 
items (21x4). The recommender cut-off is 17. The tool appears to be both agile 
and sensitive. 
• The Self-rating Depression Scale (SDS; Zung, 1965) assesses the level of 
depression. The tool explores affective, somatic, and psychological dimensions 
of depression. It consists of 20 items: two for the affective symptoms, eight for 
somatic symptoms and ten for cognitive symptoms. Items are evaluated on a 4-
point scale that corresponds to: 1 = nothing or only for a short time; 2 = a little 
bit of time; 3 = a big part of the time; 4 = continuously or much of the time. The 
tool is very simple and quick. 
• The Rome Depression Inventory (RDI; Pancheri, & Carilli, 1982) consists of a 
series of 25 items evaluated on a 4-level scale, from 1 (no) to 4 (very severe). 
The items of this tool use the phrases most frequently complained by depressed 
patients to describe their illness and discomfort. 
• The Plutchik-Van Praag self-report depression scale (PVP; Plutchik, & Van 
Praag, 1987) was developed with 34 items to cover all the DSM-III diagnostic 
criteria for depression. Items are evaluated on a 3-point scale (0 to 2), where 0 = 
absent 1 = moderate; 2 = marked. Scores of 20-25 indicate a likely depressive 
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disorder. Since these diagnostic criteria have remained largely unchanged in 
DSM-5, this scale still holds great validity. 
• The Carroll Rating Scale (CRS; Carrol, Feinberg, Smouse, Rawson, Greden, 
1981), is a self-report version of the Hamilton Rating Scale for Depression 
(HAMD; Hamilton, 1960), consisting of 52 dichotomous items. Items can only 
have a “yes” or “no” answer. 
• The Self-Assessment Scale for Depression (SAD; Cassano & Castrogiovanni, 
1982). It consists of 31 items. Items are evaluated on a 4-level scale, from 1 
(absence of symptom) to 4 (maximum severity). The authors tried to use a 
language close to that of patients in the formulation of the items to contribute to 
a better comprehension of questions and a higher reliability of the instrument.  
• Finally, the Center for Epidemiological Studies Depression (CES-D; Radloff, 
1977; Eaton, Muntaner, Smith, Tien, Ybarra, 2004) has been one important 
instrument in depression epidemiology since its first use in Community Mental 
Health Assessment Surveys in the 1970s. The self-report version is widely used 
and consists of 20 items. 
In conclusion, the total number of items adds up to 266. All these items were placed in 
the rows of the Boolean matrix.  
2.3. Procedure 
Every item in the clinical self-report questionnaires described above was initially 
considered. 
These items became the objects of the matrix and represented the rows of the matrix for 
an initial 266 items: 84 in BDI-II, 20 in SDS, 25 in RDI, 34 in PVP, 52 in CRS, 31 in 
SAD, 20 in CES-D. 
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The attributes of the clinical context were obtained from the DSM-5 (15), Beck’s theory 
(2), Seligman’s theory (1), and the literature (2) for a total of 20 attributes, which are 
placed in the columns of the matrix. 
In this way it is possible to find out what attributes belong to each item, what attributes 
describe any particular object, and to identify relationships of great clinical and formal 
importance among objects and attributes (Serra et al., 2015a). Two experts in the field 
of depression built the clinical context (i.e., the Boolean matrix). The two Psychologists 
were asked to fill independently a Boolean matrix with the items in rows and the 
attributes in columns. Whenever an item, in their opinion, investigated a specific 
attribute (symptom), the corresponding cell in the matrix should have been filled with 1, 
otherwise with 0. The agreement was calculated using Cohen’s K coefficient, and the 
value was 0.83 indicating a good agreement between experts. The remaining 
disagreements were discussed and solved by means of a focus group between the 
experts. 
Applying the FPA, four different configurations that may occur within the matrix 
deserve a separate description, since they produced important modifications in the 
number of items to be included in the final model: 
1. Items that investigate none of the attributes for depression are not useful for the 
measurement of the construct (their row in the matrix will contain only zeroes). 
In this case the items were not considered sufficiently precise for the depression 
construct by the two experts. However, if an item investigated an important 
attribute that was not included in Table 4.1, it was taken into account by the 
experts in the final evaluation. 
2. Different items investigating the same set of attributes form equivalence classes. 
It is then useful to choose the items that relate better with the investigated 
attributes. 
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3. Attributes not investigated by any item necessitate the construction of new ad 
hoc items to investigate them. Attributes (i.e. symptoms) for MDE were chosen 
by experts in the field of mood disorders, so the selected clinical criteria were all 
considered essential for evaluating the construct. 
4. Some items present problems with phrasing, construction, or validity. In this 
case, the experts could not consider that specific item by explaining the reason. 
The resulting formal context is the starting point for the evaluation of a single item and 
of a single self-report questionnaire. Moreover the clinical context is the reference point 
for the future construction of a new tool through FPA (the description of this following 
passage will be the core of the next Chapter which is the second research of this work). 
 
3. Results  
 
3.1 The clinical context   
The clinical context is the first result. Therefore, from Table 4.2, it can be seen that the 
first key result is that we were able to get 30 equivalent classes collecting the same 
information redundantly investigated by the initial 266 items.  
Conditions 1, 2, and 4, described in the previous section, allowed:   
 To group many questions repeated with different words, in the various self-
report questionnaires consulted. Items that investigated the same attributes, and 
consequently formed equal rows, were replaced by a single item that included 
the set of attributes belonging to the items. The item was chosen as the most 
representative of the equivalence class. 
 To eliminate some items since they did not investigate any of the selected 
attributes; they were not considered part of the depression construct. 
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 To exclude others items because of problems with their phrasing (double 
sentences, fuzzy adverbs). The two professionals have judged some items as 
potentially difficult to interpret for patients and therefore potentially unsuitable 
for evaluation. 
Through these procedures, we were able to get a much more malleable matrix with 
30 equivalent classes covering all the identified diagnostic criteria. 
Another interesting result of the application of FPA to the set of items was the 
identification of several items with methodological problems such as:  
- Double phrases (“I’m depressed” or “I often want to cry”) with the consequent 
problem of investigating separately in the same item different attributes making the 
patient’s response questionable.   
- Fuzzy adverbs (“my life is pretty full”).  
- On the other hand, problems with content validity (item CRS.40: “I got sick 
because of the bad weather we have been having”). 
Another important key finding is that the matrix allowed analysis of the equivalent 
classes of items and their attributes; some classes investigate subsets of attributes 
assessed by others. In this way, a prerequisite relationship among different classes is 
derived. For instance, RDI-10, “I feel quite useless,” which investigates feelings of 
worthlessness, is a subset of RDI.2, “I feel a burden to others,” which also contains 
feelings of guilt; and these two items are prerequisites for SDS.19, “I feel that others 
would be better off if I were dead,” which contains feelings of worthlessness and 
guilt, and thoughts of death. 
The relationships created among items in the matrix generate the clinical structure. 
Many other inclusion relations among equivalent classes were observed and can be 
derived from Table 4.2. All these relations are critical because they describe FPA’s 
adaptive reasoning, suggesting the possibility of applying prerequisite relations in 
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the clinical context. In fact, if the response to the prerequisite of a particular item is 
negative, a positive response to the other item will be logically excluded (as 
explained in the previous Chapter). 
Table 4.2 displays the clinical context containing the thirty items and the twenty 
attributes. It has to be stressed that this representation, that is convenient for 
explanatory purpose, is equivalent to the Boolean matrix with thirty rows and 
twenty columns explained in the FPA section and in this research. 
 
Table 4.2: The clinical context containing the thirty items and the twenty attributes.  
ID Item Text Attributes 
I1 BDI-II.24 I feel like I am being punished A 11 
I2 BDI-II.42 I feel more restless or wound up than usual A7 
I3 BDI-II.47 I have lost most of the interest in other people or things A2, 20 
I4 BDI-II.51 I have much greater difficulty in making decisions than I used to A13 
I5 BDI-II.58 I have less energy than I used to have A9 
I6 BDI-II.63 I sleep a lot more than usual A6, 8, 9 
I7 BDI-II.74 I can’t concentrate as well as usual A12 
I8 BDI-II.82 I am less interested in sex than I used to be A2, 3 
I9 ZUNG.1 I feel down-hearted and blue A1 
I10 ZUNG.3 I have crying spells or feel like it A1, 7 
I11 ZUNG.4 I have trouble sleeping at night A6 
I12 ZUNG.15 I am more irritable than usual A 19 
I13 ZUNG.19 I feel that others would be better off if I were dead A14, 10 11 
I14 RDI.4 I do not really want to eat A5 
I15 RDI.7 I do not want to do anything A2 9 
I16 RDI.8 I seem to have lost interest in the future A2, 17, 20 
I17 RDI.10 I feel quite useless A10 
I18 RDI.23 I feel a burden to others A10, 11 
I19 PVP.23 the speed of my thinking seems to be reduced A8, 12 
I20 PVP.28 I think of the families and friends who have died A14 
I21 PVP.31 I have made a suicide attempt A15 
I22 CRS.2 I am losing weight A4 
I23 CRS.12 Dying is the best solution for me A14, 15 
I24 CRS.19 I wake up often in the middle of the night A6, 7 
I25 CRS.21 I am so slowed down that I need help with bathing and dressing A8, 9, 20 
I26 CRS.47 I get hardly anything done lately A 8, 9, 18 
I27 CRS.48 There is only misery in the future for me A 17 
I28 SAD.30 I have the impression of being aloof and not to feel affection for my family members A 20 
I29 CES-D.3 I felt that I could not shake off the blues, even with help from my family or friends A1, 18 
I30 CES-D.15 People were unfriendly A16 
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An important observation concerns RDI.2, “I feel better in the evening than in the 
morning.” It is difficult to assign attributes to this item, but despite this, it is very 
representative of depressive symptoms. Perhaps it would be appropriate to create an ad 
hoc attribute for this item. 
Thanks to the analysis of all the items of the seven self-report tools, we achieved 
different aims:  The clinical context obtained by the 30 chosen items of the total 266, 
which investigate all the clinical criteria selected, represents the starting point for the 
construction of a new tool. Indeed, these items contain all the clinical information 
considered by us to be important for the assessment of depression; moreover, we have 
also been able to observe potential new attributes (symptoms) to consider in the next 
step (the construction of a new tool trough FPA methodology). Finally, the first clinical 
context obtained by the total 266 items allowed us to underline the weaknesses of the 
seven self-report tools. 
3.2 Self-report questionnaires analysis. 
None of the explored questionnaires could cover all the attributes for depression alone. 
 BDI-II does not provide information concerning change in weight, Beck’s 
negative view of the world and Seligman’ learned helplessness.  
 In SDS, there are no items investigating psychomotor retardation, possible 
feelings of guilt, possible suicidal attempts, or thoughts of death and Seligman’ 
learned helplessness. Some symptoms are part of the diagnostic criteria of the 
DSM-5 and, despite their obvious importance, are not considered.  
 Even in RDI, some of the attributes derived from the DSM-5 are not 
investigated: weight modifications, the decrease in sexual interest and pleasure, 
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psychomotor retardation, thought of death, possible suicidal attempts and 
Seligman’ learned helplessness.  
 PVP was built to create an ad hoc self-report questionnaire for depression 
investigating all DSM diagnostic criteria, however, it does not take into account 
negative view of the world, negative expectation for the future of beck theory, 
and Seligman’ learned helplessness. 
  The only attribute missing in CRS is indecision. Nevertheless, some items have 
problem of content validity (i.e. item CRS.40: “I got sick because of the bad 
weather we have been having”). 
  SAD does not take into account psychomotor retardation and suicidal ideation 
or attempts.  
 Finally, the CES-D does not investigate decreased interest in sex, change in 
weight, indecision, recurrent thoughts of death, suicidal ideation or attempts and 
irritability 
 
4. Discussion 
This work has shown how the FPA highlights each self-report questionnaire’s strengths 
and weaknesses in terms of correspondence to a set of diagnostic and clinical criteria. 
The FPA details the relations between objects (items) and attributes (decomposition of 
clinical and diagnostic criteria). This methodology allows to eliminate useless 
redundancy and to increase efficiency. FPA also allows for the pinpointing of the 
relations among sets of items and attributes by analyzing the presence or absence of 
diagnostic criteria in the items.  
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Flexibility is another crucial advantage of FPA: the set of attributes could be easily 
modified or updated according to new versions of DSM or to different theoretical 
approaches, while the methodology remains equally effective and reliable.  
One important result of this first research is the identification of 30 equivalent classes 
representing the basis for an assessment tool for depression. Such an instrument would 
explore all the selected diagnostic criteria in term of attributes, without redundancy, and 
would provide the clinician with a clear reference between items and construct criteria 
to mimic the interview procedure. The careful analysis of the items of the 
questionnaires has allowed creating the skeleton for the construction of a new 
instrument for the major depressive episode.  
The strong innovation of FPA comes from the construction of the matrix that allows for 
the identifying of the actually existing relations among items in terms of the clinical 
symptoms they endorse. As stated before, such information is already present in the 
items, but it is hidden by a classical testing methodology that considers the score the 
most relevant output that questionnaire provides. 
The matrix can be expressed in terms of the clinical structure that is the core of the 
methodology. The structure is the set representation of the implications among the items 
of the domain. Indeed, it contains all the clinical states (see Chapter 3). The prerequisite 
relation allows for adaptivity, just as, in a semi-structured interview, the individual is 
driven to respond to items according to what he answered previously. For example, in 
the case of depression, if a patient answers “no” to an item relating to “thoughts of 
death,” the adaptive algorithm of FPA will not investigate whether he intends to die by 
suicide because “having thoughts of death” is a prerequisite of the suicide attempt. In 
this way, the tool becomes adaptive because it allows for a thorough analysis of the 
areas in which the patient suffers.  
 90
This work showed the multiple advantages of FPA methodology. It avoids redundancy 
and unnecessary collection of information saving time and energy. Moreover, the 
clinician obtains qualitative information about a patient’s symptoms in a systematic and 
methodologically solid framework (Serra et al., 2015a). Indeed, different response 
patterns (i.e., different attribute configurations) may characterize people who obtain the 
same scores on a self-report questionnaire. The information can be used by FPA to 
detect differences among these people, and produce specific indicators that could be 
used when planning treatments (Bottesi, Spoto, Freeston, Sanavio, & Vidotto, 2015a). 
Specific psychological mechanisms underlying each patient’s phenomenology are 
thought to have implications for treatment effectiveness (Serra et al., 2015a). 
Different combinations of symptoms could produce the same score on a self-report 
questionnaire, although such information might not be regarded in clinical practice. 
Indeed, considering two individuals who obtained similar scores on the Somatic-
Affective Scale of BDI-II, such scores may arise predominantly from an elevation in 
either somatic or affective features. BDI-II does not allow for discrimination between 
the two cases. On the contrary, FPA is useful in clarifying the specific clinical 
configuration depicted by the observed response pattern, rather than the mere score.  
Summarizing, the FPA, through its methodology, allows for the construction of new 
clinical tools for clinical evaluation following efficient and effective principles beyond 
the assessment of depression. In this particular case, starting from several self-report 
questionnaires and numerous diagnostic criteria considered essential for the assessment 
of depression, the FPA applied to depression’ questionnaires allowed for the creation of 
a start point to the construction of a new tool with many added benefits compared to the 
self-report questionnaires used in the research.  
You can find a short version of this work in “Serra, Spoto, Ghisi & Vidotto, 2015, Plos 
One”. 
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In the next chapter, the steps for the construction and the validation of a new tool will 
be discussed. In particular, the new tool built up for the assessment of Major depressive 
Episode shows the opportunity to fruitfully use the qualitative information already 
present in the questionnaire, but hidden by the score, which is crucial when it comes to 
suggesting the elective treatment strategies. Therefore, FPA could represent an 
important approach for improving case conceptualization and treatment implementation. 
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CHAPTER 5 
The construction and validation of a new tool 
through Formal Psychological Assessment: the 
clinical state as effective output. 
 
1. Introduction and research aim 
 
Over the years, many improvements have been achieved in the various stages of the 
assessment. In Chapter 2, we reviewed the history of the assessment, highlighting the 
attempts of improvement and the weaknesses that still exist. In this Chapter, we focus 
on the limitations found in depression assessment tools, and on the other hand, on the 
general limits of self-report tools, with the most important goal of finding a solution. 
Specifically, the tools for evaluating mood disorders, particularly those involving major 
depressive episodes (MDEs) ones, show some application limits. Some studies 
highlighted critical issues regarding self-report depression tools and this is crucial for 
assessment and treatment (Baldessarini, Vieta, Calabrese, Tohen, & Bowden, 2010; 
Hyman, 2014). As reported in the previous Chapter, Pettersson and colleagues (2015) 
identified sensitivity and specificity issues. Balsamo and Saggino (2007) found limits in 
the psychometric properties of six regularly used self-report questionnaires (e.g.  
Overestimation of symptoms by patients compared to the results obtained in the 
interviews); moreover, each scale reflected the author’s theories, each measuring 
different aspects of the same construct. This last issue was discussed in the previous 
Chapter, as it was found in the analysis of seven habitually used self-report 
questionnaires through the FPA approach. In fact, the analysis of relationship between 
items and diagnostic criteria highlighted as no questionnaire alone could cover all 
diagnostic criteria for the evaluation of the Major Depressive Episode. 
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More in generally, many authors underlined the weaknesses of self-report tools and in 
particular, the psychometric approach issues.  
Gibbons, Clark, Cavanaugh, & Davis (1985) emphasized that the traditional method of 
scoring can be “wrong” because it is based on assumptions that may be false: it gives 
equal “weight” to each item, assuming that each item or symptom of a clinical scale 
represents an equal level of psychiatric severity. 
Moreover, as many authors showed, self-evaluating questionnaires allow for a 
systematic and quick collection of a large amount of information and the avoidance of 
patient embarrassment. However, they redundantly (non-adaptively) investigate 
constructs and provide only a quantitative numeric score that does not systematically 
account for qualitative information (Bottesi et al., 2015a; Fava, Ruini, & Rafanelli, 
2004; Shapiro, 1951; Spoto et al., 2013; Wright and Feinstein, 1992). 
Based on the assumptions of the studies described above, it is important to consider all 
of the limits that self-report tools have, by taking into account the possible 
overestimation of symptoms by patients (Faravelli, Albanesi, & Poli 1986), and the 
inability of MDE self-report measures to enclose the whole set of depressive symptoms, 
whether agitated or inhibited (Koukopoulos and Koukopoulos, 1999; Serra et al., 
2015a), in the construction of the item. Finally, it is also relevant to remember not to 
take into account only the patient’s cut-off scores (Bottesi et al., 2015a; Fava et al., 
2004; Gibbons et al., 1985). As a consequence of the last statement, even overtaking or 
not overtaking the cut-off may not always be so important. In fact, the cut-off provides 
only a quantitative score, but if two patients have the same score, it does not mean that 
they have equal symptomatology (one could be much more serious than the other, since 
he/she responded positively to more severe symptoms). 
The purpose of this study is to create a new tool for Major Depressive Episode (MDE) 
evaluation to overcome the difficulties of the MDE tools described above. The present 
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study aims to construct an adaptive-qualitative tool that investigates all MDE clinical 
features and provides qualitative information (and not just a score) to differentiate 
patients with the same score but different symptoms as well as differing severities of 
psychopathology. In this work, we applied again the FPA framework and fruitfully use 
the main concepts described in chapter 3.   
2. Materials and Methods 
2.1.Tool Construction 
Three important steps were achieved in constructing the new tool: 
First, various features and symptoms (clinical criteria) of MDEs were analysed and 
categorized as attributes of the clinical context. As described in the DSM-5, there are 
different types of Major Depressive Episodes (MDEs); in particular, a MDE may be 
part of major depressive disorder (MDD) or bipolar disorder (BD, Type I or II), with 
symptoms more agitated or more inhibited. 
Second, the items (objects of the clinical context) were constructed on the basis of one 
or more chosen clinical criteria (attributes). 
Third, In line with the FPA methodology, the matrix was obtained to analyse all of the 
relationships among items (objects) and diagnostic criteria (attributes). More 
specifically, the items of the tool were verified as covering the entire set of clinical 
criteria (all columns contained at least one “1”). This result was achieved through the 
agreement of four specialists in the field of mood disorders selected on the basis of their 
expertise in the field of Cognitive Behavioural Therapy and psychological assessment. 
More specifically, experts were asked to fill independently a Boolean matrix with the 
items in rows and the attributes in columns. Whenever an item, in their opinion, 
investigated a specific attribute, the corresponding cell in the matrix should have been 
filled with 1, otherwise with 0. The Cohen’s k coefficient was computed for each pair of 
experts’ matrices and resulted in an average value of 0.88 indicating a very good 
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agreement among experts. The remaining disagreements were discussed and solved by 
means of a focus group. 
First of all, MDE is described by the decomposition of the DSM-5 diagnostic criteria 
(2013) for this disorder (it may be part of both MDD and BD). All of the described 
diagnostic criteria were taken into account:  
• A1 (depressed mood), A2 (diminished interest and pleasure), A3 (decreased 
interest in sex), A4 (increase or loss of weight), A5 (gain or loss of appetite), A6 
(insomnia or hypersomnia), A7 (agitation), A8 (psychomotor retardation), A9 
(fatigue or energy loss), A10 (feelings of worthlessness), A11 (feelings of guilt), 
A12 (diminished ability to think and concentrate), A13 (indecision), A14 
(recurrent thoughts of death), and A15 (suicidal ideation or attempted suicide).  
Criterion A15 underlines the seriousness of “suicidal ideation” in MDE. We 
decided to separate this symptom by thoughts of death. According to several 
authors, suicide is indeed the third-highest cause of death in the population 
between 15 and 35 years old (Baldessarini et al., 2006a; Gunnell and Middleton, 
2003) and it is often associated with misdiagnosis. Moreover, suicide is 
associated with a mood disorder in 90% of cases (Baldessarini et al., 2006a). 
• Attributes A16, A17, and A18 are related to two cognitive behavioural theories, 
Beck’s hopelessness theory and Seligman’s helplessness theory, which are 
described in the first Chapter. 
After a careful literature review, other clinical criteria for MDE were taken into account 
because they are widely described in the literature, and they are potentially able to 
discriminate between different types of MDEs: 
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• Criterion A19 refers to irritability (Henderson et al., 2013; Pedrelli et al., 2013); 
a person with depression can easily feel frustrated, which often results in anger, 
crying, nervousness, and mood lability (Benazzi & Akiskal, 2005). 
•  Criterion A20 refers to apathy (Mulin et al., 2011; Alexopoulos et al., 2013). 
Patients with depression often are characterized by decreased emotional 
reactions to situations and events in everyday life. Apathy is expressed in the 
form of indifference, physical inertia, or lack of reaction when facing situations 
that would normally arouse interest or emotion, as well as a reduction of 
purposeful behaviour, a lack of initiative, and submission in one’s daily choices. 
The clinical criteria described above are the same as used in the previous research. In 
keeping with the previous research and the self-report questionnaires content, (see 
Chapter 4) we have added three other clinical criteria: 
• Criterion A21 refers to health concerns (House, 1989; Magariños, Zafar, 
Nissenson, & Blanco, 2002). It can take on the characteristics of real 
hypochondria in MDE, and the concerns may be related to somatization 
disorders. 
• Criterion A22 refers to somatic disorders (Goodwin and Jamison, 2007; Al 
Busaidi, 2010; Campo, 2012). It can be expressed through a myriad of 
symptoms in people with MDE: neuro-vegetative disorders, stomach cramps, 
vomiting, difficulty of digestion, diarrhoea, palpitations, hyperventilation, 
paraesthesia, sweating, flushing, tremors, headaches, increased heart rate, an 
urgent need to urinate often, a feeling of heaviness in the limbs or in the head, 
and back or muscle pain. 
• Criterion A23 was inserted as the last in the list of clinical criteria for assessing 
MDE. The literature review and the presence of this attribute in the items of 
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almost all MDE scales analyzed by Serra et al. (2015) demonstrate its important 
contribution to depression evaluation. In fact, individuals with depression 
usually feel better at the end of the day when they can go to sleep and do not 
have to face their daily problems anymore. 
Table 5.1 summarizes all of the sets of clinical criteria that we considered in 
constructing the MDE assessment tool. 
Table 5.1. The twenty-three clinical criteria for major depressive episode construct. 
Attribute Explanation 
A1 Depressed mood  
A2 Diminished interest and pleasure  
A3 Decreased interest in sex 
A4 Increase or loss of weight  
A5 Gain or loss of appetite  
A6 Insomnia or hypersomnia 
A7 Agitation 
A8 Psychomotor retardation 
A9 Fatigue or energy loss 
A10 Feelings of worthlessness (or Beck’s negative view of self)  
A11 Feelings of guilt 
A12 Diminished ability to think and concentrate  
A13 Indecision 
A14 Recurrent thoughts of death 
A15 Suicidal ideation or attempted suicide  
A16 Beck’s negative view of the world  
A17 Beck’s negative expectation of the future  
A18 Seligman’s learned helplessness 
A19 Irritability 
A20 Apathy 
A21 Health concern 
A22 Somatic disorders 
A23 More positive mood in the evening 
  
 
On the base of the criteria described above, 41 items have been constructed.  Some of 
them contain a single diagnostic criterion; for example, the item “I feel helpless in the 
face of life events” contains A18 (the learned helplessness of Seligman). Other items 
were constructed to include two or more diagnostic criteria; for example, the item “I 
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feel nervous about this sadness I never abandon” contains three diagnostic criteria: A17 
(Beck's negative expectation of the future), A1 (depressed mood), and A7 (agitation). In 
line with the FPA methodology, the matrix allowed analysing all of the relationships 
among these items and diagnostic criteria. The whole set of clinical criteria (attributes) 
in Table 5.1 were investigated by the set of 41 items. The new perspective of this tool is 
more deeply explored in the Results and Discussion sections. 
2.2.Participants 
The research participants who were tested were divided into clinical and non-clinical 
groups.  
The clinical group consisted of 38 subjects with MDE (who were diagnosed with major 
depressive disorder or bipolar disorder, or else with MDE during their first access in the 
day hospital) of the Neurosciences, Mental Health, and Sensory Organ (NESMOS) 
Department of La Sapienza University, Rome. In particular, the patients included in the 
study comprised eight individuals who were on their first access to the day hospital, 
four people who had a reactive MDE (caused by a stressful event or a death event), two 
who had an MDE with familiar genetics in mood disorders highlighted by their medical 
history, and two who suffered from unspecified MDE. Eleven patients were suffering 
from MDE within a major depressive disorder; one patient of this group had comorbid 
obsessive compulsive disorder (OCD), one patient had comorbid social anxiety 
disorder, and two others had comorbid eating disorder (anorexia nervosa). Nine patients 
were suffering from an MDE within bipolar disorder type I; two of them had comorbid 
OCD, and two other patients had comorbid eating disorder (anorexia nervosa and 
bulimia). Finally, ten patients were suffering from MDE in bipolar disorder type II; 
three of them had comorbid OCD, two of them had comorbid panic disorder, and one of 
them had comorbid social anxiety disorder. The exclusion criteria were mental 
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retardation and psychotic traits to avoid problems in interpreting the responses to the 
QuEDS. Of the participants, 47% were male and the remaining 53% were female. A 
majority of the participants had a high school diploma, and their ages ranged between 
21 and 69 years.  
The non-clinical group consisted of 265 Italian individuals from different regions. The 
convenience non-clinical sample of the present research included individuals recruited 
in the area of the University of Padova (both students and non-students). The exclusion 
criteria in the non-clinical group involved all individuals suffering from MDE (e.g., 
those who were under pharmacological or psychotherapeutic treatment for depression). 
Among these participants, 70% were female. A majority of participants had a high 
school diploma, and their ages ranged between 19 and 56 years. 
 
2.3. Clinical Tools 
 The Qualitative–Quantitative Evaluation of Depressive Symptomatology 
(QuEDS). The QuEDS tool (Serra et al., 2017) contains 41 dichotomous items  
constructed on the basis of 23 clinical criteria of major depressive episodes from 
the DSM-5 and the literature. The maximum score is 41, and the minimum is 0. 
It is assumed that if a person responds positively to an item, then he/she has the 
symptoms (in terms of clinical criteria or attributes) included in this item. The 
respondents are asked to reply “yes” or “no” to indicate the presence of 
symptoms. 
 Depression-Anxiety-Stress-Scale 21 (DASS-21). The DASS-21 is the short 
version of the self-report test designed to measure the three related negative 
emotional states of depression, anxiety, and stress (Bottesi, Ghisi, Altoè, 
Conforti, Melli, & Sica 2015b; Henry and Crawford, 2005). DASS-21 contains 
seven items for assessing depression, seven items for assessing anxiety and 
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seven items for assessing stress. The Depression scale evaluates dysphoria, 
hopelessness, devaluation of life, self-deprecation, lack of interest/involvement, 
anhedonia, and inertia. The Anxiety scale assesses autonomic arousal, 
situational anxiety, and subjective experience of anxious affect. The Stress scale 
(items) is sensitive to levels of chronic non-specific arousal. It assesses difficulty 
in relaxing as well as being easily agitated, irritable, and impatient. The 
respondents are asked to use a 4-point Likert scale to indicate the severity and 
frequency of symptoms. 
2.4. Procedure and Administration  
All of the research participants completed informed consent and sociodemographic 
forms before answering the questionnaire items. No time limit was imposed to complete 
the questionnaires. All 265 subjects of the non-clinical group completed the QuEDS for 
major depressive episodes.  
A subgroup of 113 individuals of the non-clinical group also answered the self-report 
measure DASS-21 to evaluate the convergent and divergent validity of the QuEDS. 
Moreover, 63 out of these 113 subjects compiled the QuEDS twice, after 1 month, to 
evaluate the temporal stability of the scale (test–retest). 
The NESMOS Department’s psychiatrists, diagnosed the patients of clinical group as 
Major Depressive Episode patients through a depression rating scale (SCID-I). Then 
these patients responded to the QuEDS. 
At clinic intake, participants provided written, informed consent for potential research 
analysis and anonymous reporting of clinical findings in aggregate form, in accord with 
Italian legal and ethical requirements. The study was conducted in accordance with the 
Declaration of Helsinki. All participants entered the study of their own free will and 
they were informed in detail about the aims of the study, the voluntary nature of their 
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participation, and their right to withdraw from the study at any time. Furthermore, 
participants were allowed to ask for restitution about their own score, providing authors 
with their own auto generated code, used during the administration phase. 
2.5. Data Analysis 
 
The data of all 303 participants were used for analysis, no missing data were observed. 
Different kinds of data analyses were conducted to test the validity and reliability of the 
new tool (QuEDS).  
Inferential analyses were conducted by means of the software R 3.3.0 (R Core Team, 
2013), while confirmatory factor analysis (CFA) was conducted by means of the 
software LISREL 8.80 (Jöreskog, & Sörbom, 1986; 1989; 1993). The discriminant 
validity was evaluated by means of both a comparison between the scores of non-
clinical and clinical groups, and referring to the classical ROC curves approach. 
Convergent validity was evaluated by computing the correlation between the QuEDS 
and the DASS-21 scores.  The reliability of the scale was tested both with respect to the 
internal consistency and to the test-retest. Content validity has been evaluated by 
referring to the FPA methodology. Finally, again by means of the FPA, the capability of 
the tool to clinically discriminate patients has been tested and reported. 
3. Results 
3.1.Construct Validity 
The construct validity of the QuEDS was evaluated by investigating its factorial 
validity, discriminant validity, and convergent–divergent validity. 
 Factorial validity: From a conceptual point of view, depression is a strong and 
united construct; some authors, including Beck, attributed more importance to 
the cognitive dimension of depression (Rainone & Mancini, 2007) without 
neglecting the somatic-affective dimension. Many authors identified three 
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dimensions in the depression construct: cognitive, somatic, and affective (Dinger 
et al., 2015; O'Hara, Neunaber, & Zekoski, 1984; Roca, Wigley, & White, 
1996). A hierarchical model having three sub-dimensions (namely: cognitive, 
affective and somatic) and one second order factor (depression) could be the 
factorial solution that is most likely to represent the structure of the investigated 
construct; in fact, this model would have the advantage of offering an interesting 
explanation, from the clinical perspective. Indeed, the QuEDS was constructed 
both specifically for evaluating depressive symptoms and sensitively to evaluate 
thoughts (cognitive), somatic aspects (somatic), and emotions (affective) related 
to depression. The authors are interested in testing, on the non-clinical sample 
(Osborne & Costello, 2004), a hierarchical factorial structure (Berrios, Kellett, 
Fiorani, & Poggioli, 2015; Roberts, Hart, & Eastwood, 2015) with three sub-
factors (i.e., cognitive, affective, and somatic), all linked to a second-order factor 
(i.e., depression). The clinical sample for factor analysis was not considered due 
to the low number of participants (i.e. N = 38). Furthermore, in order to compare 
the fit of this model to different theoretically plausible solutions, it was 
compared with three other different factorial models to the collected data:  
1. A model with one latent construct which we called “depression”.  
2. A model with two latent factors, which we called “somatic-affective factor” 
and “cognitive factor”. 
3. A model with three factors: cognitive, somatic and affective factors.  
In the proposed hierarchical model, the items were grouped into the sub-
factors as follows: 
• The cognitive factor includes items 5, 6, 9, 10, 14, 19, 20, 21, 24, 25, 27, 30, 32, 
33, and 41. It comprises symptoms related to distortions of thought systems and 
also to feelings of guilt, helplessness, worthlessness, hopelessness, and death. 
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• The somatic factor includes items 1, 2, 3, 4, 11, 13, 16, 22, 23, 26, 28, 31, 35, 
and 39. It comprises symptoms related to fatigue, sleep, appetite, psycho-motor 
retardation, and other somatic disorders that often involve MDEs. 
• The affective factor includes items 7, 8, 12, 15, 17, 18, 29, 34, 36, 37, 38, and 
40. It comprises the emotions that characterize different types of MDEs, 
including sadness, apathy, irritability, agitation, and various concerns. 
Table 5.2 displays a comparison of the fit indexes for the four tested factorial structures. 
The table shows that the hierarchical model fits the data better than any of the three 
other models. All of the fit indexes for the hierarchical model (with no use of 
modification indexes) had adequate values. More specifically, the ratio between the 
Chi-square and the degrees of freedom, the RMSEA, the CFI, and the NNFI showed a 
good fit, while the NFI indicated an adequate model fit (Marsh, Hau, & Wen 2004). 
Furthermore, no significant double loadings were observed, nor correlation among error 
terms. 
Table 5.2. The fit indexes of the three tested models. 
Fit Index Mono-factorial Two-Factor Model Three-Factor Model Hierarchical Model 
χ²/df 2.67 2.51 2.54 2.45 
RMSEA 0.07 0.07 0.07 0.06 
NFI 0.93 0.94 0.94 0.94 
NNFI 0.95 0.96 0.96 0.96 
CFI 0.96 0.96 0.96 0.96 
SRMR 0.08 0.08 0.08 0.07 
AIC 2204 2121 2141 2068 
 
 
For the hierarchical model, all of the items’ saturations on the respective factors were 
significant and ranged between 0.26 and 0.76 for the cognitive factor; between 0.32 and 
0.71 for the somatic factor; and between 0.33 and 0.70 for the affective factor (Table 
5.3). The results support the selection of the hierarchical model by confirming that its 
underlying factorial structure has a higher-order factor accounting for the relationship 
among lower-order specific factors (Subica et al., 2014). In second-order models, it is 
 104
necessary for the lower-order specific factors to be correlated among each other and 
with the higher-order factor (Schmid and Leiman, 1957). In this specific case, the links 
between the sub-factors and the higher-order factor were in the range of 0.70–0.91, once 
more supporting the selected model. 
Table 5.3. Factor loadings of each of the 41 items of the QuEDS. No double loading were observed. In 
the last line of the table are displayed the strengths of the links between the first and second-order 
factors. 
 Cognitive Factor Somatic Factor Affective Factor 
Item 5 .68 - - 
Item 6 .53 - - 
Item 9 .54 - - 
Item 10 .65 - - 
Item 14 .76 - - 
Item 19 .56 - - 
Item 20 .75 - - 
Item 21 .53 - - 
Item 24 .78 - - 
Item 25 .80 - - 
Item 27 .45 - - 
Item 30 .66 - - 
Item 32 .72 - - 
Item 33 .45 - - 
Item 41 .82 - - 
Item 1 - .61 - 
Item 2 - .47 - 
Item 3 - .71 - 
Item 4 - .44 - 
Item 11 - .33 - 
Item 13 - .58 - 
Item 16 - .61 - 
Item 22 - .53 - 
Item 23 - .51 - 
Item 26 - .59 - 
Item 28 - .76 - 
Item 31 - .57 - 
Item 35 - .68 - 
Item 39 - .44 - 
Item 7 - - .41 
Item 8 - - .30 
Item 12 - - .77 
Item 15 - - .74 
Item 17 - - .50 
Item 18 - - .80 
Item 29 - - .64 
Item 34 - - .72 
Item 36 - - .70 
Item 37 - - .69 
Item 38 - - .53 
Item 40 - - .39 
Depression .91 .87 .92 
 
 Discriminant validity: The scores of 38 patients with MDE were compared with 
those of the 265 non-clinical subjects to test the discriminant validity of the 
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QuEDS. The clinical group obtained an average score of 28.5 (sd = 6.5), while 
the non-clinical group obtained an average score of 6.5 (sd = 6). The difference 
between the two groups, tested using a t-test for independent samples, was 
significant (t299 = −20.20; p < .001) and supported the validity of the QuEDS. 
Furthermore, in order to test the ability of the QuEDS in separating the two 
groups, an analysis based on the ROC curves has been carried out. Results 
showed a very good value of the AUC statistic (confidence interval 0.97 - 0.99). 
Moreover an optimal threshold score of 19 was determined that allowed for a 
specificity of .98 and a sensitivity of .94. 
 Convergent–divergent validity. The convergent validity of the QuEDS was 
verified by comparing its scores in the non-clinical sample with those of the 
DASS-21 (which, as described above, is constituted by three sub-scores for 
Depression, Anxiety, and Stress). We chose to use the DASS-21 as considered 
the most suitable tool for the specific case thanks to the rapidity of 
administration and sensitivity in the measurement of all the three constructs 
(Depression, Anxiety and Stress). The correlations among the 113 subjects’ 
scores in the QuEDS and the three sub-scales of DASS-21 were all significant. 
More specifically, the correlation between the QuEDS and the Depression 
subscale of the DASS-21 was r = .72 (p < .05); the correlation between the 
QuEDS and the Anxiety subscale of the DASS-21 was r = .39 (p < .05); and the 
correlation between the QuEDS and the Stress subscale of the DASS-21 was r = 
.59 (p < .05). These results are not surprising, since the depression construct may 
have several features in common with the stress and anxiety constructs (Bayram, 
& Bilgel, 2008). However, it has to be stressed that the correlation between the 
QuEDS and the Depression subscale was significantly higher than the 
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correlation between the QuEDS and the Anxiety subscale (z = 3.32, p < .001); 
on the contrary, a not significant difference was observed between the 
correlation of the QuEDS with the Depression subscale and the correlation of 
the QuEDS and the Stress subscale (z = 1.71, n.s.). These results indicate a good 
divergent validity of the QuEDS. The correlations among the sub-factors 
(cognitive-somatic-affective) of the QuEDS and the subscales of the DASS-21 
have also been computed, and the results are displayed in Table 5.4. While the 
correlation between the Anxiety subscale of the DASS-21 and the factors of the 
QuEDS was systematically and significantly lower than the correlations between 
the QuEDS subscales and the Depression subscale of the DASS-21 (cognitive: z 
= 2.57, p < .01; somatic: z = 2.24, p < .05; affective: z = 2.03, p < .05), the 
situation was the opposite with respect to the Stress subscale. In fact, all the 
correlations between the three sub factors of the QuEDS and the Depression 
subscale of the DASS-21 were not significantly higher than their correlation 
with the Stress subscale (cognitive: z = 1.65, n.s., somatic: z = 1.23, n.s.; 
affective: z = −0.11, n.s.). Table 4 displays the 7x7 correlation matrix of the 
QuEDS total score, QuEDS subscales, and the subscales from the DASS-21. 
Table 5.4. The correlation matrix of the 3 subscales from the DASS-21, the three subscales of the QuEDS 
and the total score of the QuEDS. 
 
 DASS-21 
Depression 
DASS-21 
Anxiety 
DASS-21 
Stress 
QuEDS-
cognitive 
QuEDS-
somatic 
QuEDS-
affective 
QuEDS-
TOT 
DASS-21 
Depression -       
DASS-21 
Anxiety 0.37 -      
DASS-21 
Stress 0.44 0.50 -     
QuEDS-
cognitive 0.64 0.37 0.48 -    
QuEDS-
somatic 0.53 0.25 0.40 0.37 -   
QuEDS-
affective 0.58 0.34 0.56 0.61 0.46 -  
QuEDS-TOT 0.72 0.39 0.59 0.80 0.78 0.84 - 
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3.2 Reliability 
A reliability analysis, on the sample, showed that the QuEDS scale has a very good 
internal consistency, Cronbach’s α = .948. Even the alpha values relative to the three 
sub-factors were good: cognitive factor (α = .91; average item inter-correlation = .41), 
somatic factor (α = .86; average item inter-correlation = .31), affective factor (α= .82; 
average item inter-correlation = .41). Given such values and the number of items in the 
scale, the alpha precision can be considered adequate (Cortina, 1993).  
Regarding the test–retest reliability of the QuEDS, the correlation among the scores of 
the 63 test subjects at Time 1 and Time 2 (after one month) was .74, which indicates 
good stability for the tool. 
3.3.Content validity 
 
The QuEDS was created to answer the following question: Does it include the most 
common symptoms related to various types of MDEs? The FPA methodology was used 
to answer this question. A matrix was created with 41 items in the rows and 23 clinical 
criteria in the columns, called the “clinical context.” Thus, it was verified that each item 
would include one or more clinical criteria. Four specialists in the field of mood 
disorders carried out this analysis. Table 5.5 shows the content of the items and the set 
of attributes (symptoms) that each item investigates. 
Concerning content validity, the first key result is that the QuEDS was able to collect all 
of the information from 41 items, in terms of clinical criteria, to evaluate different types 
of MDEs. In addition, the items in the Table 5.5 may include one or more clinical 
criterion. The previous research (Chapter 4) highlights that none of the widely used tests 
to assess depression alone is able to investigate all clinical criteria, even those related to 
the DSM-5 (Serra et al., 2015a). 
Table 5.5 represents the clinical context in a different way to Boolean matrix. 
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Table 5.5. The items with their attributes 
Items Clinical Criteria 
1. I feel that I don’t have the same energy to have sex A3, A9 
2. I often wake up in the middle of the night and I can’t asleep again A6, A7 
3. I feel like that my thinking is slowing down A8, A12 
4. I have sleeping problems  A6 
5. I am stressed by feeling of guilt A11 
6. I am think the world is cruel and unhappy A16 
7. I keep crying very easily A1, A7, A19 
8. I get irritated very easily A19 
9. I think my life is hell and I only deserve to feel bad A1, A11, A16 
10. I fell incapable to face life’s events A18 
11. I suffer of somatic disorders (e.g. headache stomach ache) A22 
12. I have lost interest in the future which doesn’t save anything good for me A2, A17 
13. I am less interest in sex A3, A20 
14. I feel incapable and totally useless A10, A18 
15. I see the same unhappiness I have now in the future A1, A17 
16.  My desire to eat is not the same A5 
17.  I often feel like crying,  but I cannot do it A1, A20 
18.  I cannot have any interest and pleasure in people and things that before I was interested 
in 
A2, A20 
19.  I thought to kill my self A14, A15 
20.  Sometimes I think it would be better if  I were dead A14 
21.  I am really worried about my health A21 
22.  My weight has had significant changes A4 
23. I’ve visibly lost (or gained) weight A4 
24. I am afraid of about everything that it will happen to me because I am not able to do 
anything 
A17, A18 
25. I feel like I don’t have any more power over my empty and sad life A1, A16, A18 
26.  My appetite has changed A5 
27.  To make choices is hard for me A12, A13, A20 
28.  I feel I ‘m slowing down  in my daily routines A8, A9 
29.  I feel helpless and inhibited facing my incapacity to concentrate A12, A20 
30.  I feel too much on the other people that it would be better if I killed myself A10, A11, A14 
31.  I have not much energy and I feel tired A9 
32.  I am disappointed of myself and the choices I made A10, A11 
33.  I have problems in making decisions A13 
34.  I feel sad A1 
35.  My ability to think and memorize has been reduced A8, A9, A12 
36. I don’t have any interest and desire in doing  anything A2 
37. I am agitated of the idea that this sadness won’t ever leave me A1, A7, A17 
38. I feel agitated A7 
39.  I feel so tired and without any energy that I need help to wash myself and  to get dressed  A8, A9, A18, A20 
40. I am better in the evening more than in the morning A23 
41.  I often feel like a loser A10 
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Furthermore, in formulating the items, we avoided methodological problems such as 
double phrases (“I’m depressed” or “I often want to cry”), fuzzy adverbs (“my life is 
pretty full”), or problems with content validity. In other words, each item of the QuEDS 
includes one or more clinical criteria described in Table 5.1; none of the items 
investigate other symptoms that may be related to depression but are not part of the 
construct (e.g., items about anxiety, obsessions). In the matrix, this means that there 
were no empty rows (with all “0”). Moreover, there were no empty columns in the 
matrix; this means that the 41 items of the QuEDS investigate all 23 of the clinical 
criteria in Table 5.1.  
Items 22 and 23, as well as items 16 and 26 have the same attribute to check that the 
reply to the item is valid since these attributes are not present in other items of the tool. 
By applying FPA, it became possible to conduct a content analysis even for the three 
sub-factor included in the model. For each factor, it has been possible to create a clinical 
context including all of its items and the subset of attributes investigated by the items of 
the sub-factor. The results of this procedure are displayed in Table 5.6. 
 
Table 5.6. The clinical contexts of QuEDS three factors. Each row is an item, while each column is a 
clinical criteria either investigated or not by the item. Every time an item investigates a specific criterion, 
the corresponding cell will contain “1,” (otherwise “0).” 
 
COGNITIVE FACTOR 
 A1 A10 A11 A12 A13 A14 A15 A16 A17 A18 A21 
Item 5 0 0 1 0 0 0 0 0 0 0 0 
Item 6 0 0 0 0 0 0 0 1 0 0 0 
Item 9 1 0 1 0 0 0 0 1 0 0 0 
Item 10 0 0 0 0 0 0 0 0 0 1 0 
Item 14 0 1 0 0 0 0 0 0 0 1 0 
Item 19 0 0 0 0 0 1 1 0 0 0 0 
Item 20 0 0 0 0 0 1 0 0 0 0 0 
Item 21 0 0 0 0 0 0 0 0 0 0 1 
Item 24 0 0 0 0 0 0 0 0 1 1 0 
Item 25 1 0 0 0 0 0 0 1 0 1 0 
Item 27 0 0 0 1 1 0 0 0 0 0 0 
Item 30 0 1 1 0 0 1 0 0 0 0 0 
Item 32 0 1 1 0 0 0 0 0 0 0 0 
Item 33 0 0 0 0 1 0 0 0 0 0 0 
Item 41 0 1 0 0 0 0 0 0 0 0 0 
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SOMATIC FACTOR 
 A3 A4 A5 A6 A7 A8 A9 A12 A18 A20 A22 
Item 1 1 0 0 0 0 0 1 0 0 0 0 
Item 2 0 0 0 1 1 0 0 0 0 0 0 
Item 3 0 0 0 0 0 1 0 1 0 0 0 
Item 4 0 0 0 1 0 0 0 0 0 0 0 
Item 11 0 0 0 0 0 0 0 0 0 0 1 
Item 13 1 0 0 0 0 0 0 0 0 0 0 
Item 16 0 0 1 0 0 0 0 0 0 0 0 
Item 22 0 1 0 0 0 0 0 0 0 0 0 
Item 23 0 1 0 0 0 0 0 0 0 0 0 
Item 26 0 0 1 0 0 0 0 0 0 0 0 
Item 28 0 0 0 0 0 1 1 0 0 0 0 
Item 31 0 0 0 0 0 0 1 0 0 0 0 
Item 35 0 0 0 0 0 1 1 1 0 0 0 
Item 39 0 0 0 0 0 0 1 0 1 1 0 
 
AFFECTIVE FACTOR 
 A1 A2 A7 A12 A17 A19 A20 A23 
Item 7 1 0 0 0 0 1 0 0 
Item 8 0 0 0 0 0 1 0 0 
Item 12 0 1 0 0 1 0 0 0 
Item 15 1 0 0 0 1 0 0 0 
Item 17 1 0 0 0 0 0 1 0 
Item 18 0 1 0 0 0 0 1 0 
Item 29 0 0 0 1 0 0 1 0 
Item 34 1 0 0 0 0 0 0 0 
Item 36 0 1 0 0 0 0 1 0 
Item 37 1 0 1 0 0 0 0 0 
Item 38 0 0 1 0 0 0 0 0 
Item 40 0 0 0 0 0 0 0 1 
 
It is noteworthy how the sets of attributes investigated by each factor are different. More 
specifically, only the cognitive factor investigates feelings of worthlessness and guilt, 
indecision, recurrent thoughts of death and suicidal ideation, Beck’s negative view of 
the world, and finally health concerns; in fact, all of these symptoms are related to 
thoughts. The somatic factor alone includes decreased interest in sex, increased or loss 
of weight, gain or loss of appetite, insomnia or hypersomnia, psychomotor retardation, 
fatigue or energy loss, and somatic disorders; all of these manifestations are physical 
dysfunctions. Instead, the affective factor alone comprises diminished interest and 
pleasure, irritability, and a more positive mood in the evening. Finally, some symptoms 
are investigated by two sub-factors, and one of them is investigated by all of the sub-
factors. 
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The following table briefly describes the links between the sub-factors and the attributes 
(symptoms) that they share. 
 
Table 5.7. The factors that investigate each single attribute of the clinical context. 
FACTORS ATTRIBUTES 
All three factors A12 
Cognitive & affective A1, A17 
Cognitive & somatic A18 
Somatic & affective A7, A20 
Cognitive A10, A11, A13, A14, A15, A16, A21 
Somatic  A3, A4, A5, A6, A8, A9, A22 
Affective A2, A19, A23 
 
The analysis of relationships between items and symptoms allows clinicians to go 
beyond the score, acquiring qualitative information on the individual, and understanding 
the patient’s symptomatic areas. A descriptive example about how the FPA could 
integrate the quantitative information collected through the questionnaire is presented 
below. 
3.4. Beyond the Numeric Score: The “Clinical State” of the Patient 
 
The new QuEDS allows clinicians to go beyond the numeric score and focus their 
analysis on the symptoms that patients experience or about which they complain (Serra 
et al., 2017).  
It may be useful to introduce a practical example from the patients of this study; two of 
the 38 patients in the clinical group were chosen. They obtained the same score on the 
QuEDS: 31. This means that both answered “yes” to 31 items out of the 41 total items. 
This score is clearly high, and the patients, who had already been diagnosed with MDE, 
were confirmed to have a severe depressive symptomatology with this scoring. 
However, the two patients did not have exactly the same disorder. Patient SC was 
suffering from a reactive MDE (subsequent to a stressful life event), while patient FG 
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was suffering from MDE inside bipolar disorder type 1 (see chapter one). As stated in 
first chapter, many authors (e.g., Benazzi & Akiskal, 2005; Koukopoulos and 
Koukopoulos, 1999; Maj et al., 2003; etc.) reported that MDEs in bipolar disorder often 
occur with mixed or agitated features. According to the classical methodology, the 
questionnaire’s output is the same for both patients. In agreement with several other 
authors (Bottesi et al., 2015a ; Fava et al., 2004; Gibbons et al., 1985; Serra et al., 2015a 
Wright and Feinstein, 1982), in this study, it was assumed that if the two patients had 
the same score, this did not mean that they had equal symptomatology. Indeed, they 
may have answered affirmatively to the same number of items but not to the same 
items, and the whole symptomatology may be more serious in one of them. Unlike in 
the usual methodology, qualitative information on the two patients’ symptoms were 
collected through their clinical state. 
Patient SC responded affirmatively to items 1, 3, 5, 6, 10, 12, 13, 14, 15, 16, 17, 18, 20, 
22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 39, 40, and 41. Consequently, 
his clinical state contained the following symptoms (attributes) in terms of clinical 
criteria: A1, A2, A3, A4, A5, A8, A9, A10, A11, A12, A13, A14, A16, A17, A18, A20, 
and A23. Patient FG responded affirmatively to items 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 
14, 15, 16, 18, 19, 20, 21, 24, 25, 26, 27, 29, 32, 33, 34, 36, 37, 38, 40, and 41. 
Accordingly his clinical state contained the following symptoms (attributes) in terms of 
clinical criteria: A1, A2, A3, A5, A6, A7, A10, A11, A12, A13, A14, A15, A16, A17, 
A18, A19, A20, A21, A22, A23 (to see which criteria the items are related to, see 
Tables 5.1 and 5.5). 
The listed attributes of both patients comprise the items they answered positively. As 
can be seen, the two patients had two different clinical states. Specifically, they shared a 
large number of attributes (namely, A1, A2, A3, A5, A10, A11, A12, A13, A14, A16, 
A17, A18, A20, and A23). This fact indicated that many of the general characteristics of 
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the affective episode of both patients were the same. Nevertheless, each patient 
presented some specific characteristics that the other did not share. These characteristics 
discriminate between the two clinical conditions and are crucial for effective treatment. 
More in detail, patient SC had the following additional symptoms: A4 “increase or loss 
of weight”, A8 “psychomotor retardation” and A9 “fatigue or energy loss.” On the other 
hand, patient FG, in addition to the shared symptoms, presented the following attributes: 
A6 “insomnia”, A7 “agitation”, A15 “suicidal ideation”, A19 “irritability”, A21 “health 
concerns” and A22 “somatic disorders”. 
Furthermore, we considered the two patients’ replies to the items of the three sub-
dimensions of the QuEDS (cognitive, somatic, and affective). Patient SC responded 
positively to 12 out of 15 items of the cognitive factor, 11 out of 14 items of the somatic 
factor, and 7 out of 12 items of the emotional factor; in contrast, FG responded 
positively to 14 out of 15 items of the cognitive factor, 6 out of 14 items of the somatic 
factor, and 11 out of 12 items of the affective factor. It has to be stressed, however, that 
the mere score to the subscales of the QuEDS, even if useful to help clinicians in 
preliminarily understand the situation of patients, is not sufficient to clearly differentiate 
the specific kind of depression characterizing the two patients. In fact, neither a high 
score in the affective factor implies a mixed depression, nor a high score in the somatic 
factor implies the presence of an inhibited depression. Such characterizations can be, on 
the contrary, easily deduced by the clinical states provided through the FPA approach 
(Serra et al., 2017). Indeed, for example, a high score in somatic scale may represent 
more agitated symptoms, and at the same time more psychomotor retardation. The 
analysis through FPA allows a better classification of the individual symptoms’ case, 
which therefore allows for planning different pharmacological and psychological 
treatments for the two patients.  
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Moreover, the proposed methodology even provides information to clinicians about the 
possible symptoms of a person who does not have MDEs and who belongs to the non-
clinical group. To illustrate, MT obtained a score of six to the questionnaire (the mean 
of the non-clinical group) after responding affirmatively to items I1, I11, I13, I27, I31, 
and I33. His clinical state was A3, A9, A13, A20, and A22. Even if he did not show a 
depressive symptomatology, dysfunctions related to his sexual desire, his energy, and 
his indecision emerged from his clinical state; also, he has somatic complaints. A usual 
questionnaire only provides a quantitative score (6), which only means that MT is not 
suffering from MDEs. This information could underline symptoms in common with 
some other psychological disorder and could show alarming manifestations, which 
occur in a “broad spectrum” evaluation, in which the clinician understands some crucial 
symptoms of the subject and then explores them with more specific and targeted tests 
(See Chapter 2, CBA 2.0). 
Then the main output of the QuEDS is the clinical state of the patient. Indeed, the 
QuEDS takes into account all of the positive responses of the subject, which are closely 
linked to the symptoms through the FPA (MDE clinical criteria).   
4. Discussion 
According to the DSM-5, there are different types of MDE, and depressive symptoms 
may have different features, depending on the individual and his/her particular disorder. 
The present research was aimed to introducing a new assessment tool capable of 
account for the differences among the clinical symptomatology of patients that are not 
evaluable using traditional test scores alone. This task was carried out by using FPA as 
the theoretical framework in constructing the tool. Concerning the different clinical 
features, some specific illustrations showed how the tool could be used to more deeply 
investigate the clinical state of different patients. 
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Statistical results confirmed the goodness of the proposed tool, in terms of both validity 
and reliability. The high internal consistency of both the subscales and the whole scale 
indicates how the items are coherent in exploring the construct. With respect to the test-
retest reliability, the correlation shows a good stability of the measure. Concerning the 
factor structure, the hierarchical model explains best the observed data. As shown in the 
results MDE can be explained both by the general “depression” factor and by the three 
sub-factors (cognitive-somatic and affective), and a patient may have more somatic 
symptoms, or more cognitive/affective symptoms depending on the features of his 
illness. The results of the divergent/convergent validity on the one hand showed the 
difference between the correlation of anxiety subscale (A) of the DASS and QuEDS and 
the correlation between the depression subscale (D) of the DASS and QuEDS, 
highlighting the convergent validity between the D-scale and QuEDS. On the other 
hand, the correlation between the subscale stress (S) of the DASS and QuEDS showed 
the presence of many shared clinical features between the two constructs. Specially, the 
affective and somatic sub-factors of the QuEDS have a high correlation with the scale S. 
This result may seem unusual at first, but as the literature suggests (Dumont & Provost, 
1999; Hewitt & Flett, 1993; Tafet et al., 2001) stress and depression have many 
symptoms in common, in particular the people vulnerable to mood disorders are more 
sensitive to stress (Bidzi, 1984). Furthermore, the Stress scale of DASS is sensitive to 
levels of chronic non-specific arousal. It assesses difficulty relaxing, nervous arousal, 
and being easily upset/agitated, irritable/over-reactive and impatient; all these 
symptoms are highly correlated to the affective dimensions, as our results suggested. 
Concerning the content validity, from this new perspective, the relations among the 41 
items and the 23 clinical criteria play a crucial role. The matrix shows that all the 
clinical criteria are investigated by at least one item. This result is very important 
because it means that the presence or absence of the 23 symptoms selected for 
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describing the MDE can be detected using the QuEDS. Having information on all of 
these symptoms makes it possible to compare the observed responses of the subject 
according to the clinical symptoms he/she demonstrated up to the present. This fact, for 
instance, allows for determining whether an individual has more inhibited symptoms, 
more agitated ones, or both. Indeed, the set of items to which the individual responds 
includes a well-defined series of clinical criteria, which are useful for a first psycho-
diagnostic examination. Thus, the output of the QuEDS is no longer crucially related to 
some sort of cut-off (or score) that shows whether the person could be classified as 
suffering from the disease or not. On the contrary, it consists of qualitative and 
quantitative information about the patient’s clinical state. Such output provides the 
potential capability to go beyond the scores and investigate the configuration of the 
patients’ symptoms to differentiate people who received the same score on the test but 
have different symptoms. Indeed, they responded affirmatively to the same number of 
items but not to the same items; this allow considering when the whole symptomatology 
is more serious (Serra et al., 2017). 
Moreover, unlike many self-report measures in use to assess MDEs, the QuEDS deeply 
investigates the symptoms related to agitated depression, including irritability, 
insomnia, crying spells, somatic disorders, and agitation. The investigation the 
symptoms related to mixed depression is quite important because people with mixed 
depression need completely different pharmacological and psychological treatments 
from those with other types of MDE; for example, antidepressants can increase the 
psychomotor agitation and the risk of suicide in people with agitated depression 
(Baldessarini et al., 2006a; Balázs, Benazzi, Rihmer, Rihmer, Akiskal, & Akiskal, 
2006). 
You can find a similar version of this work in “Serra, Spoto, Ghisi & Vidotto, 2017; 
Frontiers in psychology.” However, in this version, the FPA methodology has not been 
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repeated since it is already in depth in Chapter 3, and some parts of the introduction and 
the results in this chapter have been further deepened. 
To conclude, another important result obtained by the QuEDS is the possible future 
application of an adaptive logic based on the matrix in Table 5.6, which will be the core 
of the next Chapter. Indeed, we divided the matrix of 41 items into three sub-matrices 
related to the three sub-factors cognitive, somatic, and affective (Table 5.6). This will be 
useful for the future implementation of the three algorithms of the QuEDS to respond 
adaptively and individually to the test. The step to achieve this goal will be explain in 
the next Chapter, the third research. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 118
CHAPTER 6 
An adaptive version of the new Major Depressive 
Episode assessment tool (QuEDS). 
 
1. Introduction and research aim 
In clinical practice, self-report questionnaires and interviews are the main methods used 
for clinical evaluation. As stated in the previous Chapter, the score of a questionnaire is 
helpful in distinguishing individuals with critical clinical features but is not sufficient to 
differentiate patients with different symptom configurations who obtained the same 
score to the test. Moreover, not all the items have the same “weight” from the clinical 
point of view; in fact, they reflect different symptoms that may be more or less severe 
(Serra et al., 2017). On the other hand, the main problem of the interviews stands in the 
possible wrong inferences of the clinician that can lead to misdiagnosis and consequent 
inappropriate treatment. 
Currently, a valid tool that the clinician can use in the assessment is the computerized 
adaptive testing (CAT; Reise & Waller, 1991; Baek, 1997). In this way, a questionnaire 
can be administered adaptively, such that an individual responds only to items that are 
most appropriate for assessing his or her level of impairment mimicking the semi-
structured interview (Gibbons et al., 2008). In Chapter 2 the main computerized 
adaptive assessment methods were described and it was shown how all the mentioned 
systems, are based on a representation of the domain of interest that is different from 
that of FPA (as described in the third Chapter). As far as we know, the system we 
propose is unique as it provides adaptivity, a formal definition of the clinical field, and a 
probabilistic model to account for both false positive e false negative of each item.  
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The aim of this work is to develop the adaptive form of QuEDS. We present an adaptive 
testing system based on a formal representation of items and diagnostic criteria 
presented in the previous research (Table 5.6), able to provide the adaptive logic of 
semi-structured interview but in the way of self-report tool. In particular, the three sub-
scales of QuEDS (cognitive, affective and somatic) are used in the FPA representation 
taking advantage of the adaptive assessment algorithm of KST.  
1.1. Adaptive assessment through FPA 
The three matrices in Table 5.6 (Chapter 5), represent the three clinical contexts through 
which the three deterministic clinical structures can be obtained. As explained in 
Chapter 3, the clinical structure may be depicted as lattice that represents the 
relationships among the items and attributes and among different items. Each node of 
the lattice associates to each admissible response pattern (K) the set of attributes that an 
individual endorses if he is in that clinical state. Thus, the clinical structure represents a 
deterministic “skeleton” that identifies a starting point for adaptive assessment. Given 
the clinical structure, the deterministic adaptive assessment would proceed as follows: 
1. It selects the item that is closest to be present in 50% of the clinical states and 
proposes it to the patient. 
2. It registers the answer (YES-NO) and excludes all the clinical states that do not 
contain the investigated item if the answer is “yes”, or vice versa all the clinical 
states that contain the state if the answer is “no”. 
3. It selects the next item by choosing the one closest to be present in 50% of the 
remaining clinical states; 
4. The assessment stops when there is only one clinical state remaining and the 
output is the clinical state with all the attributes (diagnostic criteria) it 
investigates. 
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It is evident how a completely deterministic approach is inadequate for the assessment 
in clinical practice since it is not representative of reality. The deterministic structure 
needs to be tested on real data. Indeed, in self-report tools, problems with patient insight 
or with item wording may produce false positive answers (lucky guess; η) or false 
negative answers (careless error; β) and not all the clinical states have the same 
probability to occur. As described in Chapter 3, Section KST, the probabilistic structure 
(P, K, π) is needed to provide a probabilistic framework to the deterministic structure. 
The probabilistic model applied is the Basic Local Independent Model (BLIM; Doignon 
& Falmagne, 1999), which takes into account the probability of false positive (η) and  
false negative (β) for each item; the probability of occurrence (π) for each clinical state 
(see pg. 65). Each observed response pattern should derive from the patient’s clinical 
state (latent), the probability of error (η, β) for each item, the probability of the states. 
Given the clinical structure and the parameters (η, β, π) a probabilistic assessment 
proceeds as follows: 
1. It selects and administers the item that best splits into two equal parts the 
probability mass of the clinical states (questioning rule). 
2. It registers the answer (YES-NO). So, it reduces the probability π of all the 
states that do not contain the investigated item and increases the probability π of 
all the other states if the reply is “yes”; vice versa if the answer is “no” (updating 
rule). 
3. It repeats the procedure until one of the states exceeds a predetermined 
probability value (e.g., .70; stopping rule). 
4. The output is the clinical state which represents the most likely symptomatic 
representation of the patient’s situation regarding a specific disorder. 
Two studies will be presented in this Chapter. In the first study, the parameters will be 
estimated on the real data in order to proceed with the adaptive form of the tool. In the 
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second one, a simulation study is carried out to test the efficacy and accuracy of the 
implemented adaptive procedure. 
2. First study: Parameter estimation 
2.1. Method 
In order to validate the three clinical structures obtained (cognitive, somatic and 
affective), the parameters of the BLIM have been estimated for each of the three 
structures based on data from the 383 participants.  
Participants: The sample included:  a clinical group consisted of 38 subjects with MDE 
(who were diagnosed with major depressive disorder or bipolar disorder) of the 
Neurosciences, Mental Health, and Sensory Organ (NESMOS) Department of La 
Sapienza University, Rome. (This sample is the same of the previous research, chapter 
5). A non-clinical sample of 345 individuals recruited in the area of the University of 
Padova (both students and non-students; 68% were female). The majority of 
participants had a high school diploma, and their ages ranged between 19 and 58 years. 
(The criterion of exclusion was the same of the previous research, chapter 5). 
Administration: All the research participants completed informed consent and 
sociodemographic forms before answering the questionnaire items. No time limit was 
imposed to complete the questionnaires. All 383 subjects completed the written form of 
QuEDS (41 dichotomous items). This tool has been described in the previous research, 
presented in Chapter 5. At clinical intake, participants provided written, informed 
consent for potential research analysis and anonymous reporting of clinical findings in 
aggregate form, in accord with Italian legal and ethical requirements. The study was 
conducted in accordance with the Declaration of Helsinki. All participants entered the 
study of their own free will and they were informed in detail about the aims of the 
study, the voluntary nature of their participation, and their right to withdraw from the 
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study at any time. Furthermore, participants could ask for restitution about their own 
score, providing authors with their own auto generated code, used during the 
administration phase. 
Procedure: The estimate was performed with a specific version of the Expectation-
Maximization Algorithm (Dempster, Laird, & Rubin, 1977) for MatLab, i.e., 
CEMBLIM. For the description of the algorithm, refer to Spoto (2011). The fit of each 
of the three models has been tested by Pearson’s chi-square. It is well known that for 
large data matrices (as those used in the present study) the asymptotic distribution of χ2 
is not reliable. Therefore, a p-value for χ2 has been obtained by parametric bootstrap (n. 
of replications = 5000).  
2.2. Results and discussion 
 
In Table 1 are displayed the fit indexes of the three models estimated by CEMBLIM. 
Results show adequate fit indexes for all three models. In particular, this table shows the 
global fit indexes obtained for the three models together with the corresponding p-
values obtained by parametric bootstrap and the number of clinical states for each sub-
scale. 
 
Table 6.1: The global fit indexes of the three models 
Sub-
factor 
Num. of states df χ 2 Bootstrap P 
Cognitive 
Somatic 
Affective 
124 
163 
142 
32144 
15972 
3928 
23348 
7237 
8696 
.07 
.16 
.06 
 
Table 6.2, displays the false positive (η) and a false negative (β) for each item of the 
three sub-scales of QuEDS.  Note that the sum of η and β do not exceed the value 1 in 
line with the BLIM model assumptions.  
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Formally:    η + β < 1 for all q ∈ )        η < 1- β and β < 1- η 
Indeed, the probability that a false positive (η) occurs must be less than the complement 
to 1 of the probability of a false negative (β). In other words, the probability of a false 
positive (η) on an item i, must be less than the answer is “yes” without false positive. 
Same explanation as regards the false negative. 
 
Table 6.2: Estimated parameters β and η for each item of the three sub-scales 
COGNITIVE SOMATIC AFFECTIVE 
 β η  β η  β η 
Item 5 0.25 <.001 Item 1 0.20 0.04 Item 7 0.44 0.02 
Item 6 0.18 <.001 Item 2 <.001 0.01 Item 8 0.14 <.001 
Item 9 0.50 <.001 Item 3 0.13 0.04 Item 12 0.09 <.001 
Item 10 0.09 <.001 Item 4 0.01 <.001 Item 15 0.11 0.01 
Item 14 0.33 0.01 Item 11 <.001 <.001 Item 17 0.45 0.07 
Item 19 <.001 0.03 Item 13 0.15 <.001 Item 18 0.08 0.03 
Item 20 0.19 <.001 Item 16 0.12 0.01 Item 29 <.001 <.001 
Item 21 <.001 <.001 Item 22 0.10 <.001 Item 34 0.06 0.07 
Item 24 <.001 <.001 Item 23 0.05 <.001 Item 36 0.36 0.02 
Item 25 0.03 0.01 Item 26 0.02 0.04 Item 37 0.17 0.01 
Item 27 <.001 0.18 Item 28 0.06 <.001 Item 38 0.09 <.001 
Item 30 0.44 0.01 Item 31 0.12 <.001 Item 40 <.001 <.001 
Item 32 0.11 0.06 Item 35 0.16 0.07    
Item 33 0.02 <.001 Item 39 <.001 <.001    
Item 41 0.01 <.001       
 
As we can see from the table, the single items’ η parameters seem quite small for almost 
all items. On the contrary, there are two items with high probability of false negative (β) 
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in the cognitive scale of QuEDS: item 9 (β = .50) “I think my life is hell and I only 
deserve to feel bad”, and item 30 (β = .44) “I feel too much on the other people that it 
would be better if I killed myself”. The false negative indicates that some subjects 
answered “no”, although the symptoms investigated by that item were also investigated 
by other items where individuals answered “yes”. This could mean that the 
interpretation of these specific items could be complicated for some subjects (maybe 
because they are composed of two sentences) and therefore the symptoms included in 
those items were more easily understood within other items. To better understand the 
links among the items and the attributes look at Table 5.5, Chapter 5.  
In the affective scale of QuEDS, there are two other items with high false negative rate: 
item 7 (β = .44) “I keep crying very easily” and item 17 (β = .45) “I often feel like 
crying, but I cannot do it”. Both high values of β are related to “crying”; in this case we 
could suggest that the feel like crying as well as the “crying” were underestimated in the 
non-clinical sample. We can suppose that the subject could either intentionally fake the 
specific answer, or the subject’s answer could be affected by the poor introspection 
about “crying”. However, all the other items show reasonable error parameters. 
Parameter estimates will be essential for the implementation of the algorithm to obtain 
the adaptive form of the QuEDS. 
3. Second study: Experimental simulation 
3.1. Introduction 
The aim of this simulation study was reproducing the clinical testing in an adaptive way 
using real data. This study presents the adaptive assessment algorithm for the three 
QuEDS sub-scales (cognitive, somatic, affective), which is an extension and adaptation 
to the clinical domain of an algorithm designed for the Adaptive Knowledge 
Assessment of an individual (AKA algorithm; Falmagne & Doignon, 2011) namely the 
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ATS-PD (Donadello et al., 2016). In the present section, we used all the concepts 
described in Chapter 3, and explain the operating principles of the ATS-PD algorithm. 
3.2. ATS-PD Algorithm 
The algorithm is based on three main steps: the questioning rule, the updating rule, and 
the stopping rule. The questioning rule selects the item to ask, i.e. the item q 
‘‘maximally informative’’, such that the sum of the likelihoods of all the states 
containing q has to be as close as possible to .50. If several items are equally 
informative, one of them is chosen at random. At each step of the procedure, we call 
Ln(K) the probability of the state K at the step n. The subject’s response is collected by 
the system, then the updating rule is applied to obtain the likelihood Ln+1(K) of every 
state K. If a subject answers “yes” to q, the likelihoods of the states containing q are 
increased and, correspondingly, the likelihoods of the states not containing q are 
decreased. On the contrary, if a subject answers “no” the likelihoods of the states 
containing q are decreased and, correspondingly, the likelihoods of the states not 
containing q are increased. If we indicate an affirmative response with r = 1 and a 
negative one with r = 0, we can formalize the updating rule as:  
 
*+,- = . *+  ∑  . *+′1∈ 2  
Where:  
.,3 45
6.,-     78 9 ∈ , : = 11         78 9 ∉ , : = 11         78 9 ∈ , : = 0.,=       78 9 ∉ , : = 0 
 
In which ζ is a parameter that increases the likelihood and influences the efficiency of 
the adaptive assessment process, and ζ > 1. The higher is the value of ζ, the more 
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reliable are considered the answers provided by the subject. It has been observed 
(Falmagne & Doignon, 2011) that ζ values less than 2 make the assessment redundant 
since a higher number of answers are needed to achieve a reliable conclusion about the 
patient’ clinical state K. However, assign an high fixed value to ζ could affect algorithm 
efficacy because it can generate errors due to the overestimation of the truth of the 
answer, so that the output of the assessment can be returned in a very fast but not exact 
way. It has been proven that the algorithm, with a value of 21 of the parameter, should 
tend to converge to the correct clinical state in different applications, e.g. ALEKS 
(Falmagne & Doignon, 2011). An alternative way to estimate ζ is to assign the ζ value 
based on the η, β parameters according to Koppen (see Doignon & Falmagne, 2011, pg. 
265). Formally:  
 
 >,- = -?@A BA    and   >,= = -?BA @A  
 
The rule based on η, β is local, meaning it takes into account the false positive and false 
negative of the last item asked to the individual. If the answer is “yes” then the value 
of > is calculated according to the first formula, otherwise if the answer is “no”, the 
value is calculated according to the second formula. In this way, the parameter > is 
conditioned by the probabilities of false positive and false negative, so that if the answer  
is “yes” and if η is a high value, the > value will be always lower, and the answer will 
have a lower weight in the assessment. If the answer is “no”, and if the value of β is 
high, at equal measure, the > value will be lower and the answer will have a lower 
weight in the assessment (see Koppen, Doignon at Falmagne, 2011, pg. 265). 
At this point of the procedure, the algorithm performs the Bayesian updating rule 
(Donadello et al., 2016). Formally:  
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where C|D = (R, Ki) is given by Equation: 
 =  	 
, ∈  
 
The algorithm stops when a stopping condition is satisfied. It means that the procedure 
is repeated with the questioning rule and the updating rule until one of the states 
exceeds a predetermined probability value fixed to .70. The outcome of the assessment 
is the clinical state that reaches this predetermined high probability. At this point, the 
attributes that are implicated in this state with their relative probabilities are displayed. 
3.3.Simulation Design 
Six different conditions were considered in which the following two variables were 
manipulated: 
 The value of the parameter ζ used for the updating rule: Two levels were defined 
for its value; in the first situation, it was set to 21; in the second one ζ value was 
calculated on the basis of η, β as shown above. 
 The Bayesian updating rule (see Donadello et al., 2016): Three levels were 
defined for this variable: online, offline, absent. When the Bayesian updating is 
“online”, it means that the subject’s answers for each item asked, step by step, 
were taken into account to update the likelihood of each state in each step. If we 
use the Bayesian updating rule “offline” the update is implemented only at the 
end of the simulation. Finally, when the Bayesian updating is “absent” means 
that this rule is not used at no stage of the simulation. 
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Table 6.3 contains the six possible conditions, obtained by manipulating the two 
variables as descripted above. 
 Parameter >  Bayesian update 
1 21 offline 
2 21 online 
3 21 absent 
4 µ, β function offline 
5 µ, β function online 
6 µ, β function absent 
 
3.4. Method 
Participants: The sample is the same of the previous study: 383 subjects (38 clinical-
sample, 345 non-clinical sample).  
Procedure and administration: The ATS-PD algorithm takes as input the clinical 
structure of each sub-scale of QuEDS (cognitive, somatic, affective) and the parameters 
estimates (the probability (η, β) of false positive and false negative for each item and the 
probability of the states K). Thus starting from a probabilistic structure (P, K, π), it is 
possible to assign to each response pattern (R) its probability p(R, K) given a 
knowledge state K. Formally: 
 =  	 
, ∈  
Because the response function satisfies local independence for each item q ∈ Q, the 
conditional probability p(R, K) is determined by the probabilities β, η related to each 
item q. Formally: 

,  =   ∈\    1 − ∈∩    ∈\    1 − ∈∪  
 
 129
These last equations reported represent the basic local independence model (BLIM; 
Doignon & Famagne, 1999). Once the error parameters were estimated (previous 
study), the algorithm (ATS-PD) was applied for the adaptive simulation of the written 
form of QuEDS sub-scales.  
The clinical assessment phase was reproduced, evaluating whether the adaptive form of 
QuEDS could generate the same response pattern of a subject who answered the written 
version (system efficacy), but with a reduced number of questions (system efficiency). 
The reproduction of the testing started when the system imports the clinical structures of 
the subscales and the response patterns of 383 subjects. For every response pattern R, 
the system performs the testing by asking a question, answering automatically, and 
updating the likelihood until it uncovers the latent state K. Since the number of the 
states in the structures was relatively high compared to the sample size, the estimates of 
πk were not reliable. Therefore, we choose to use a uniform probability distribution on 
all the states Ln(K) at time 0.  
To better understand the results of the simulation we introduce some concepts. A 
response pattern R is a list of the observed answers provided by a subject in the written 
version of QuEDS. We have the response patterns (R1, R2, R3 ….Rn) of the 383 
participants. We call K* the state in the structure  that is the output of the adaptive 
assessment given a response pattern Rn. It is important to emphasize that the output of 
the assessment for any response pattern Rn through the adaptive simulation is always a 
state of the clinical structure. We call d( K*, R) the cardinality of the set difference 
between the output K* and the pattern R. 
The results of the simulation for each subject can fall into one of the following 
categories: 
1. K*∈  = R. This happens when the response pattern R is a state K of the 
clinical structure . In this case the distance between the state and the response 
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pattern R is: d( K*, R) = 0. In the specific condition, the output of the adaptive 
assessment is exactly the same of the output obtained with the written version 
of the sub-scale. 
2. K* ∈  ≠ R In this case of course, d( K*, R) > 0. It means that the response 
pattern R is not a clinical state K of the structure . In this situation two 
alternatives may occur: in the first case the distance d( K*, R) is minimum. It 
means that there is no K ∈  such that d(K, R) < d( K*,R). In the second case 
the distance d( K*, R) > minimum. It means that exist K ∈  such that d( K, R) 
< d( K*, R). indeed, there is another clinical state K in the structure that is 
closer to the response pattern R even if it is not the output of the assessment. 
This latter situation can occur for several reasons; it may depend on the error 
parameters (η, β), on the sequence of questions posed by the system, and on the 
Bayesian update and parameters used by the algorithm. 
3.5.Results and Discussion 
The aim of this study was reproducing the clinical testing in an adaptive way using real 
data (N =383) to verify if:  
 The new system of QuEDS is able to identify as output of the assessment the 
clinical states corresponding to the response patterns (accuracy). 
 The adaptive form of QuEDS asks a smaller number of questions with respect to 
the standard written version questionnaires (efficiency). 
As we know, the adaptive form of QuEDS sub-scales return only clinical states in the 
clinical structure. We verified that the three clinical structures are good model of the 
reality, after fit indexes estimates (Spoto et al., 2010). Thus, a response pattern R, with 
an assigned clinical state K in which d(K*,R) ≠ 0 , indicates that R is affected by false-
positive or false-negative errors.  
 131
In our clinical structure, the simulation works better with the Bayesian updating rule 
online, and with the parameter > calculated on the basis of η, β.  
Tables 6.4, 6.5, 6.6 display the comparison of the main indexes of the different tested 
adaptive procedures. Each table relates to one of the three QuEDS subscales (cognitive, 
somatic, affective). In particular, the first column contains the two solutions (explained 
in the simulation design section) in which was assigned the value of parameter >. The 
second column refers to the three ways in which we manipulated the Bayesian update 
(online, offline, and absent). The third column contains the maximum number of 
questions asked to finish adaptive assessment and reach the output. The fourth column 
contains the number of the R (response pattern) in which d( K*, R) > minimum. Thus, 
in these cases the response pattern R was not a state K of the structure, and the output of 
the assessment is not the state of the clinical structure closest to R. 
Table 6.4: Cognitive factor 
parameter ζ Bayesian update n. max of questions n. states d (K,R) ≠ 0 
d(K,R) ≠ minimum 
21 offline 17 12 
21 online 11 15 
21 absent 17 11 
µ, β function offline 20 7 
µ, β function online 11 10 
µ, β function absent 20 7 
 
Table 6.5: Somatic Factor 
 
parameter ζ Bayesian update n. max of questions n. states d (K,R) ≠ 0 
d(K,R) ≠ minimum 
21 offline 9 8 
21 online 9 6 
21 absent 9 8 
µ, β function offline 11 8 
µ, β function online 9 5 
µ, β function absent 11 8 
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Table 6.6: Affective factor 
 
parameter ζ Bayesian update n. max of questions n. states d (K,R) ≠ 0 
d(K,R) ≠ minimum 
21 offline 8 40 
21 online 8 35 
21 absent 8 39 
µ, β function offline 23 39 
µ, β function online 8 29 
µ, β function absent 29 34 
 
As we can see from the tables in all three clinical structures, the system works better 
with online Bayesian update and, with the parameter ζ calculated on the basis of η, β.  
Starting from the cognitive scale, which has 15 items in total, with this condition we 
have a maximum of 11 questions asked and a minimum of 7 question (items) asked in 
the adaptive form to achieve the output of assessment; the average is 8,83 items asked 
(s.d= .47). It means that the saving in terms of question posed is between 31% and 53% 
for the cognitive factor of QuEDS. We found 10 response patterns R in which the 
condition d(K*, R) = minimum was not satisfied, so K* is not a minimum distance to a 
response pattern R. We have in total 383 subjects and 129 different response patterns; 
10 of the 129 response patterns R in writing form were not a minimum distance. It 
means that the states K*
 
generated as outputs by the algorithm are states of the clinical 
structure that are not as close as possible to the response patterns R; indeed, there are 
some clinical states in the structure that are closer than K* to each of the 10 response 
patterns R even if they are not the output of the assessment. Formally we say that: 
d(K, R) < d(K*, R) 
In the specific case, d(K, R) - d(K*, R) ≤ 2. It means that the distance between the state 
K*
 
output of the assessment and the state closer to the response pattern is never greater 
than 2. 
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The somatic scale has 14 items in total. Through the Bayesian update online simulation 
and the parameter ζ calculated on the basis of η, β, we have a maximum of 9 items 
asked and a minimum of 8 item asked to achieve the output of the assessment; the 
average is 8,42 items asked (s.d= .82). It means that the saving in terms of questions 
posed is between 36% and 50% for the somatic factor of QuEDS. We have in total 173 
different response patterns, and we found 5 response patterns R in which the condition 
d(K*, R) = minimum, was not satisfied. There are some clinical states closer than the 
clinical state K*, output of the assessment, for those 5 response patterns.  
In the specific case, d(K, R) - d(K*, R) ≤ 2. It means that the distance between the state 
K* output of the assessment and the state closer to the response pattern is never greater 
than 2. 
Finally, on the affective scale, some difficulties emerged. Indeed, we have a total 12 
items in the written version and using the same condition, we have a maximum of 8 
item asked and a minimum of 7 items asked in the adaptive version (experimental 
simulation); the average is 7,66 items asked (sd= .47). The saving in terms of questions 
posed is between 33% and 42% that is on average lesser than the saving in the other two 
scales. Moreover we found 29 response pattern in which the condition d(K*, R) = 
minimum was not satisfied (as defined above). In the specific case d(K, R) - d(K*, R) ≤ 
3. It means that the distance between the state K* output of the assessment and the state 
closer to the response pattern is never greater than 3. 
 
4. General Discussion 
 
The adaptive form of QuEDS is based on an extension of an algorithm for the 
assessment of knowledge (Falmagne & Doignon, 2011). Several new features are added 
to the procedure according to Donadello et al. (2016): first, the definition of the 
reference structure for the algorithm is performed through the application of FPA. 
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Second, the parameters estimates are carried out by referring to CEMBLIM (Dempster, 
Laird, & Rubin, 1977). Third, the parameter ζ was calculated on the basis of η, β; finally 
the algorithm updates the states’ probabilities through a Bayesian rule step by step 
online in the testing.  
The aim of this study was to build an adaptive version of QuEDS using its sub-factors 
(cognitive, somatic, affective). This tool should support the clinician in the diagnosis of 
different types of major depressive episode. Indeed, as explained in the previous 
Chapter, the numerical score provides information on the level of depression but is not 
able to differentiate individuals with the same score but different symptoms. The FPA 
through the relationship between items and symptoms allows to obtain qualitative 
information. However, with the written version, the clinician’s work to obtain the 
information is time-consuming, and errors in interpreting the answers may also occur as 
the error parameter estimates are not considered. 
In the first study, in order to validate the obtained three clinical structures (cognitive, 
somatic and affective), the parameters of the BLIM have been estimated for each of the 
three structures based on data from the 383 participants. The models showed adequate 
fit indexes; the estimated µ and β were essential for the implementation of the algorithm 
in order to obtain the adaptive form of the QuEDS. 
The ATS-PD algorithm taking into account the false positive and false negative 
answers, allows to individualize a patient’s precise critical areas in efficient way, that is, 
a system poses fewer questions than the standard written questionnaire does. Moreover, 
it is able to achieve a clinical evaluation that goes beyond the score, indicating, 
adaptively, all the problems presented by an individual in a way that mimic the semi-
structured interview. 
The performance results reported in the previous section showed that all of the response 
patterns that are states are assigned to that state, so the system is able to correctly 
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reproduce the patient’s admissible response pattern of a questionnaire. It is worth noting 
some crucial differences between a classical questionnaire administration and the 
assessment through ATS-PD algorithm.  
The adaptive form of QuEDS returns the individual’s clinical state for each sub-scale, 
with the subset of symptoms included. Indeed, the clinical state is the subset of items in 
which the individual answers affirmatively with a set of attributes (in terms of 
symptoms) endorsed by those items. This information permits to distinguish the 
individuals showing different critical areas and, thus, leading to different diagnoses. In 
Chapter 5 we showed the importance of obtaining the clinical state for differential 
diagnosis. The adaptive model allows to reach the clinical state as a test output directly 
without the clinician’s hard work. 
According to the model (supported by the fit indexes) the admissible response patterns 
should be the states of the structure, so the system will always complete its evaluation in 
one of these states. However, the response patterns observed could be affected by errors 
(µ, β) and could differ from the assigned state. Indeed, the response patterns that are not 
states are assigned to states with d(K*, R) = minimum.  
In some cases, we have seen that d(K*, R) > minimum. This means that some response 
patterns R (as input) had a clinical state K* as output that was not as close as possible to 
R. Indeed, there was another K state of the structure closer to the pattern. This could 
depend on the sequence of questions asked by the system, either by the error parameters 
(µ, β), or by the type of update used by the system. However, this situation has rarely 
occurred in the cognitive and affective sub-scales, while in the case of the affective sub-
scale it has occurred more often. 
Another important result to be stressed is the reduction of the number of questions 
asked together with the improvement of the quality and quantity of information 
collected. In the classical written form of the QuEDS, each participant has to answer all 
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41 items, 15 of the cognitive sub-scale, 14 of the somatic subscale, 12 of the affective 
subscale. In the adaptive form of QuEDS only a percentage ranging between 50% and 
70% of the items are asked and the clinician is provided with the clinical state of the 
individual, including the diagnostic symptoms presented by the patient. 
Thus, the adaptive version of QuEDS differentiates the individual’s depressive 
symptoms beyond the score and allows to administer only the items related to its 
symptomatology following the logical flow of question-answer. 
As future work, we intend to extend the number of participants in order to obtain more 
precise fit indexes, and more reliable error parameters. Another objective is to achieve a 
simple graphical user interface providing the clinician with a helpful way to interact 
with the system. Finally, there can be several improvements of ATS-PD system, for 
example the possibility of simplifying the updating rule for real-time application of 
QuEDS (i.e. Augustin, Hockemeyer, Kickmeier-Rust, Podbregar, Suck, & Albert, 
2013). Another important future direction will be to extend the adaptive version of the 
tool also with politomicous items with Likert scale. There are two main solutions under 
evaluation to solve this issue: the fuzzy logic approach and an IRT oriented solution. In 
both cases, there is the possibility to take into account the case in which the answering 
format is not dichotomous. The implementation of either of these proposals would allow 
FPA to construct tools with not only dichotomous replies works becoming much more 
fruitful in clinical practice. 
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CHAPTER 7 
Clinical evidence for differential diagnosis of 
Agitated Depression  
 
1. Introduction and research aim 
 
In the previous Chapters, we demonstrated the possibility of achieving a differential 
diagnosis of depressive symptoms starting from a new evaluation approach. Through 
the FPA, we built a tool that is able to differentiate patients with the same score on the 
questionnaire but with different symptom configurations. We have also shown how a 
computerized adaptive system can mimic the semi-structured interview process in 
which only the patient’s symptomatic areas are investigated. 
In evaluating depression, an adaptive tool able to going beyond the numerical score is 
essential. In fact, clinicians have to face different types of major depressive episodes 
that often requiring a different diagnosis and a specific treatment. The case of agitated 
depression, or mixed, represents perhaps the most important. In fact, agitated depression 
is classified as a mixed episode, with both depressive and manic symptoms, and for this 
reason it can not be treated in the same way as the typical depressive episode. 
The research that will be presented below has been carried out in collaboration with the 
University of Cardiff and Worcester, in particular with the Bipolar Disorder Research 
Network (BDRN) during the research period abroad.  
In line with the topics discussed in the previous Chapters regarding the importance of 
differential diagnosis, a study of 3750 patients with bipolar disorder or major depression 
has been conducted with the aim of deepening all issues related to agitated depression.  
The study was part of the ongoing programme of research into the genetic and non-
genetic determinants of BD and related mood disorders (Bipolar Disorder Research 
Network, BDRN; bdrn.org) which has UK National Health Service (NHS) Research 
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Ethics Committee approval and local Research and Development approval in all 
participating NHS Trusts/Health Boards. Data come from BDRN. 
Agitated Depression (AD) still have an unclear place in mood disorders and different 
definitions (Akiskal et al., 2005; Benazzi et al., 2002; Koukopoulos, & Sani, 2014) 
despite it is not at all a rare observation and many authors underscored the necessity of a 
corrected diagnosis in order to avoid erroneous treatment (Baldessarini et al., 2006a, 
2006b; Olin et al., 2012; Vázquez et al., 2013). Kraepelin (1913; 1921) classified 
agitated depression as a result from the combination of opposite polarity of symptoms: 
mood and thought in depressive polarity and activity in manic polarity. In his view, it 
was enough to have one of the three components (psychomotor activity, mood and 
thinking) in manic polarity to have mixed state (Akiskal & Benazzi, 2004). According 
to DSM-5 criteria (American Psychiatric Association, 2013), Major Depressive Episode 
(MDE) with mixed features replaced the agitated depression of Research Diagnostic 
Criteria (RDC, Spitzer,  Endicott, & Robins, 1978) and it is defined as a depression with 
at least three manic/hypomanic symptoms. However different authors consider the 
DSM-5 picture of AD as a very rare feature with the lack of satisfaction of these criteria 
(Faedda et al., 2015; Koukopoulos, & Sani, 2014; Maj et al., 2003). Koukopoulos and 
colleagues (1999; 2014) defined AD as an MDE with at least one of the following 
criteria: inner psychic tension, psychomotor agitation, irritability, and racing/crowded 
thoughts. Olgiati, Serretti, & Colombo (2006) defined AD as MDE with OPCRIT item 
of agitated activity (excessive repetitive activity, such as fidgety restlessness, wringing 
of hands, pacing up and down) all usually accompanied by expression of mental 
anguish (McGuffin et al., 1991). There is therefore no univocal definition of agitated 
depression. 
Regarding the ratio of AD in Major Depressive Disorder (MDD), Bipolar Disorder I 
(BD-I) and Bipolar Disorder II (BD-II), different findings have been reported although 
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currently the classification of AD in mood disorder’s population is still unclear. In 
Bipolar I reports of AD vary from 20% (Maj et al., 2003) to 50% (Koukopulus et al., 
2007). In Bipolar II reports of AD vary from 30% (Benazzi et al., 2002) to 52% 
(Takeshima, & Oka, 2013). In MDD reports of AD vary from 11% (Benazzi et al., 
2002) to 30% (Koukopulus et al., 2007). The various ways of defining and assess 
agitated depression in many different studies (Akiskal et al., 2005; Benazzi 2004a; 
Koukopulus et al., 2007; Maj et al., 2003; McIntyre et al., 2015; Takeshima & Oka 
2013; Olgiati et al., 2006) could mirror the different findings found on prevalence in 
MDD, BD-I, and BD-II.  
The previous studies on AD have been performed in a relatively small sample (Benazzi 
et al., 2002; Koukopoulus et al., 2007; McIntyre et al., 2015 etc.); moreover only few 
studies were focused on the prevalence of AD in Bipolar Disorder I and II and in the 
differences of the lifetime and episode features linked with AD in the two disorders. 
Indeed the studies focused more on exploring illness course and hypomanic features 
related to AD in MDD to investigate possible indicators of bipolarity as well as mood 
switching in the polarity of episode induced by antidepressant drugs (Akiskal et al., 
2005; Angst, Gamma, Benazzi, Ajdacic, & Rössler 2009; Biondi, Picardi, Pasquini, 
Gaetano, & Pancheri 2005; Olgiati et al., 2006). 
Concerning the possible lifetime features associated with AD, some studies correlated 
the AD with lower age at onset (Benazzi et al., 2002; Koukopoulus et al. 2007) of the 
mood disorder, bipolar spectrum (Akiskal et al., 2005; Sato et al., 2003), longer duration 
of the illness period (Maj et al., 2003; Benazzi et al., 2002). Agitated episode was very 
often associated with intra-depressive hypomanic symptoms (Maj et al., 2003; Oligiati 
et al., 2006; Perugi et al., 2001), more severity of depressive symptoms (Benazzi et al., 
2002; Oligiati et al., 2006), more atypical features specifiers such as mood lability 
(Benazzi et al., 2002). In Bipolar disorder I patients with AD compared to patients with 
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non-AD were more likely to receive standard antipsychotic drugs during that episode 
(Goodwin & Jamison, 2007; Maj et al., 2003). The demographic features correlates with 
AD according to the previous studies are female gender (Benazzi et al., 2002; 
Koukopulus et al., 2007; Maj et al., 2003), lower educational levels (Oligiati et al., 
2006), and more family history of bipolar disorders (Akiskal et al., 2005; Koukopulus et 
al 2007; Maj et al., 2003).  Moreover, psychomotor agitation and suicidal ideation were 
found to be correlated in many studies (Andreasen and Grove, 1982; Kendler et al., 
1996; Korszun et al., 2004; Maj et al., 2003; Raskin et al., 1969; Sullivan et al., 2002).  
Agitated depression have a significant clinical relevance, nevertheless, there are limits 
of information, underestimation of the consequences, which could result in 
misdiagnosis of AD and inappropriate/wrong treatment, often with very dangerous 
outcomes (Akiskal et al., 2005; Bocquier et al., 2013). In particular, treatment with 
antidepressant drugs of AD could worsen the excitatory symptoms with the failure to 
relieve the patient’s pain (Baldessarini et al., 2006; Koukopoulos, & Koukopoulos, 
1999; Vázquez et al., 2013). Moreover, antidepressants monotherapy in AD could 
increase the risk of suicide (Akiskal et al., 2005; Baldessarini et al., 2006a; 
Koukopoulos, & Koukopoulos, 1999; Vázquez et al., 2013). 
In keeping with this background, the present study have two main aims:  
The first one concerns the re-evaluation of the prevalence of AD in the worst episode in 
a large sample (N= 3750) of patients with MDD, BD-I and BD-II exploring the 
differences in the rate of AD among the three disorders. 
The second aim is to investigate the possible correlations of AD with socio-
demographic variables, lifetime features, and the episode features in line with the other 
researches. Unlike the previous studies, we focus on the differences in Bipolar I and 
Bipolar II (BD-I, BD-II) agitated depression because many researches have already 
focused on AD in unipolar disorder (MDD) and treatment-related issues (Biondi et al, 
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2005; Akiskal et al., 2005; Oligiati et al., 2006; Swann, 2013). Moreover, previous 
studies have highlighted the association between psychomotor agitation and risk for 
mood-switching in MDD, suggesting that agitated depression was almost always 
associated with indicators of bipolarity (Akiskal et al., 2005; Angst et al., 2009; 
Iwanami et al., 2015) and, MDD patients are often reclassified in the bipolar spectrum 
(Benazzi, 2006; Cassano et al., 2012; Fiedorowicz, Endicott, Leon, Solomon, Keller, & 
Coryell, 2011). Thus, to avoid confusion, we preferred to focus on patients with Bipolar 
Diagnosis.  
2. Materials and methods 
 
2.1.Participants 
Participants are recruited systematically through NHS psychiatric services and non-
systematically using advertisements for volunteers via the BDRN website, leaflets, 
posters, media coverage about the research and also through the UK-based user-led 
charity, Bipolar UK.  All patients in the UK who have a diagnosis of bipolar disorder I, 
II or major depressive disorder, and are aged 18 years or over are eligible to take part in 
the BDRN study and enrol after giving written informed consent. The exclusion criteria 
are patients who: a) have only experienced affective illness as a consequence of alcohol 
or substance abuse or dependence; b) have only experienced affective illness as a 
consequence of medical illness or medication; c) have an organic brain disorder or other 
cognitive problem that impedes their ability to complete the assessments; d) are 
biologically related to another study participant. 
Participants in the current study (N= 3750) were those from whom we had information 
on the presence or absence of agitated features during a depressive episode who met 
DSM-IV diagnostic criteria for BD-I (N= 2123), BD-II (N= 915), and MDD (N= 712). 
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2.2. Psychiatric Assessment 
Clinical data for each individual in the BDRN study is collected by a trained BDRN 
interviewer (research psychologist or psychiatrist) using a semi-structured psychiatric 
interview, the Schedules for Clinical Assessment in Neuropsychiatry (SCAN, Wing et 
al., 1990). Further clinical data are gathered from participants’ psychiatric case notes. 
Diagnoses and clinical ratings are made using all available clinical data according to 
pre-specified guidelines. The OPCRIT criteria are used to evaluate the worst depressive 
episode of participants (McGuffin et al., 1991). Diagnostic and clinical ratings are made 
by at least two members of the research team blind to each other’s ratings. Inter-rater 
reliability was formally assessed using 20 random cases. Mean kappa statistics were 
0.85 for DSM–IV diagnoses and ranged between 0.81 and 0.99 for other key clinical 
categorical variables. Mean intra-class correlation coefficients were between 0.91 and 
0.97 for key clinical continuous variables. Team members involved in the interview, 
rating and diagnostic procedures were all research psychologists or psychiatrists. 
2.3. Agitated Depression (AD) definition 
We defined AD according to the OPCRIT (Operational Criteria for Psychotic Illness 
checklist) definition, which requires the presence of excessive repetitive activity (such 
as restlessness, wringing of hands, pacing up and down) all usually accompanied by 
expression of mental anguish.  In this study, agitated activity was rated as present/absent 
during the worst ever episode of depression and mean kappa is 0.85. 
2.4. Data analysis 
The data were analysed using SPSS (2012). The majority of data were normally 
distributed so parametric statistical tests were used. The ratio of Agitated Depression 
present/absent in the three different disorders (BD-I, BD-II, and MDD) was compared 
using chi-square test. Demographic and clinical characteristics of the two groups (AD 
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and non-AD) in BD-I and BD-II were compared using chi-square tests for categorical 
data and t student test for independent samples for continuous data. All OPCRIT 
episodic features significant at P ≤ 0.05 in the univariate analyses were included as 
explanatory variables in logistic regression models using the enter likelihood ratio 
method with absence or presence of AD as the outcome/dependent variable. All the 
demographic and lifetime characteristics significant at P ≤ 0.05 in the univariate 
analyses were included as predictors in a logistic regression models using the enter 
likelihood ratio method with absence or presence of AD as the outcome/ dependent 
variable. 
3. Results 
 
3.1. The prevalence of Agitated Depression in MDD, BD-I and BD-II 
There are no significant differences in the demographic features among MDD, BD-I and 
BD-II. The people with agitated features are 1098 (29,3%) out of 3750. 
There is a significant greater proportion of AD in BD-II (see Table 1): 37% of the 
sample; 29% in BD-I, and 21% in MDD. The difference in the proportion of AD in the 
different Diagnosis is significant (χ2= 46.407, p<.001). In particular, all the different 
ratios are significantly different. AD in BD-I and BD-II (29% vs. 37%, p<.001), AD in 
MDD and BD-I (21% vs. 29%, p<.001), AD in MDD and BD-II (21% vs 37% p<.001). 
 
 
 
TABLE 7.1:  Agitated depression ratios in BD-I, BD-II and MDD 
 
DSM DIAGNOSIS 
 
NO Agitated features YES Agitated features tot 
BD-I 1513 (71%) 610 (29%) 2123 
BD-II 579 (63%) 336 (37%) 915 
MDD 560 (79%) 152 (21%) 712 
Tot 2652 (71%) 1098 (29%) 3750 
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3.2. Demographic and lifetime features according to agitated depression. 
There wasn’t significant difference in the proportion of male and female, both in BD-I 
that in BD-II. There was a significantly greater proportion of lowest educational 
attainment in AD compared with no AD in patients with BD-I and II.  
Concerning the lifetime characteristics related to agitated features in BD-I (see Table 
7.2), the individuals in the agitated group had significantly: 
- Higher rate of history of alcohol misuse, defined as > 14 units in women and 
>21 units in men at any point of life, with related impairments (50% vs. 42%). 
- Higher rate of history of panic attacks (74% vs. 54%). 
- Higher rate of dysphoric mania episodes, defined as manic episode in which the 
predominant state was dysphoria- i.e. an unpleasant state characterized by unease or 
mental discomfort including low mood (52% vs. 36%). 
- Higher rate of history of suicide attempts (59% vs. 44%). 
- Higher rate of rapid cycling, defined as 4 or more affective episodes in one year 
(37% vs. 28%). 
- Higher rate of depressive polarity as the first episode (81% vs. 66%). 
- Younger age at illness onset, defined as the age in which symptoms of affective 
disorder first caused significant impairment (22 vs. 24 years). 
 
The lifetime characteristics related to agitated features in BD-II showed that agitated 
group had significantly: 
- Higher rate of history of Alcohol misuse, defined as > 14 units in women and 
>21 units in men at any point of life, with related impairments (58% vs. 48%). 
- Higher rate of history of panic attacks (85% vs. 64%). 
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- Higher rate of dysphoric (Hypo)mania episodes, defined as hypomanic episode 
in which the predominant state was dysphoria- i.e. an unpleasant state characterized by 
unease or mental discomfort including low mood (33% vs. 25%). 
- Higher rate of history of suicide attempts (56% vs. 47%). 
- Higher rate of rapid cycling, defined as 4 or more affective episodes in one year 
(54% vs. 44%). 
There were no other significant differences in BD-II lifetime characteristics between the 
agitated and no agitated group. 
TABLE 7.2. Demographic characteristics, and lifetime features according with agitated features 
in the worst episode of depression. 
DEMOGRAPHIC 
characteristics 
BIPOLAR DISORDER I 
AGITATED FEATURES 
BIPOLAR DISORDER II 
AGITETED FEATURES 
 NO (1513) YES (610) χ2(df=1)  p NO (579) YES (336) X2 (df=1) p 
Sex, n (%) 
MALE 
FAMALE 
 
 
496 (33%) 
1017 (67%) 
 
179 (29%) 
431 (71%) 
 
 
χ2=2,370 
p=.124 
 
188 (33%) 
391 (67%) 
 
100 (30%) 
236 (70%) 
 
χ2=.723 
p=.395 
Education, n (%) 
Non graduate 
Degree/Postgrad Degree 
 
804 (57%) 
606 (43%) 
 
365 (65%) 
198 (35%) 
 
 
χ2=10,164 
p=.001 
 
320 (57%)  
238 (43%) 
 
219 (69%) 
77 (31%) 
 
χ2=10,950 
p=.001 
LIFETIME FEATURES 
 
      
Alcohol abuse 586 
(42%) 
288 
(51%) 
χ2=11,96 
p=.001 
269 
(48%) 
186 
(58%) 
χ2=8,01 
p=.005 
Cannabinoids abuse 296 
(20%) 
133 
(23%) 
χ2=1,52 
p=.217 
149 
(26%) 
101 
(31%) 
χ2=2,60 
p=.107 
Panic comorbidity 
 
419 
(54%) 
278 
(74%) 
χ2=42,25 
p<.001 
244 
(64%) 
204 
(85%) 
χ2=31,57 
p<.001 
Dysphoric Mania  461 
(36%) 
263 
(52%) 
χ2=37,98 
p<.001 
121 
(25%) 
86 
(33%) 
χ2=4,09 
p=.042 
Suicide attempts 655 
(44%) 
349 
(59%) 
χ2=37,09 
p<.001 
284 
(47%) 
185 
(56%) 
χ2=3,69 
P=.040 
Rapid Cycling 309 
(28%) 
148 
(37%) 
χ2=11,23 
p=.001 
161 
(44%) 
99 
(54%) 
χ2=7,52 
P=.006 
Polarity 1st episode 
DEPRESSION 
MANIA 
 
 
853 (66%) 
439 (34%) 
 
 
404 (81%) 
98 (20%) 
 
χ2=36,54 
p<.001 
 
465 (92%) 
41 (8%) 
 
268 (92%) 
23 (8%) 
 
χ2=.59 
p=.75 
Impairment age at onset 
MEAN 
S.D 
RANGE 
 
24 
9,88 
4-73 
 
22 
8,70 
4-55 
 
T=-3.674 
p<.001 
 
21 
9,15 
5-58 
 
20 
8,80 
5-63 
 
T=-1,89 
p=.059 
Total vary due to unknown/missing data 
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The demographic and lifetime characteristics that were significantly higher in the 
agitated group (p≤ .05) of BD-I were included in the logistic regression analysis. The 
characteristics that best predicted the presence of agitation in BD-I group were history 
of panic attacks (OR 1.932, 95% C.I: 1.271 – 2.936, p=.002); lifetime episodes of 
dysphoric mania (OR 1.689, 95% C.I: 1.140 – 2501, p=.009); lower educational 
attainment (OR .661, 95% C.I: .448-.976, p=.037) and depression as the polarity of the 
first episode (OR .584, 95% C.I: .360 – .948, p=.029). This model considers 15,4% of 
the variance and correctly classified 72% of participants who have agitated features or 
not. 
At the same way of BD-I, the demographic and lifetime characteristics that were 
significantly higher in the agitated group of BD-II (p ≤.05) were included in the logistic 
regression analysis. The characteristics that best predicted the presence of agitation in 
BD-II group were history of panic attacks (OR 2.655, 1.416 – 4.978, p=.002) and 
suicide attempts (OR 1.919, 95% C.I: 1.129 – 3.264, p=.016). This model considers 
10% of the variance and correctly classified 66,3% of participants who have agitated 
features or not. 
Furthermore, in the Agitated group there was a greater lifetime use of psychiatric drugs. 
In particular BD-I individuals had a significant higher use of antidepressant (96% vs. 
88%, p<.001), anxiolytics (76% vs. 64% p<.001), and hypnotics (78% vs. 71%, 
p=.004); BD-II individuals had a significant higher use of anxiolytics (70% vs 55%, 
p<.001) and antipsychotics (66% vs 55%, p=.004). 
  
3.3.Worst episode symptoms according to agitated features. 
In BD-I almost all the symptoms of the worst depressive episode are more connected 
with agitated features (see Table 7.3). Indeed, there were significantly greater 
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proportions of depressive symptoms in the agitated group compared to no agitated 
group (Loss of pleasure, diurnal variation, suicidal ideation, etc.). 
Even in BD-II disorder, many severe symptoms in the worst depressive episode are 
associated with agitated features (see Table 7.3). 
 
TABLE 7.3:  Worst episode symptoms associated with agitated features 
OPCRIT 
VARIABLES 
BIPOLAR DISORDER I 
AGITATED FEATURES 
BIPOLAR DISORDER II 
AGITETED FEATURES 
N (%) NO (1513) YES (610)  χ2 (df=1)p NO (579) YES (336) χ2 (df=1)p 
Loss of 
pleasure 
1301 (88%) 
 
572 (98%) χ2=49,76  
p<.001 
558 (98%) 319 (99%)      χ2=1,33  
p=.248 
Diurnal mood 
variation 
674 (47%) 
 
301 (55%) χ2=10,49  
p<.001 
261 (47%) 157 (49%) χ2=.263  
p=.608 
Suicidal 
ideation 
1015 (70%) 
 
503 (87%) χ2=67,57  
p<.001 
460 (81%) 284 (89%) χ2=7,92  
p=.002 
Excessive 
self-reproach 
1163 (81%) 
 
548 (94%) χ2=56,76 
 p<.001 
519 (95%) 294 (94%) χ2=.23  
p=.632 
Poor 
concentration 
1180 (82%) 
 
550 (97%) χ2=72,74  
p<.001 
517 (95%) 315 (99%) χ2=5,57  
p<.001 
Slowed 
activity 
704 (52%) 
 
370 (70%) χ2=47,16  
p<.001 
317 (64%) 197 (71%) χ2=3,32  
p=.069 
Loss of 
energy 
1257 (86%) 
 
557 (96%) χ2=36,63  
p<.001 
552 (98%) 318 (97%) χ2=.936  
p=.333 
Poor appetite 703 (50%) 
 
362 (66%) χ2=39,87  
p<.001 
249 (47%) 208 (66%) χ2=26,6  
p<.000 
Weight loss 370 (27%) 225 (44%) χ2=49,74  
p<.001 
132 (26%) 118 (40%) χ2=19,19  
p<.000 
Increased 
appetite 
331 (24%) 145 (27%) χ2=2,04  
p=.152 
149 (29%) 88 (29%) χ2=.007  
P=.932 
Weight gain 237 (18%) 113 (23%) χ2=5,07  
p=.024 
118 (23%) 69 (23%) χ2=.002  
p=.967 
Initial 
insomnia 
484 (35%) 
 
317 (60%) χ2=90,01  
p<.001 
213 (41%) 197 (64%)  χ2=38,42  
p<.000 
Middle 
insomnia 
386 (29%) 
 
266 (53%) χ2=88,72  
p<.001 
150 (30%) 164 (55%) χ2=40,04  
p<.000 
Early morning 
waking 
359 (27%) 
 
255 (49%) χ2=84,04  
p<.001 
161 (32%) 137 (47%) χ2=18,80  
p=.016 
Excessive 
sleep 
653 (49%) 
 
236 (45%) χ2=1,70  
p=.192 
275 (54%) 141 (47%) χ2=3,60  
p=.058 
Diminished 
libido 
783 (60%) 
 
406 (82%) χ2=75,44  
p<.001 
405 (84%) 238 (85%) χ2=.353  
p=.552 
Total vary due to unknown/missing data 
 
All the BD-I episode features that were significantly higher in the agitated group (p 
≤.05) were included in the logistic regression analysis. The episode features that best 
predicted the presence of agitation in BD-I group were poor concentration (OR 2.694, 
95% C.I: 1.176 – 6.172, p=.019), suicidal ideation (OR 1,809, 95% C.I: 1.078 – 2.710, 
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p=.023), middle insomnia (OR 1.820, 95% C.I: 1.277 – 2.593, p=.001), diminished 
libido (OR 1.939, 95% C.I: 1.361 – 2.764, p<.001), weight loss (OR 1.637, 95% C.I: 
1.099- 2.438, p=.015) and slowed activity (OR 1.597, 95% C.I: 1.129 – 2.259, p=.008). 
This model considers 22% of the variance and correctly classified 75% of participants 
who have agitated features or not. 
As for BD-I group, all the episode features with the ratios significantly higher (P ≤.05) 
in BD-II people with agitated features were included into a logistic regression analysis. 
The episode features that best predicted the presence of agitation were suicidal ideation 
(OR 1.711, 95% C.I: 1.011 – 2.897, p=.045), middle Insomnia (OR 2.234, 95% C.I: 
1.499 – 3.330, p<.001) and poor appetite (OR 1.619, 95% C.I: 1.019- .2.572, p=.041). 
This model considers 14,5% of the variance and correctly classified 66,4% of 
participants who have agitated features or not. 
4. Discussion 
This study is carried out in a large clinical sample of UK, i.e. N=2123 BD-I, N=915 
BD-II and N=712 MDD patients. Unlike the majority of the other studies that 
investigated agitated depression, we consider all the three mood disorders (MDD, BD-I 
and BD-II) in evaluating the rates of patients with agitated features in the worst 
depressive episode. We found AD episodes in the 29,3% of the whole sample. 
Specifically our study showed a prevalence of AD in Bipolar patients (BD-II 37%, BD-I 
29% vs 21% MDD). This finding is in agreement with previous studies that compared 
the presence of agitated current episode both in the three disorders (Koukopulus et al., 
2007; McIntyre et al., 2015; etc.) and in MDD and BD-II (Benazzi et al., 2002; Benazzi, 
2004a; Dunner, & Tay, 1993; Takeshima, & Oka, 2013). However, regarding the 
proportions, our data are different from all the other studies. Moreover, our finding of 
the higher proportion of agitated depression in BD-II (37%) is inconsistent with some 
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previous researches in which the proportion was higher in BD-I (Koukopulus et al., 
2007) or equal in BD-I and BD-II (McIntyre et al., 2015). 
This heterogeneity of the results again highlights the problem in defining and evaluating 
agitated features of depression in different way. In particular, we used the definition of 
OPCRIT item of agitated activity (McGuffin et al., 1991) where the symptoms are 
easily recognizable by both the clinician and the patient (Olgiati et al., 2006). We 
suggest that the proportion of bipolar II in some other studies was lower (or equal) of 
bipolar I because some hypomanic symptoms of the AD (i.e. racing or crowded 
thoughts, irritability, talkativeness, dramatic descriptions of suffering, mood lability, 
etc.) may have been underestimated in BD-II as less severe (Judd et al., 2012).  
Moreover, we investigated the possible correlations of AD in BD-I and II with 
demographic, lifetime and episode features. We don’t consider MDD in this analysis to 
avoid confusion in the results. Indeed, many researches, which are already focused on 
AD in MDD, highlighted the association between psychomotor agitation and risk for 
mood-switching, suggesting that AD patients are often reclassified in the bipolar 
spectrum (Akiskal et al., 2005; Ansgst et al 2009; Benazzi et al., 2004; Benazzi, 2006; 
Biondi et al, 2005; Cassano et al., 2012; Fiedorowicz et al., 2011; Iwanami et al., 2015; 
Oligiati et al., 2006; Swann, 2013).  
Some previous studies have suggested the relation between bipolar depression, panic 
comorbidity and more severity of the episode symptoms, in particular suicidal 
behaviour (Coryell, Endicott, Andreasen, Keller, & Clayton 1988; Dilsaver et al., 1997; 
Goodwin & Hoven, 2002; Kilbane, Gokbayrak, Galynker, Cohen, & Tross, 2009). In 
our finding the regression model in BD-I and II highlight the strong connection between 
AD episode and lifetime history of panic attacks. The combination agitated depression-
panic attack makes the illness more severe. Moreover, patients suffering from panic 
disorder are usually treated with antidepressants (Furukawa, Watanabe, & Churchill 
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2006; Tsuboi & Masuko, 2001), which could result in the worsened of agitated 
symptomatology and the disorder’s course (Koukopoulos, & Koukopoulos, 1999; 
Vázquez et al., 2013) and increase risk of suicide (Baldessarini et al., 2006a; 
Koukopulus & Koukopulus, 1999; 2007). Thus, the use of antidepressant in panic 
disorder should be closely monitored in order to individuate signs of excitatory 
phenomena and reconsider the treatment. On the other hand, patients with MDE, which 
have suffered from panic disorder, should be considered a high risk of agitated 
depression, and the risk/benefit of the administration of antidepressants carefully 
examined according to the psychiatric history of the individuals.  
Moreover in BD-I, the result of regression model underlines the relationship between 
AD and the higher rate of people with depression as polarity of the first affective 
episode (81% vs 66%). Previous studies correlated the depressive polarity of the first 
onset with a lifetime depressive illness (i.e. more depressive episode in life), an 
increased risk of suicide attempts (Forty et al., 2009; Perugi et al., 2000) and DMI 
course (depression-mania-interval) with more severe symptomatology resistant to mood 
stabilizing treatments (Koukopoulos et al., 2013; McIntyre et al., 2014). In keeping with 
these studies, our finding highlights that when the onset of the bipolar illness is a 
depressive episode the course is more severe with high risk of agitated depression, and 
suicidal behaviour. Indeed, the DMI course has been associate with more resistance to 
mood stabilizer treatments. 
Furthermore in BD-I, the regression model showed the link between agitated depression 
episode and lifetime dysphoric mania episodes. Dysphoric mania is an episode of mania 
in which the predominant mood is characterized by unease or mental discomfort 
(including low mood) that is consistent with mixed states definition of Kraepelin (1913, 
1920) as well as agitated depression (Faedda et al., 2015; Goodwin &, Jamison, 2007; 
Koukopoulos, & Sani, 2014). Indeed, AD it is characterized by depressive polarity but 
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also by excitatory phenomena, such as agitation, restlessness and repetitive activity 
(Kraepelin, 1913; McGuffin et al., 1991; Oligiati et al., 2006). According patients with 
dysphoric mania episodes will most likely have agitated episode of depression, 
therefore much more mixed states in a lifetime (Swann et al., 1993). Thus, although 
depressive mood in mixed state can led the clinicians to administered antidepressants, 
these drugs should be avoid and the treatment with mood stabilizers or antipsychotics 
appears the most appropriate both for the agitated episode and for the course of the 
illness.  
Previous studies underlined that patients with agitated depression were significantly 
more likely to have suicidal ideation and suicide attempts during the episode (Akiskal et 
al., 2005; Angst, Angst, & Stassen 1999; Balazs et al., 2006; Busch, Fawcett, & Jacobs 
2003; Maris, 1985; Rihmer, Gonda, Balazs, & Faludi, 2008). Our results provide a 
further strong evidence that both in BD-I and -II, the “suicidal ideation” is more 
frequent in the AD compared with NON-AD episodes (BD-I 87% vs. 69% and BD-II 
89% vs. 82%) in agreement with previous studies. Moreover, our results remark that 
patients, which experience agitated depression, have a higher risk of suicide attempts in 
lifetime (BD-I 59% vs. 44%, BD-II 56% vs. 47%). 
The regression models showed that agitated features are closely associated with 
symptoms of biological nature - somatic symptoms - such as insomnia, diminished 
libido, weight loss, poor appetite and slowed activity in Bipolar Disorder, emphasizing 
the somatic features of agitated depression. This finding suggest that agitated and 
somatic symptoms in depression could share similar biological mechanisms. Therefore, 
deepening the aetiology of all the peculiar features associated with agitated symptoms 
episode may be helpful in recognizing and treating AD. 
In addition, we found a higher proportion of alcohol misuse in agitated depression 
compared with non-AD. We suggest, in line with other studies (Himmelhoch, Mulla, 
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Neil, Detre, & Kupfer 1976; Sato et al., 2003), that patients with agitated features, 
having a more painful symptomatology, use alcohol to relieve symptoms (i.e. anguish, 
panic, insomnia, etc.) more often than non-AD patients. We also found a significant 
younger age at illness onset related to agitated features in BD-I (22 vs 24 years) in 
agreement with other studies (Koukopoulos, & Sani, 2014; Maj et al., 2003; Swann; 
2013). Moreover, the agitated group had a significant higher rate of rapid cycling course 
both in BD-I and in BD-II (37% vs. 28%, and 54% vs 44%); this last finding is in 
agreement with some studies (Koukopoulos, & Sani, 2014; Maj et al., 2003) that 
correlated agitated depression with more affective recurrences  and treatment resistant 
illness (Koukopulus et al., 2013).  
Finally, in lifetime, patients with AD had a significant higher use of pharmacological 
drugs, suggesting once again the resistance to conventional treatments. 
The potential limitation of this research is the difficulty in the conceptualization of the 
term “agitated depression”. In fact, it is known that in the literature and in the different 
versions of the DSM this term has been the subject of controversy (Akiskal & Benazzi, 
2004; Benazzi, 2004, Benazzi et al., 2004; Faedda et al., 2015; Koukopulus & Sani 
2014; Maj et al.,2003; Olgiati et al.,2006). There is not a univocal definition of AD, and 
therefore there is not a univocal assessment. For this reason, our study that uses the 
OPCRIT criteria (McGuffin et al., 1991; Oligiati et al., 2006) could not include patients 
with other manic symptoms (i.e. talkativeness, or racing crowed thought). Nevertheless, 
OPCRIT definition (McGuffin et al., 1991) is consistent with original Kraepelin 
definition of AD in which mood and ideation are in the negative polarity and activity in 
a positive polarity (Akiskal & Benazzi, 2004). Indeed, Kraepelin distinguished agitated 
depression by depression with the flight of ideas characterized by mood and activity in 
negative polarity and ideation in positive polarity. Instead, Koukopulus includes in the 
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definition of mixed states (also called “agitated depression”) both of the two forms of 
depression. This could explain the higher percentages of AD identified by Koukopulus 
in his studies (Koukopulus et al., 2007). Anyway, both agitated depression and 
depression with flight of ideas have common symptoms of manic polarity; for this 
reason, treatment should take into account the presence of excitatory symptoms as well 
as mixed states (Balazs et al., 2006; Baldessarini et al., 2006b; Baldessarini et al., 2013; 
Benazzi et al., 2004; Cuomo, Nikolova, Yalin, Arnone, Fagiolini, & Young 2017; 
Goldberg et al., 2007). 
Our findings have a meaningful clinical relevance for the diagnosis and treatment of 
AD, a very severe form of depression occurring in a high percentage of patients with 
mood disorders and in particular in Bipolar Disorder. Moreover, AD is correlated with 
other excitatory phenomena (dysphoric mania, mixed state and panic attack), DMI 
course and suicidality. The occurrence of suicidal ideation along with agitation is a 
serious risk, because it might increase the probability of suicide in depression (Ağargün, 
Kara, & Solmaz, 1997; Angst et al., 1999; Busch et al., 2003). In agreement with 
several other studies (Forty et al., 2008; Godwin & Jamison, 2007; Sachs et al., 2007), 
our finding suggest again caution in the pharmacological treatment of bipolar 
depression; the symptomatology of any MDE, should be carefully evaluated in order to 
individuate agitation symptoms and provide an appropriate treatment. According to 
many authors, the most appropriate treatment of agitated depression could be the 
administration of anti-manic/mood stabilizer or antipsychotic drugs and to avoid 
antidepressants (Baldessarini et al., 2006b; Goodwin & Jamison, 2007; Koukopulus et 
al., 2007; Maj et al., 2003). 
This research was intentionally entered at the end of the thesis project. It refers to the 
work done during the research period abroad; In particular, in collaboration with the 
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Bipolar Disorder Research Network (BDRN) of the University of Cardiff and 
Worcester, which allowed to work on a large clinical sample. The authors who 
contributed in a similar version of this work for the submission, are: Serra F 1, Knott S 2, 
Perry A 2, Forty L 3, Jones I 3, Craddock N 3, Gordon-Smith K 2, & Jones L 2. (1= 
University of Padova; 2= University of Worcester; 3= University of Cardiff). 
The methodological and clinical implication of this work are strictly related with the 
research done with University of Padua in these three years. Indeed, this last work 
emphasizes the need of appropriate tools for the correct diagnosis of each form of 
depression in order to avoid wrong treatment followed by dangerous consequences for 
the outcome of the illness and for the pain of the patients.  
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CHAPTER 8 
OVERALL DISCUSSION 
 
Mood disorders are among the most prevalent of all mental health diagnoses and their 
incidence has increased in last decades, becoming the most significant public health 
problem. Suicide is the most tragic consequence of mood disorders. It is associated with 
a mood disorder in 90% of cases and with a standard mortality ratio compared to the 
general population of 20:1. 
A missed diagnosis of the specific episode means that the patient does not receive 
specific treatment, with dangerous consequences. Despite different efforts, under-
diagnosis and under-treatment of mood disorders remain two serious problems 
worldwide. 
Psychologists as well as Psychiatrists should develop the competence to detect the 
entire spectrum of mood disorders and should have the availability of appropriate tools 
for a differential diagnosis of every single case. The result of a good assessment is the 
possibility of treating the individual in an effective way. 
The assessment is a wide spectrum evaluation the psychologists carry out in view of a 
proper treatment. Clinical interview, semi-structured interview and observation provide 
a large amount of information (i.e., exhaustivity), following an adaptive logic, and they 
take advantage from multiple channels (verbal, non-verbal). Despite the multiple pros of 
these tools, the problem of the inferences of the clinician can cause errors in later 
evaluation and diagnosis. Indeed, the clinician’s evaluation could be affected by 
underestimation or overestimation of patient’s symptoms. Regarding the psychometric 
approach, typically, the self-report questionnaires return a total score, which determines 
the impairment level of the individual. Psychometric testing allows the collection of a 
 156
lot of information in a short time; nevertheless, it is primarily data oriented, and the 
product is only a series of numeric scores that do not allow differentiating the 
symptomatology. 
The CBA 2.0 suggested a valid option for a comprehensive approach to the psycho-
diagnostic examination. Tests are used in a hierarchical way: in the initial stages, they 
explore several potentially problematic areas; then they investigate specific constructs. 
The CBA 2.0 provides a descriptive computerized report of the patient score which 
includes both the analysis of the validity and reliability of the test with high scores 
obtained in problematic areas and the positive replies to critical items. This attempt 
represented a great improvement in circumscribing problems to successive phases and 
proposing hypotheses concerning therapy. Despite this, it does not include the natural 
and logical flow of question-answer and it provides only quantitative information 
related to the unsatisfactory use of the resulting scores. Although there have been 
several attempts to apply adaptive clinical assessment, as far as we know, no system 
was able to combine adaptability, quantitative and qualitative information, and estimate 
error parameters through a probabilistic model. 
A new methodological approach, called Formal Psychological Assessment (FPA), was 
designed to cope these problems. 
The FPA was born in the University of Padova, and developed in an original way from 
the conjunction of two mathematical psychology theories: Knowledge Space Theory 
and Formal Concept Analysis.  
FPA application to mood disorders assessment has been the core of this work, as well as 
a further step to overcome some obstacles encountered in the differential diagnosis of 
depression. Indeed, FPA could represent an important approach for improving case 
conceptualization and treatment implementation. 
 157
FPA allows for developing an instrument with multiples benefits based on the formal 
representation of the relationship between the “items” of a questionnaire and a given set 
of “clinical criteria”. 
FPA is potentially capable of maximizing the advantages of both semi-structured 
interviews and self-report questionnaires managing the problems of traditional 
assessment. The first step of FPA is the deterministic model, which consists of the 
construction of the Boolean matrix assigning to each item of the self-report scale, the 
subset of symptoms it investigates. The second step concerns the construction of the 
clinical structure from the attributes (symptoms) assignment, where each node 
represents a clinical state and its set of attributes. The clinical structure is a deterministic 
representation of the prerequisite relation among the items of the domain. However, a 
completely deterministic approach is inadequate for assessment in clinical practice since 
not all clinical states have the same probability and possible patient’s answering errors 
may prevent a perfect correspondence between the observed response pattern and the 
actual clinical condition of the patient. Therefore, a probabilistic approach (i.e. the 
BLIM) was considered. It takes into account the probability of each clinical state and 
the probability of the false negative and the false positive rates for each item. The 
clinical structure, by means of the probabilistic weights obtained through the application 
of the BLIM, could be used to implement an adaptive algorithm. 
In the present work of thesis, Formal Psychological Assessment has been applied both 
for the description of the self-report instruments used in clinical practice and for the 
construction of a new effective tool for Major Depressive Episode Assessment. 
The first research, described in Chapter 4, aimed to define a practical application of 
FPA to illustrate procedural issues, discusses the advantages of the approach, and shows 
its potential for psychological assessment, relating to depression. Specifically, in this 
first part FPA was applied to analyse the “item content” of the most used self-report 
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questionnaires for the depression’s evaluation. Indeed FPA allowed creating relations 
between “item content” and “diagnostic criteria” to the assessment of Major Depressive 
Episode (MDE). In keeping with previous researches, the main task of the first study 
was to underline the strengths and the weaknesses of widely used depression tools, in 
relation of their ability to investigate all the symptoms of MDE. To achieve this aim we 
used the main concept of FPA described in the third Chapter. The clinical criteria used 
came from the DSM-5, the literature and the Beck and Seligman’s theories of 
depression. Through FPA, we highlighted each self-report questionnaire’s strengths and 
weaknesses in terms of correspondence to a set of diagnostic and clinical criteria. None 
of these tools was able to investigate alone the whole set of symptoms considered 
essential for the evaluation of MDE by the experts in the field of mood disorders. This 
methodology allowed to eliminate useless redundancy and to increase efficiency. The 
careful analysis of the items of the questionnaires has allowed creating the skeleton for 
the construction of a new instrument for the major depressive episode.  
Flexibility is another crucial advantage of FPA: the set of attributes (symptoms or 
clinical criteria) could be easily modified or updated according to new versions of DSM 
or to different theoretical approaches, while the methodology remains equally effective 
and reliable. 
The second research, presented in Chapter 5, aimed to construct a quantitative-
qualitative tool that investigates all Major Depressive Episode (MDE) clinical features 
and provides qualitative information (and not just a score) to differentiate patients with 
the same score but different symptoms as well as different severity of psychopathology. 
In this research, we applied the FPA framework and fruitfully used the main concepts 
described in the third Chapter. The main purpose of this study was to create an 
innovative tool that takes into account the strengths and weaknesses of the tools 
analysed in the previous research. The research explains the construction of 41 
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dichotomous items based on 23 clinical criteria of major depressive episodes from the 
DSM-5 and the literature. The Quantitative and Qualitative Evaluation of Depressive 
Symptomatology (QuEDS) was tested and validated in both clinical and non-clinical 
sample. The QuEDS takes into account all of the positive responses of the subject, 
which are closely linked to the symptoms through the FPA (MDE clinical criteria). In 
this way, clinicians will no longer be bound to the patient’s score but will be interested 
in the patient’s clinical state that is the set of items to which the patient responded 
positively, along with the set of symptoms investigated by those items. Such 
information is already present in the items, but it is hidden by a classical testing 
methodology that considers the questionnaire score to be the most relevant output used 
by the clinicians. The qualitative differences in symptoms between the two patients are 
highly relevant for a correct diagnosis and for future psychological and pharmacological 
treatment.  
It is noteworthy to observe that physicians sometimes prescribe antidepressants without 
carefully analysing the individual’s depressive symptoms, also when these drugs can be 
very dangerous and can increase the risk of suicide in patients with mixed depression. 
Therefore, the output of the proposed tool (QuEDS) is the patient’s clinical state; it is no 
longer the score. From a clinical point of view, a qualitative self-report tool overcomes 
the cut-off limit, which can be helpful just to have an idea about the test score, but it 
cannot be mistaken for a correct estimate of a person’s symptomatology. 
Thus, the QuEDS could be a useful contribution for many reasons: first, for the broad 
spectrum of clinical criteria investigated by the test. Second, for the importance given to 
qualitative information about the symptoms (through the patient’s clinical state) and not 
only to the score. Third, for the relevance given to the differences in symptoms and 
especially in their severity. Fourth for its appreciable validity and reliability results. 
Finally, for the application of an adaptive logic.  
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Indeed, the third research, presented in the Chapter 6, showed the implementation of the 
three algorithms on the three sub-dimensions of the QuEDS. We derived the clinical 
structures of the three sub-matrices related to the three sub-factors cognitive, somatic, 
and affective (Chapter 5, Table 5.6) of depression. The three models were tested on the 
data of all the participants who completed the written form of the QuEDS in order to 
estimate the parameters (the false negative and the false positive rates for each item) and 
the fit indexes. The following step involved the simulation and aimed to reproduce the 
writing version of QuEDS in an adaptive way. The ATS-PD algorithm took as input the 
clinical structure of each sub-scale of QuEDS (cognitive, somatic, affective) and the 
parameters estimates (β, µ), and reproduced the assessment, evaluating whether the 
adaptive form of QuEDS could generate the same response pattern of a subject who 
answered the written version (system efficacy), but with a smaller number of questions 
(system efficiency). The ATS-PD implementation showed that, through a computerized 
system of FPA, the tool allows to administer a smaller number of items to the individual 
without loss of measurement precision and according with his previous answer. In this 
way, a sequence of question is asked and at the end, one of the all clinical state of the 
structure should achieve a high probability value (with a fixed cut-off .70). This clinical 
state represents the most likely symptomatic representation of the patient’s situation 
regarding a specific sub-factor. At this point, the algorithm stops and provides the 
clinician with the score, the response pattern, and the attributes configuration (all the 
symptoms complained by patients). The adaptive version of QuEDS mimics the semi-
structured interviews process that allowed examining in depth only the individual’s 
symptomatic areas. 
The QuEDS allows for an adaptive, quantitative and qualitative evaluation of depressive 
symptomatology. Adaptive because, based on the structure and the algorithm, it selects 
each question to maximize the collectable information. Quantitative because it could 
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provide a numerical score with the level of impairment. Qualitative because it provides 
information about all the subjects’ symptoms allowing the differentiation among 
different types of Major Depressive Episode. 
In evaluating depression, an adaptive tool able to going beyond the numerical score is 
essential. In fact, clinicians have to face different depressive symptoms that often 
require a different diagnosis and appropriate specific treatment. The case of agitated 
depression, or mixed depression, represents perhaps the most important. In fact, agitated 
depression is classified as a mixed episode, with both depressive and manic symptoms, 
and for this reason it cannot be treated in the same way as the typical depressive 
episode. 
The fourth research, in the Chapter 7, underlined the clinical relevance of Agitated 
Depression (AD) in mood disorders. It appears to be a form of depression with very 
severe symptomatology (i.e. associated with more depressive episodic symptoms); in 
particular somatic symptoms (i.e. insomnia, poor appetite, etc.) and suicide ideation. 
Agitated patients have a significant higher use of psychotropic drugs in lifetime and 
higher rate of panic comorbidity and suicidality compared with depressive patients 
without agitation. In agreement with several other studies, our finding of this last 
research suggest again caution in the pharmacological treatment of bipolar depression. 
The recognition and the differential diagnosis of AD is crucial to avoid erroneous and 
dangerous pharmacological treatments. Indeed, antidepressant administration could 
worsen the excitatory symptoms resulting in the failure to relieve the patient’s pain and, 
as more serious consequence, they could increase the risk of suicide. According to many 
authors, the most appropriate treatment of agitated depression could be the 
administration of anti-manic/mood stabilizer or antipsychotic drugs. 
The methodological and clinical implication of this last work, carried out in England 
(with the University of Cardiff and Worcester), are strictly related with the research 
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done with University of Padua in these three years. Indeed, it emphasizes the need of 
the correct diagnosis of agitated depression in order to avoid wrong treatment followed 
by dangerous consequences for the outcome of the illness and for patients’ pain. To 
achieve this goal we need to develop new effective tools that are able to differentiate 
major depressive episode with mixed features from major depressive episode without 
mixed features. The QuEDS could represent a valid support in the assessment phase 
since the recognition of agitated depression is not initially easy; indeed, both the patient 
and the clinician often underestimate the excitatory symptoms (such as irritability, 
agitation, mood lability, anguish, racing thought) considering only depressive 
symptoms. Notwithstanding the various pros of the self-report tools, it is important to 
note that for a complete assessment the importance of the interviews cannot be ignored 
for the ability to investigate non-verbal behavior. 
Future implementations will be oriented to the improvement of the new created tool, 
considering all the possible symptoms of mixed depression and updating the adaptive 
form of the QuEDS. Indeed, the quality of clinical evaluation is crucial for both 
diagnosis and treatment and, as stated in this work, an erroneous psycho-diagnostic 
evaluation could result in misdiagnosis and therefore in therapeutic failures.  
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